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ABSTRACT
DEVELOPMENT OF SUPERCRITICAL FLUID PROCESSES FOR PARTICLE
COATING/ENCAPSULATION WITH POLYMERS
by
Yulu Wang

This work presents the investigation of particle coating using supercritical fluid processes
as novel coating approaches to coat particles from 20 nanometers to 500 microns with
different polymers. Particle coating using different supercritical technologies of a
modified rapid expansion of a supercritical solution (RESS) for particle coating and a
supercritical antisolvent (SAS) process was described.
In the modified RESS process for particle coating, experiments were performed
using a pilot-scale supercritical apparatus, glass beads as host particles and two different
polymers as coating materials. By adjusting temperature and pressure, the polymer
nucleated and precipitated onto the surface of the host particles in a precipitation chamber
due to the significantly lowered solubility of polymer in supercritical CO2. The glass
beads were found coated with poly vinyl chloride-co-vinyl acetate (PVCVA) and
hydroxypropyl cellulose (HPC) although the coating was not uniform and not
continuously distributed over the surface of the particles.
The main part of this work is the study of the SAS process for particle coating. The
supercritical fluid worked as an antisolvent in the SAS process instead of a solvent in the
RESS. The SAS process is based on the principle of SC CO2 induced phase separation in
which the solute precipitates due to a high super-saturation produced by the mutual
diffusion between organic solvent and SC CO 2 when an organic liquid solution comes

into contact with SC CO2. Systematic study of the effects of process conditions on the
coating of particles in the SAS process was performed. The polymer weight fraction and
polymer concentration played critical roles in the agglomeration of coated particles and
the thickness of coating. Higher pressure facilitated the T g depression, enhancing the
agglomeration of coated particles. Operating temperature had no visible effect on the
coating effect when the temperature was below T g . The coating quality also was
independent of spraying velocity. Surfactants had adverse effects on the coating quality.
The application of SAS particle coating process in the design of drug delivery
system was studied. A biopolymer of poly lactide-co-glycolide (PLGA 50/50) and
hydrocortisone were selected as the coating material and the model drug, respectively.
The hydrocortisone particles were successfully coated with PLGA. At higher polymer
loading ratios, the coated drug particles showed sustained release behavior. Higher
polymer loading ratio produced higher encapsulation efficiency.
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CHAPTER 1
BACKGROUND
1.1 Introduction
Particulate materials are critical to many industries, such as chemicals, pharmaceuticals,
agriculture and cosmetics, since over 60 % of their products are either in the form of
particles or related to particles, which act as important intermediates in the product cycle.
In 1993, the US Department of Commerce estimated that particle products contribute $1
trillion annually to the US economy. The surface properties of particulate materials are
very important because most of the properties of bulk materials, such as solubility,
stability, wettability, durability, dispersability, and flowability are dependent on surface
properties. Therefore, surface modification of particles to produce desirable properties is
of great interest and has become an important topic for research.
Coating or encapsulation of particles is most widely used for particle surface
modification. Coating or encapsulation is defined as the application of a layer of another
material on the surface of a particle, forming a barrier or film between the particle and its
environment. Coating of particles are required for a variety of reasons. Coating of drug
particles provides controlled release behavior, achieving targeted release and more
effective therapies, while eliminating the potential for both under and overdosing. For
example, Ike et al., 1992, showed that encapsulated cisplatin (an anti-cancer agent) in
poly lactide (D, L-PLA) provided controlled release in vivo for 21-42 days.
Film coating of particles made of sensitive materials provides protections from
degradation due to moisture, oxygen, light, or acids. For instance, the surface of titanium
dioxide particles is coated with alumina to protect photoactivation by sunlight. Silica
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coating on the surface of titanium dioxide for pigment application suppresses surface
reactions when particles are dispersed in resins and polymers (Iler, 1959, Allen, 1978,
Jacobson, 1980). Antistatic coating improves powder handling; poly vinyl alcohol
particles coated with an antistatic agent can make these powders safe from explosion in
pneumatic transport and bulk storage. The coating of titanium dioxide pigment with
naphthenic acid improves its flowability (Davis, et al., 1998). Surface modification of
drug loaded microspheres with polyethylene oxide (PEO) or poly vinyl alcohol (PVA)
was reported (Luck, et al., 1998) to improve the biocompatibility and bio-distribution of
the drug delivery carriers.

1.2 Particle Coating or Encapsulation Techniques
Particle coating or encapsulation is achieved by a number of wet or dry coating methods.
Traditional particle coating employs wet coating methods. Wet approaches include
emulsion evaporation, double emulsion evaporation, spray drying, fluidized bed coating,
sol-gel process, coacervation, melting solidification, interfacial polymerization, and
others.
1.2.1 Emulsion Evaporation
The emulsion evaporation technique is widely used in the fabrication of microsphere drug
delivery systems. Depending on the properties of the active drugs, a variety of emulsions
can be used. Oil-in-water (0/W) emulsion is suitable for the encapsulation of drug
compounds with very limited solubility in an aqueous system. In this emulsion method,
the active agent and a polymer are dissolved in an organic solvent. The resulting solution
is dispersed into an aqueous solution containing a surfactant. After complete evaporation
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of the organic solvent, the solidified drug loaded microspheres are filtered and vacuum
dried. For example, Yen, et al., 2001 reported the production of nalbuphine propionate
loaded microspheres for controlled release using this method. Ko, et al., 2002, applied
this approach to microencapsulate drug components for controlled drug delivery. For
water-soluble material, a non-aqueous emulsion is used for the encapsulation process.
The aqueous phase is replaced by a solvent, which is a non-solvent for the active
ingredient. With this method, Ogawa, et al., 1988, efficiently entrapped leuprolide acetate
into microcapsules of poly (lactic acid) or poly (lactic-co-glycolic acid).

1.2.2 Double Emulsion
A double emulsion method is a modification of emulsion evaporation employing a
multiple emulsion. It is quite popular in the design of microspheres for drug delivery
systems. In the double emulsion method, the active agent is first dissolved in an aqueous
solution and then added into an organic polymer solution to form a primary emulsion
under stirring. The resulting primary emulsion is added to the aqueous solution
containing a surfactant and subjected to mixing. The formed microspheres are collected
by filtration after evaporation of the organic solvent. For double emulsion systems, the
encapsulation rate of active compounds is a function of the surfactant concentration and
the ratio of the aqueous phase to the organic phase. Compared with emulsion
evaporation, double emulsion methods favor higher loading of active drug. Yamaguchi,
et al., 2002 and Blanco-Prieto, et al., 1997 used this approach to make protein and peptide
loaded microspheres for drug delivery. The encapsulation of plasmid DNA in
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microspheres for gene delivery system using the same technique was demonstrated in the
work of Wang, et al., 1999 and Capan, et al., 1999.

1.2.3 Spray Drying
Spray drying has been used for coating and encapsulation of particles for some time. In
the encapsulation of drug component, the active ingredient is dissolved or dispersed in an
organic or aqueous solution. The suspension or solution is atomized by spraying through
a nozzle into hot air (150-200 ° C), which is used to evaporate the solvent and produce
microspheres of the active drug compound and polymer. The spray drying approach is a
single step process, which is easy and cost-effective to operate. Numerous drug
compounds can be encapsulated by using this method. Fang-Jing and Chi-Hwa, 2002
used spray-drying technique to produce sustained release of etanidazole in microspheres.
Walter, et al., 1999 prepared a DNA vaccine delivery system by DNA encapsulation in
polymer microspheres using spray drying. Bergna, 1987 patented an approach using a
spray drying process to coat catalyst granular particles with a porous thin layer of silica.

1.2.4 Fluidized Bed Techniques
A fluidized bed equipped with a spray nozzle has been widely utilized in the coating of
particles. The Wurster Coater is a well known technique used by the pharmaceutical,
chemical, food, and agricultural industries. This method has the advantages of uniformity
coating, good controllability, versatility, and operability. It is a very efficient and costeffective coating method for the coating of granules, tablets, pellets, and large particles.
For example, Wan and Lai, 1992, using a fluidized bed, demonstrated multilayer coated
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particles for drug controlled release. Kage, et al., 1996, reported the coating of seed
particles in a fluidized bed. Sudsakorn and Turton, 2000 also showed particle coating
using a fluidized bed coater.

1.2.5 Coacervation
The coacervation process makes use of the partial precipitation of macromolecules and
their aggregation induced by a chemical or physical change in a dispersing medium. The
aggregation of polymer chains leads to a phase separation within an initially uniform
colloidal solution. This operation proceeds with the presence of a solid or liquid
dispersion, resulting in the formation of microspheres or microcapsules. Host particles
are dispersed in a solution of coating material at a high temperature and the temperature
of the dispersion is step-wise decreased, while the dispersion is stirred. Due to the cooling
effect, the polymer precipitates onto the surface of the host particles. The encapsulation
of a water-soluble drug of clomipramine HC1 in ethylcellulose was done by WielandBerghausen, et al., 2002, using the coacervation method. Ozyazici, et al., 1996 reported a
very similar coacervation technique to produce microcapsules of nicardipine
hydrochloride in ethyl cellulose.

1.2.6 Sot-Gel Process
The sol-gel approach is a well known method for the preparation of complex coating and
encapsulation of fine particles. The method was demonstrated by Ruys and Mai, 1999 to
coat nanoparticles. A core-shell structure was observed in the coated particles by TEM
characterization. Zhang and Gao, 2001 described a heterogeneous nucleation in a sol-gel
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process to coat SiC nanoparticles with Al(OH)3 for the fabrication of nanocomposite
powders. Chang, et al., 1994 also used the sol-gel method to produce monodisperse
colloidal silica-cadmium sulfide nanocomposites with tailored morphology.

1.2.7 Melting Solidification
Melting solidification is used to produce a matrix of microspheres to encapsulate an
active component. In the melting solidification process, the active component is dissolved
or dispersed in a molten substance. The mixture is then emulsified in a dispersing phase,
such as water, organic solvent, or vegetable oil. The dispersing phase is not a solvent for
the molten polymer and the active component. As the temperature is lowered, the liquid
droplets solidify, encapsulating the active compound. Benita, et al., 1986 studied this
approach for the encapsulation of chemoembolization in carnauba wax microspheres.

1.2.8 Interfacial Polymerization
Interfacial polymerization was initially developed by Pennwalt Corp. (Ivy and Pencap,
1972) to encapsulate pesticide. The interfacial polymerization approach involves
preparation of an organic or aqueous solution of the active component containing
monomer A. The solution is then dispersed and emulsified in a continuous phase
containing monomer B. The polycondensation at the interface between A and B results in
the formation of a film, which isolates the solution from the active component. The
resulting encapsulated particles are separated by filtration or centrifugation. This
approach has been applied to produce carbon free paper (Baxter, 1977) and to
encapsulate perfume (Curt, 1987).
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Suspension polymerization for microencapsulation is similar to the previously
described interfacial polymer approach except that only one monomer is used.
Polymerization in a suspension of the monomer is carried out around the active
component in the presence of an initiator. Most studies focus on the encapsulation of
inorganic particles. Luna-Xavier, 2002 did research on surface coating of silica particles
with PMMA using an emulsion interfacial polymerization approach. In their research,
silica particles were coated using a cationic initiator, 2,2'-azobis (isobutyramidine)
dihydrochloride (RIBA), and a nonionic polyoxyethylenic surfactant (NP30) in the
emulsion polymerization. The coated particles showed a core-shell structure. Shim, 2002
reported similar work of the surface modification of zinc oxide particles with
polymethylmethacrylate (PMMA) using suspension interfacial polymerization. The
encapsulation of active component in polymer nanoparticles for anticancer treatment was
illustrated by Chiannikulchi, 1989. A similar research was carried out (Fattal, 1989) for
ophthalmological use.
Although the above described wet coating methods are widely utilized for particle
coating or encapsulation in chemical, pharmaceutical, food, agrochemical, and advanced
materials industries, there are many drawbacks associated with them. Usually, a large
amount of organic solvent is required in the wet coating processes. In addition, some
other chemicals, such as surfactants, monomers, initiators, etc., are involved in the wet
approaches. These lead to volatile organic compounds (VOCs) emissions and other waste
streams. Furthermore, heavy down stream processes, for example, separating, drying,
milling, and sieving, etc., are also required to manufacture the final products.
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When coating or encapsulation using wet methods are applied for pharmaceutical
purposes, there are some other concerns regarding the safety and maintenance of
bioactive agents. During the emulsion preparation, the organic solvent, strong shearing
forces, temperature, pH, and the interface between the oil and water phases may affect
and/or alter the structure of the bioactive agents (Leong, et al., 1998, Jong, et al., 1997,
Yang, et al., 1999, Fu, et al., 1999). Moreover, residual organic solvent in the final
product might cause toxic effects for patients. Spray drying is appealing for coating of
pharmaceutical agents because it is a single step process and low cost operation.
However, it is not suitable for the coating of thermally labile drug entities due to the high
temperature employed in this process. A fluidized bed equipped with a spray nozzle is
well accepted for the coating of tablets, pellets, and granules. However, for particles less
than 30 microns (Group C), agglomeration of particles due to strong cohesive forces
becomes serious. Hence, it is difficult to fluidize fine particles of size less than 30
microns.

1.2.9 Dry Coating
As environmental regulatory statutes became more stringent, relatively new dry coating
approaches attracted a lot of attention. Since no solvent is required, not even water,
drying and separating processes are no longer problems and dry coating processes are
environmentally benign. Pfeffer, et al., 2001 comprehensively, described the subject of
dry particle coating. Dry particle coating involves the coating of submicron-sized guest
particles onto the surface of larger host particles by mechanical forces. The size of the
guest particles is so small (sub-micron) that van der Waals interactions between guest and
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host particles are strong enough to keep them firmly attached on the surface of the host
particles, resulting in surface coating. In this coating process, agglomerates of fine
particles must first be broken into primary fine particles so that these fine particles can
adhere onto the surface of the larger host particles. The exchange and redistribution of
fine particles among the host particles proceed until a random distribution is achieved.
Dry particle coating methods can be utilized to change the properties of the host
particles. For example, the absorption of moisture from the air by wax coated magnesium
powder using a dry coating method was significantly reduced (Pfeffer, et al., 2001).
Ishizaka, et al., 1988 reported that, when aspirin was coated onto potato starch by this
approach, the dissolution rate of the aspirin was accelerated. Since there is no drying step
required, energy consumption is substantially reduced. Also it is environmentally benign
as no organic or aqueous waste is produced.
There are some other dry coating methods to modify the surface properties of
particles such as: (a) physical vapor deposition (PVD) (Zhang, et al., 2000), (b) plasma
treatment (Shi, et al., 2001, Vollath, et al., 1999), (c) chemical vapor deposition (CVD)
(Takeo, et al., 1998), and (d) pyrolysis of polymeric or non-polymeric organic materials
deposition (Sglavo, et al., 1993). However, all of these require high energy input.
Although dry particle coating processes are attractive from the point of view of
environmental concern and require less downstream operating procedures, they are not
suitable for coating particles for pharmaceutical applications since it is difficult to control
the film structure on the surface of the host particles, such as the film thickness,
uniformity, texture and robustness of the coating. In addition, in dry coating processes,
the high shear and compressive forces employed and the local increase in temperature

10
would cause some bio-active particles, such as, proteins and peptides, to lose much of
their bio-activity.
Based on the discussion of the various available particle-coating methods
presented above, it is imperative to develop a new coating or encapsulation technique to
overcome the drawbacks of these methods. The new process should be environmentally
benign, with much less organic solvent required than in wet coating methods. It should be
capable of operating at ambient temperature without any heavy downstream processing
and be able to encapsulate fine particles less than 30 microns and down to nanosize.

1.3 Supercritical Fluid
1.3.1 Fundamentals
The phase of a substance depends on the temperature and pressure to which it is
subjected. Freezing and boiling are frequently observed phenomena during which a

Figure 1.1 Schematic phase diagram of carbon dioxide.
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phase change occurs as a function of temperature and pressure. A given substance, below
a certain temperature, can be brought into the liquid state if it is subjected to sufficient
pressure. However, about this temperature, it cannot be liquefied no matter what pressure
is applied. This temperature is called critical temperature (TO. At this temperature, the
pressure at which the liquid phase and gas phase of a substance are in equilibrium is
defined as the critical pressure (P a ). When a substance is subjected to conditions where
both the temperature and pressure are above the critical temperature and critical pressure
simultaneously, the substance is said to be in the supercritical fluid state

Table 1.1 Critical Temperatures and Critical Pressures of Various Substances
Substances

Tc ( ° C)

Pc (bars)

Inorganics
Helium

-269.9

1.1

Nitrogen

-147

34

Carbon Dioxide

32

74

Water

374

221

Nitrous

37

72

Ammonia

132

114

Ethane

32

49

Propane

97

43

Butane

152

38

Methanol

239

81

Ethanol

491

61

Ethyl Acetate

250

38

Acetone

215

74

Dimethyl ether

127

52

Diethyl ether

193

36

Perfluoorobutane

14

23

Organics
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as illustrated in Figure 1.1. Each substance has a unique critical temperature and critical
pressure (I', and P c ). For example, T c and P c of carbon dioxide are 32 ° C and 74 bars,
respectively and water's critical point is at 374 ° C and 221 bars. The critical points of a
variety of substances are listed in Table 1.1.

1.3.2 Properties of Supercritical Fluid
A supercritical fluid has a very high compressibility. The density and viscosity of a
substance in the supercritical state are between their values in the gas and liquid state. A
plot of the variation in density with pressure and temperature is schematically shown in
Figure 1.2. In the vicinity of the critical point, the fluid density changes dramatically with
an increase in pressure. As can be seen in Figure 1.2, below the critical pressure the fluid

Figure 1.2 Schematic diagram of the density of a fluid change with pressure (McHugh
and Krukonis, 1986).
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is in the gaseous state and has a low density. However, above the critical pressure the
fluid is in the supercritical region and has a relatively high liquid-like density. Although a
supercritical fluid possesses liquid-like density, it has high compressibility as illustrated
in Figure 1.3 in the range of 60-120 bars.

Figure 1.3 CO2 density as a function of pressure and temperature calculated using the
Peng-Robinson equation of state (Peng and Robinson, 1976).

The compressibility of a supercritical fluid can be used to manipulate the density
by adjusting pressure. The solvent strength is related to the density of a fluid; hence, the
solvent properties of a supercritical fluid can be adjusted by simply changing the
pressure. The solubility of acridine in supercritical CO 2 is illustrated in Figure 1.4. It is
found that the solubility initially decreases slightly and then increases sharply as the
pressure is raised above the critical pressure. At high pressure the solubility gradually
levels off. This corresponds with the density profile as a function of pressure.
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A supercritical fluid also possesses other attractive physicochemical properties,
such as high diffusivity and low viscosity. The diffusivity of a supercritical fluid is
greater than that of a liquid but lower than that of a gas. McHugh and Krukonis, 1986

Pressure (MPo)

Figure 1.4 Solubility of acridine in supercritical CO2 (Debenedetti and Kumar, 1986).

compared typical diffusivities of small organic solutes in supercritical CO2 over a wide
range of pressure and temperature with those of small organic solutes in liquids. As
shown in Figure 1.5, the diffusivity in CO2 at 40 ° C in the range between 70-200 bars was
found to be from 10 -3 to 10 -4 cm2 /sec. However, the diffusivity in a typical liquid is
around 10 -5 cm2 /sec. The viscosity of the supercritical fluid falls in between that of a gas
and a liquid. Figure 1.6 illustrates the viscosity of CO2 as a function of temperature and
pressure. Below the critical point, the viscosity of CO 2 behaves as a gas and is very low.
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Figure 1.5 Diffusivity of small organic solutes in CO2 (McHugh and Krukonis, 1986).

Figure 1.6 Viscosity of CO2 as a function of pressure and temperature (McHugh and
Krukonis, 1986).
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Above the critical point, the viscosity of supercritical CO2 increases as the pressure goes
up, but it is still lower than that of liquid even at high pressure. For example, at 300 bars
and 47 ° C the viscosity of supercritical CO2 is 0.09 centipoise, roughly one order of
magnitude lower than that of liquid (McHugh and Krukonis, 1986).
As discussed above, the liquid—like density, high compressibility, high diffusivity,
and low viscosity of supercritical fluids make them appealing solvents.

1.4 Supercritical CO 2 Properties and Applications
Many organic solvents are hazardous and harmful to the environment. Water is the most
desirable solvent, but it cannot dissolve less polar substances at ambient conditions.
Although supercritical water is a good solvent for organics, its high critical temperature
(374 ° C) and critical pressure (221 bars) make it less attractive due to safety and
operating cost issues.

1.4.1 Supercritical CO2 Properties
Supercritical CO2 is of interest as a solvent because it is inexpensive, essentially
nontoxic, nonflammable, recyclable, and environmentally acceptable. In addition, the
temperature and pressure critical conditions, T c = 32 ° C and P c = 74 bars, are easily
accessible. In addition, supercritical CO 2 has a relatively high solvent strength (dissolving
power). In some cases, it can be utilized as an environmentally benign solvent substitute
for hydrocarbons, chlorofluorocarbons, and other organics (McHugh and Krukonis,
1988). Nitrogen also has low critical parameters (T c = -147 ° C, P c = 33.9 bars); it is inert,
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nontoxic, nonflammable and inexpensive. However, its dissolving power is lower than
that of supercritical CO2 (Ghaderi, et al., 2000).

1.4.2 Applications of Supercritical CO2
1.4.2.1 Extraction and Separation. Because of its remarkable solvent strength,

supercritical CO2 is an attractive solvent for extraction and separation in the food and
pharmaceutical industries. By careful control of process conditions (temperature and
pressure) to adjust the solvent power, supercritical CO2 can be used to extract specific
compounds of interest from raw materials. For example, supercritical CO2 tea and coffee
decaffeination processes have been commercialized since the 1960s. General Foods runs
a coffee decaffeination plant in Houston, Texas and SKW/Trostberg has a tea
decaffeination facility in Meunschmeunster, Germany (Brennecke, 1996). Supercritical
CO2 is also used to extract hops, spices, and flavors; Germany, France, and UK have led
in this area. Pfizer built a hop extraction plant in Nebraska in the US in 1985 (McHugh
and Krukonis, 1994).
Supercritical CO2 has also been used to extract pharmaceutical components and
various health supplements. Jennings, et al., 1992 did the extraction of taxol, which is an
effective drug for the treatment of ovarian cancer, from the ground bark of Taxus
brevifolia using supercritical CO2. King and his co-workers at the US Department of

Agriculture in Peoria, Illinois, found that gamma-linolenic acid, which is used as a health
aid, could be extracted from evening primrose oil seeds (Jennings, et al., 1992). In
addition, a variety of flavors and fragrances can be extracted using supercritical CO2.
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Moyler, et al., 1993 showed that more than 80 varieties of roots, barks, leaves, flowers,
fruits and seeds have been successfully extracted with either supercritical or liquid CO2.

1.4.2.2 Environmental Applications. Supercritical CO2 has also been extensively used
for environmental applications. As an environmentally friendly solvent, supercritical CO2
has been used to replace many organic solvents for extraction and separation, as a
reaction medium, and for material processing. A new discovery showed that supercritical
CO2 could be utilized to extract hazardous compounds from soil and slurries (Agkerman
and Yeo, 1989, Andrews, et al., 1991). Another interesting application is the use of
supercritical CO2 to clean oils and greases from electronic materials and sophisticated
machineries. The high solubility of greases and oils in supercritical CO2 and the high
diffusivity and low surface tension of the supercritical CO2 allow complete cleaning
without any residue left on the parts (Jennings, et al., 1992). In addition, because of its
very low surface tension, supercritical CO2 can get into very fine pores of micro-chips for
rinsing without damaging them while normal liquids would destroy them due to their
high surface tension (Gallagher-Wetmore, et al., 1994).

1.4.2.3 Reaction medium. The high diffusivity and low viscosity of the supercritical CO2
make it an appealing solvent for chemical reactions due to enhanced mass transfer. In
addition, the physical properties, such as dielectric constant, density, solubility parameter,
are highly sensitive to pressure, especially in the near-critical region. Therefore, it is
possible to optimize the chemical reaction rate, conversion, and selectivity by
conveniently changing pressure. Free radical polymerization in supercritical CO2 had
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been extensively studied by DeSimone, et al., 1992. Fluoropolymers are traditionally
synthesized in chlorofluorocarbon (CFC) solvents; however, DeSimone successfully
carried out free radical polymerization of highly fluorinated acrylic monomers in
supercritical CO2. A review article by Kendall, et al., 1999 introduces a more
comprehensive description of polymerization reactions in supercritical CO2, including
chain growth polymerization, precipitation polymerization, ring-opening polymerization,
step-growth polymerization, dispersion and emulsion, etc. Jessop, et al., 1999
summarized the homogeneous catalytic reactions carried out in supercritical CO2 in a
review article. This article describes in great detail the hydrogenation, isomerization,
hydrosilylation of CO2, olefin metathesis, cyclization and other C-C bond forming
reactions, and phase-transfer catalysis, etc.

1.4.2.4 Material processing. Recent discoveries show that supercritical CO2 is a good
processing medium either acting as solvent or as an anti-solvent in material processing.
When supercritical CO2 is used as solvent to dissolve a substance of interest and then the
resulting supercritical solution is depressurized to low pressure or ambient condition, this
process is called rapid expansion of supercritical solution (RESS). If supercritical CO2 is
used as an anti-solvent to precipitate the substance of interest, the process is known as the
supercritical anti-solvent (SAS) process. The RESS process is suitable for substances that
have reasonably good solubility in supercritical CO2, while supercritical CO2 insoluble
substances can be processed using SAS. Both RESS and SAS can be utilized for particle
generation and particle coating. A more detailed overview of supercritical CO2 for
particle generation and coating will be discussed in the next chapter.
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1.5 Objectives, Outline, and Environmental Significance of This Thesis
1.5.1 Objectives
As described above, traditional wet coating methods are associated with many
drawbacks, such as VOC emissions and other waste streams, the need for drying and
other extensive down-stream processes, residual organic solvents in the final products,
and possible drug component damage. Dry coating approaches do not provide a
satisfactory coating structure and could have destructive effects on active agents. Thus it
is necessary to develop an environmentally friendly coating method, which can provide
good coating quality without harsh conditions involved. The new coating process should
be able to be operated simply with no further downstream processing required.
Supercritical CO 2 has a wide variety of applications in extraction and separation,
as a reaction medium, and material processing due to its attractive properties as a solvent.
Thus it is interesting to investigate the use of supercritical CO 2 as a solvent for particle
coating or encapsulation. Therefore the objectives of this research are two-fold. The first
is to develop a supercritical coating process for fine particle coating or encapsulation. The
second is to apply this coating technique to the area of drug delivery system design.

1.5.2 Environmental Significance of Supercritical Coating Processes
As discussed before, conventional wet coating processes require large amounts of organic
solvents, surfactants and additives. Thus, wet-coating processes can lead to substantial
VOC emissions and other waste streams. They are also associated with high-energy
consumption because further down-stream processing, including milling and sieving,
would be usually required. Therefore wet coating processes are environmentally

21
unfriendly. However SC CO2 is nontoxic, nonflammable, easily recyclable, and
environmental friendly. It has proven to be an ideal processing medium for many
processes, such as reaction (DeSimone, et al., 1992, Jessop, et al., 1999), extraction and
separation (Agkerman and Yeo, 1989, Andrews, et al., 1991), solvent free dyeing
(Kazarian, et al., 1999), and cleaning (Jennings, et al., 1992, Gallagher-Wetmore, et al.,
1994). For example, the UNICARB spray-coating process utilizing CO2 as suspension
medium for automobiles, furniture, and other products can reduce VOC emissions as
much as 70 % (Brennecke, 1996). Shim, et al., 1999 even reported a rapid expansion of
supercritical suspensions (RESS) in SC CO2 for spray coating without using any organic
solvent.
The proposed extraction and precipitation particle coating (modified RESS)
process (Chapter 3) using SC CO2 as a solvent for the coating material can eliminate the
need for organic solvents. Although a co-solvent is sometimes used to improve the
solubility of coating material in a SC CO2 (RESS process), the amount of solvent used is
usually very low, 1.0 wt. % (Tom and Debenedetti, 1991) and 1.4 mole % (Chang and
Randolph, 1989). Therefore, the amount of organic solvent used is significantly reduced,
more than 90%.
The proposed SAS coating process (Chapter 4, 5 and 6) involves dissolving of
coating material in an organic solvent and extraction of the organic solvent by SC CO2. It
is difficult to make an exact comparision of the organic solvent usage in a SAS type
process with wet coating processes since the amount of organic solvent required is
dependent on a number of factors, such as the specific coating process, coating materials,
and thickness of coating desired, etc. However, based on the SAS coating experiments
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and literature describing wet coating or encapsulation processes, a simple comparison
could be made. In the proposed SAS coating process, when particles are coated with
polymer at a polymer concentration of 0.4 % (wt/v), 50 ml acetone is required to produce
1.0 gram of silica particles coated at a polymer weight fraction of 18.2 %. When the
double emulsion approach is used to encapsulate plasmid DNA (Wang, et al., 1999;
Capan, et al., 1999) with PLGA, 1800 ml and 2500 ml organic solvent are required to
produce 1.0 gram DNA encapsulated with PLGA at a drug loading of 0.66 % and 0.2 %,
respectively. In the spray drying process, 3330 ml organic solvent is required to
encapsulate 1.0 gram etanidazole at a loading rate of 1.0 % (Wang and Wang, 2002).
From this simple calculation, it is clear that the SAS coating process requires much less
(above 97 %) organic solvent than the double emulsion and the spray drying approaches
do. In addition, the production of free flowing coated particles in the one-step SAS
coating process does not require any further down-stream treatment where VOCs will
also be generated. Therefore, the SAS coating process is an environmentally friendly
coating process.

1.5.3 Outline of This Thesis
Following this Introduction, Chapter 2 presents a literature survey of supercritical
processes for particle engineering. First, a brief description of supercritical processes for
particle formation and a review of previous work in this area are presented. Next, a
detailed summary of supercritical coating work is given. In this part a variety of coating
techniques using supercritical CO 2 , either as a solvent or an anti-solvent, are reviewed.
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Chapter 3 describes a new modified RESS process for particle coating using a
solution of polymer in supercritical CO2. This technique involves extracting the polymer
with supercritical CO2, with or without a co-solvent in an extraction vessel, and then
precipitating the polymer onto the surface of host particles in a second precipitation
vessel by adjusting the pressure and temperature inside the precipitator to lower its
solubility. The study is performed using a pilot-scale supercritical apparatus, glass beads
as host particles and two different polymers as coating materials. Results show that the
coating of glass beads with poly vinyl chloride-co-vinyl acetate (PVCVA) and
hydroxypropyl cellulose (HPC) was successfully achieved.
Chapter 4 presents a new method using supercritical CO2 as an anti-solvent (SAS)
for nanoparticle coating/encapsulation. A model system, using silica nanoparticles as host
particles and Eudragit polymer as the coating material, is chosen for this purpose. The
SAS process causes a heterogeneous polymer nucleation with the nanoparticles acting as
nuclei and a subsequent growth of polymer on the surface of the nanoparticles induced by
mass transfer and phase transition. A polymer matrix structure of encapsulated
nanoparticles is formed by agglomeration of the coated nanoparticles.
Chapter 5 focuses on the coating and encapsulation of synthesized sub-micron
silica particles with poly lactide-co-glycolide (PLGA). A systematic study of operating
parameters that have an effect on the coating process, such as polymer to particle weight
ratio, polymer concentration, temperature, pressure, flow rate of polymer solution, and
the addition a SC CO2 soluble surfactant are performed. It is found that the polymer
weight fraction and the polymer concentration are critical for the successful
encapsulation of silica particles with minimum agglomeration.
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Chapter 6 describes an application of the supercritical antisolvent coating process
to a drug delivery system design. In this work a biopolymer of poly lactide-co-glycolide
(PLGA 50/50) is chosen as the coating material and hydrocortisone is used as the model
drug. Results of HPLC assay analysis reveal that the hydrocortisone particles are
successfully coated with PLGA. The coated drug particles show sustained release
behavior at high polymer loading ratios of 33 % and 50 %. This research demonstrates
that the SAS coating process is a very promising technique for drug coating or
encapsualtion for the design of solid and inhalation drug delivery systems.
Chapter 7 presents recommendations based on this research and suggestions for
future work.

CHAPTER 2
SUMMARY OF PREVIOUS WORK
Because of its remarkable solvent power and its easy adjustability by simply tuning
operating conditions (temperature and pressure), supercritical CO2 has received a lot of
attention for both particle synthesis and particle coating in both the academic and
industrial arena. Since the 1980's, extensive research efforts have been made in particle
engineering using supercritical processes. In this chapter, a brief description and review
of particle formation using different supercritical processes is presented first. Then the
previous work in particle coating or encapsulation using supercritical CO2 is described
and reviewed.

2.1 Particle Formation Using Supercritical Processes
Particle size and particle size uniformity (distribution) of pharmaceutical compounds are
important in pharmaceutical formulation development. Smaller particles provide higher
surface area; thus, the dissolution rate and bioavailability, which depend on surface area,
can be improved. In aerosol drug delivery applications, small particles (less than 5 μm)
with a narrow size distribution are required to achieve effective delivery of drug to the
lungs with a dry powder inhaler (DPI), a metered dose inhaler (MDI) or a nebulizer.
Conventional approaches for particle size reduction, including milling, grinding,
crystallization, freeze-drying and spray drying, have some disadvantages for these
applications. It is difficult to produce very small particles (less than 5 1.1.m) with a narrow
size distribution by grinding or milling. Spray drying is good for controlling particle size;
however, the high temperature required in the spray drying process may detrimentally
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affect the bioactivity of pharmaceutical active ingredients. Freeze drying produces
particles with a wide size distribution, requiring further processing. Crystallization uses
large amount of liquid solvents and separation of particles from the liquid involves
filtration, centrifugation, and extensive drying to remove the solvent.
It is attractive to use SC CO 2 as a processing medium since CO2 has a low critical
temperature; this allows for particle processing at ambient temperatures. SC CO2 behaves
as a low-density gas after decompression making separation of the final product very
easy. Furthermore, using SC CO2 either as a solvent (RESS) or as an antisolvent
(GAS/SAS) can be utilized to produce very small particles with a narrow size
distribution.

2.1.1 Rapid Expansion of Supercritical Solutions (RESS)
Particle formation using the RESS process takes advantage of the fact that the solvent
strength of supercritical CO 2 is a function of processing parameters, such as pressure,
temperature and nozzle geometries. In a RESS process, typically, a solute is dissolved in
supercritical CO 2 and the resulting supercritical solution is depressurized through a
nozzle. A very high degree of supersaturation is obtained in a very short period of time
since the expansion occurs very rapidly. This leads to nucleation of the solute and small
particles with narrow size distribution are formed.
To better understand this process, a schematic diagram of the RESS process is
presented below. For particle generation, the quality of the final products, such as size,
size distribution, crystalline structure and morphology, depends not only on the solubility
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of the solute in supercritical CO2, but also on the operating parameters. Since the solvent
power of the supercritical CO2 is a function of density, the operating pressure and

Figure 2.1 Schematic diagram of RESS process.

temperature need to be tuned carefully to dissolve the solute. For those substances that
have very limited solubility in supercritical CO2, a small amount of organic solvent can
be used as a co-solvent to improve the solubility, sometimes significantly. Nozzle
geometry, such as the inside diameter and ratio of length to the inside diameter, also
plays a critical role in the RESS process for particle formation.
Hannay and Hogarth, 1879 first reported the formation of solids as a result of the
expansion of a supercritical solution. They observed the precipitation of solids as "snow"
or "frost" in a gas by a quick decompression. This was considered the first RESS
experiment ever performed.
About 100 years later, Krukonis, 1984 first initiated a comprehensive study of
RESS to produce a variety of powders, which included pharmaceutical compounds,
polymers, dyes, organic catalysts, biological compounds, and surfactants. The work he
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did led to an active research field focused on exploring further applications of RESS for
particle engineering and obtaining a theoretical understanding of this process as well.
Since then, numerous studies have been performed using the RESS process for particle
generation. Matson et al., 1987 studied the precipitation of silicon dioxide (Si02) and
germanium dioxide (GeO2) from supercritical water. In his work a stainless steel
capillary tube with a dimension of 5 mm in length and 60 m I.D. was used as a spray
nozzle. At the conditions of 300 ° C (autoclave temperature), 590 bars (system pressure)
and 470 ° C (pre-expansion temperature), 0.1-0.5 m spheres of Si02 were produced by
the RESS process. Similarly, GeO2 spheres (0.5-1.3 m) were generated. He and his coworkers also studied the precipitation of polymers using RESS. However, polymer fibers
with a dimension of about 1 p.m in diameter and 100-1000 m in length were generated.
In his study solute concentration among other variables was found to have the greatest
effect on the particle size.
Lele and Shine, 1994 carried out a study of the effect of RESS dynamics on
polymer morphology. In their RESS process for polymer precipitation four parameters,
pressure, dissolution temperature, pre-expansion, and inside diameter of the capillary
nozzle, were studied. They found that the time scale for phase separation during RESS
governed the morphology of the precipitated polymers. When precipitation took place
over microseconds inside the nozzle, 0.2-0.6 m polymer particles were produced. When
the precipitation occurred over tens of seconds, the polymer had a chance to grow as 1-13
m particles and fibers. These findings can be utilized to adjust the dynamics of RESS to
control the shape and morphology of polymer precipitants.
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A carefully designed study of operating parameters in RESS was performed by
Mawson, et al., 1995 to understand the mechanism of the RESS process. In their study,
experimental variables and procedures were carefully designed. The concentration of
polymer solution was held constant at 0.5 and 2.0 %. The pre-expansion temperature was
varied above and below the cloud point, and the ratio of the length to diameter (L/D) of
the spraying nozzle from 8.5 to 508. The results supported the mechanism proposed by
Lele and Shine, 1994. The earlier the phase separation in the nozzle, the greater the time
for coalescence and fiber formation of the polymer. The L/D was found to be the most
influential factor in determining the shape of the final product of the polymer
precipitants, fibers or particles. The polymer solution concentration and pre-expansion
temperature also had an important effect on the sizes of the particles and fibers produced.
Mohamed, et al., 1989 did a systematic study of the effect of operating conditions
on the final solid products. In this study naphthalene was used as the model solute. Preexpansion and post-expansion temperature, pressure and composition were systematically
investigated. It was found that the pre-expansion temperature had a remarkable effect on
the particle size. A higher pre-expansion temperature favored larger particles. An
increase in solution concentration resulted in a decrease in the particle size. This was in
good agreement with classic nucleation theory; higher solution concentration resulted in
higher nucleation rate, leading to higher degree of supersaturation. Consequently, smaller
particles were produced. The effect of pressure was also examined in this study and the
particle size was found to be insensitive to the change of post-expansion pressure.
Domingo, et al., 1996 studied ultra-fine particle formation using the RESS
process. In their work, benzoic acid was dissolved in SC CO2 and was sprayed through a
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porous sintered plate nozzle (pore size 0.5-5 m) instead of through an orifice or a
capillary tube. The results showed that the spray nozzle determined the particle size and
crystal formation. With a porous sintered metal plate as the spray nozzle, less than 1 m
particles were produced. However, at the same operating conditions, 2-6 m particles
were generated when a capillary tube (62 m) was used as the spray nozzle. They
determined that the time scale for a solution to reach supersaturation was one of the most
important factors in determining the crystal size.
Charoenchaitrakool, et al., 2000 investigated the RESS process for the
micronization of a pharmaceutical compound to increase its dissolution rate. In their
work ibuprofen was used as a model drug and its solubility was determined at different
temperatures. The particle size of the ibuprofen product was studied as a function of
spraying distance, pre-expansion pressure, and nozzle length. Results showed that less
than 2.5 pm ibuprofen particles were generated in the RESS process. They found that the
particle size and morphology were independent of pre-expansion pressure and nozzle
length within the range of their study. An increase in spraying distance generated slightly
smaller particles with less aggregation. The dissolution rate of micronized ibuprofen in
RESS was 5 times greater than that of the original ibuprofen because the particle size and
crystallinity of micronized ibuprofen were reduced compared with the original material.
The major drawback of the RESS process is the fact that the solubility of most
substances in SC CO2 is very low. To overcome this problem a co-solvent, such as
acetone, methanol or ethanol can be used to assist the dissolution of the substance of
interest in SC CO2. Chang and Randolph, 1989 showed that the addition of toluene up to
1.4 % mole fraction as a co-solvent in supercritical ethylene enhanced β-carotene
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solubility. Submicron β-carotene particles (0.5 m) were produced in this study.
However, an increase in toluene concentration resulted in a two-phase expansion, which
produced larger particles with a wide particle size distribution. This was attributed to the
re-crystallization of β-carotene from liquid toluene after expansion. Therefore, it is
important to limit the mole fraction of co-solvent in the RESS process so as to maintain a
single phase after depressurization.
Although most of the RESS work has been experimental studies focusing on
applications to various materials and the influence of process conditions on the final
products, some fundamental theory and simulation of RESS has also been proposed to
better understand the process. Kwauk and Debenedetti, 1993 proposed a simulation
model of the RESS process based on compressible fluid dynamics, thermodynamics,
nucleation kinetics and an equation describing crystal growth. This model calculated the
solute nucleation and particle growth for a partial expansion of a dilute supercritical
solution in a subsonic converging nozzle in a steady, one-dimensional, and inviscid flow.
According to the model, the particle size was found to be related to changes in both the
extraction and pre-expansion temperatures. An increase in pre-expansion temperature
favored larger particles. However, particle size decreased with an increase in extraction
temperature or in pressure. Other effects of process variables, for example, nozzle length
and flow rate on particle size and particle size distribution were tested as well. The model
was helpful in understanding the relationship between the particle size and the process
condition in RESS, in interpreting experimental results, and in providing guidelines for
equipment design.
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A recent modeling work of the RESS process was done by Tűrk, 2000. In this
model, the calculation was based on a steady-state one-dimensional flow model, which
includes heat exchange in the capillary and the free jet, friction in the capillary and
isentropic flow in the capillary inlet area. The resulting pressure and temperature along
the expansion path were used for the calculations of solubility and supersaturation. In the
calculation of the nucleation rate, an equation based on classical nucleation theory was
used with arguments extended to fluid-phase non-ideality. The calculation results showed
that at the beginning of the free jet, supersaturation went up steeply and reached a
maximum of 10 8 . The maximum nucleation rate was about 10 26 for an interfacial tension
of 0.02 Nm-1 . In the calculation, it was found that the nucleation rate was dependent on
the solubility and the surface tension. In addition, classical nucleation theory was found
to be unsuitable to describe the correlation between particle size and RESS process
conditions.
Helfgen, et al., 2001 recently simulated particle formation in RESS. They set up a
model to calculate the flow field based on mass, momentum and energy balances and the
extended generalized Bender equation of state (Platzer & Maurer, 1989). The particulate
phase was calculated using the general dynamic equation, providing that the particle size
distribution was lognormal, the method of moments coupled with the transport equations
and a population balance. The mechanisms for particle formation and growth were
nucleation, condensation and coagulation. According to their calculations, the conditions
inside the expansion chamber were most likely the key factor, which influenced particle
characteristics, since particle growth by coagulation continued in the expansion chamber.
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Although RESS is attractive for its simplicity and easy implementation, the very
limited solubility of most compounds of interest severely limits the application of RESS.
Furthermore, proper nozzle design, scale-up, and controllability in a RESS operation pose
large challenges in applying this process.

2.1.2 Supercritical Antisolvent and Gas Antisolvent Processes (SAS and GAS)
When the substance of interest does not dissolve in SC CO2, an antisolvent process is
usually considered. Antisolvent approaches are operated on the basis that two solvents
have good miscibility. The substance of interest is soluble in the first solvent, but not
soluble in the second solvent. By adding the antisolvent into the solution the two solvents
are dissolved in each other while the solution becomes supersaturated. The
supersaturation achieved is the driving force for the solute to nucleate and precipitate out.
Thermodynamics should be considered first when one decides to utilize the
antisolvent process for particle generation. The choice of solvent is critical in a
successful antisolvent process. The solvent should not only dissolve the solute up to a
reasonable concentration, but also should have very good miscibility with the antisolvent.
Usually, the volume expansion of the solvent is used to determine the miscibility of the
solvent and antisolvent. The expansion rate (AV%) is defined as:

where V(P, T) is the volume of solvent expanded by CO2 and V0 is the volume of pure
solvent before the antisolvent addition.
The Peng-Robinson equation of state (PR-EoS) (Peng and Robinson, 1976) can be
used to predict the expansion behavior of a binary system, e.g., of CO2-acetone. The PREoS is expressed as:
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where a and b are parameters of the mixture of the binary system. Originally, the PR-EoS
had only one interaction coefficient, kij However, as suggested by Kordikowski, et al.,
1995, it is necessary to have a second interaction parameter to account for a polar
compound in the binary system. In the acetone-CO2 system, klt is —0.007 and is —0.002,
which were regressed from the experimental data reported by Katayama, 1975. The
mixing rules are given as:

where the pure component values can be determined as:

and P c; , T cl , and co; are the critical pressure, critical temperature, and accentric factor of
component i, respectively.
The calculated volume expansion rate as a function of pressure at different
temperatures is shown in Figure 2.2. The volume of acetone increases slowly with system
pressure from 0 to 60 bars at 32.5 ° C. When the system pressure is above 60 bars, the
acetone is fully expanded. The expansion behavior of acetone results in a decrease in the
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partial molar volume of the solvent so that the solvent strength is reduced considerably.
Consequently, the solution reaches supersaturation and the solute nucleates and
precipitates out.

Figure 2.2 Liquid solvent expansion by CO2.

2.1.2.1 Compressed Gas Antisolvent Process (GAS). Compressed CO2 can be
dissolved in most organic solvents, and hence it can be used as an antisolvent for particle
generation. When compressed CO 2 acts as an antisolvent the process is called GAS. In a
typical GAS process, compressed CO2 is bubbled through a liquid solution. Due to the
dissolution of compressed CO2, the solvent is expanded and its solvent strength is
lowered. Consequently, the solution becomes supersaturated and the solute nucleates and
precipitates in the form of microparticles. The processing parameters, such as
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temperature, pressure, agitation, nozzle geometry, solution concentration and flow-rate of
CO2 have direct effects on the particle size, size distribution, crystalline structure and
morphology of the resulting particles. Figure 2.3 schematically shows the GAS process.

Figure 2.3 Schematic diagram of GAS process.

Krukonis, 1988, first proposed the GAS process for fine particle production, such
as highly energetic materials (explosives) and other substances that are difficult to
pulverize. Gallagher, et al., 1992 used this approach to recrystallize nitroguanidine from
N-methylpyrrolidone and N, N-dimethylformamide. It was found that adjusting the
addition rate of gas anti-solvent could control the particle size, morphology, and size
distribution.
Berends, et al., 1996 performed a study of crystallization of phenanthrene from
toluene using the GAS process. The size of the produced particles ranged from 160 to
450 μm depending on the stirrer speed and growth time. The residual toluene in the final
product was about 70 ppm, significantly lower than that of normally prepared
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phenanthrene. They also found that stirrer speed determined the degree of attrition and
mass transfer of the gas anti-solvent into the liquid solution. A theoretical model was
proposed in this study to predict the liquid expansion by GAS and the solubility of solute
in expanded solvent very well.
Yeo, et al., 2000 reported the formation of crystals of barium chloride (BaCl2) and
ammonium chloride (NH4Cl) produced from solutions of dimethyl sulfoxide (DMSO) in
a GAS process. CO2 was introduced into the solutions at different flow-rates and the
crystals were produced with various particle sizes, crystal habits and crystalline
structures. As the CO2 delivery rate was increased the average size of the crystals
produced decreased for both compounds. When the CO 2 delivery rate was increased, the
crystal habits of BaCl2 and NH4Cl were found to change from an equant to an acicular
habit and from an equant to a tabular habit, respectively. In addition, the BaCl2 crystal
structure was changed from orthorhombic to hexagonal based on XRD patterns. These
findings showed that the GAS process could be used for crystal modification or
polymorph screening.
Cocero and Ferrero, 2002 carried out a systematic study of the effects of operating
parameters on the particle size and size distribution. In this GAS work, β-carotene was
recrystallized from ethyl acetate and dichloromethane solutions. It was found that higher
agitation and a higher CO2 addition rate favored smaller particles with narrower size
distribution. This was consistent with the conclusions of Berends, et al., 1996. The initial
solution concentration and operating temperature also affected the particle size of the
final product. A dilute initial solution at low operating temperature (25 ° C) produced less
than 1 m size particles with a very narrow size distribution. However, a high initial
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concentration at high temperature (40-60 ° C) resulted in a high yield of the final product
with a particle size of 5 m.
In a recent study of gas antisolvent recrystallization of an organic compound,
Muhrer, et al., 2003, discussed the influence of the initial solution concentration and
antisolvent addition rate on the final product quality in terms of particle size and size
distribution. As reported before (Berends, et al., 1996, Cocero and Ferrero, 2002), the
average size of produced particles varied from 0.36 to 8.1 m as the antisolvent addition
rate changed. However, it was interesting to find that the particle size distribution was
unimodal and narrow for low and high addition rates, while it was bimodal for an
intermediate addition rate. The particle size and size distribution were insensitive to the
initial solution concentrations. This finding did not agree with the results of Cocero and
Ferrero, 2002. Scale-up of the GAS process from a 300 ml to a 1000 ml precipitator was
demonstrated and the particles produced from the two different sized precipitators were
very close. This finding showed that the GAS process was very promising for industrial
applications.
Muhrer, et al., 2002 developed a mathematical model describing the GAS
recrystallization process. In this work, phenantrene and toluene were used as a model
system to study the GAS process. It was shown that the particle size was strongly
dependent on the addition rate of the antisolvent. This work clarified the importance of
secondary nucleation with respect to primary nucleation and was very significant for the
development and optimization of the GAS process.
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2.1.2.2 Supercritical Antisolvent Process (SAS). The second technique, in which
supercritical CO2 acts as an antisolvent to induce the nucleation and precipitation of a
solute, is known as the SAS process. Variations of this process, include precipitation
from compressed antisolvent (PCA) solution, enhanced dispersion by supercritical fluids
(SEDS), and aerosol solvent extraction systems (ASES). In the SAS process, a liquid
solution is delivered by an HPLC pump and is sprayed through a nozzle into a highpressure chamber, which is filled with supercritical CO2. Once the solution comes out of
the nozzle and contacts the supercritical CO2, a very fast mutual diffusion between the
bulk supercritical CO2 and the solution takes place. Therefore, the solution reaches a very
high degree of supersaturation practically instantaneously, resulting in the nucleation and
precipitation of the solute. A schematic diagram of SAS process is shown in Figure 2.4.

Figure 2.4 Schematic diagram of SAS process.
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The operating parameters, such as temperature, pressure, solution concentration,
CO2 flow rate, solution flow rate and nozzle design are important in controlling the
particle size, distribution, morphology, and crystalline structure. In particle formation,
particle size and particle size distribution are the most important parameters to be
controlled. The SAS process is very complicated since thermodynamics, mass transfer,
kinetics and hydrodynamics are coupled and are all important. However, understanding
the mechanism of particle formation in the SAS process is very useful in controlling the
final product.
Hydrodynamic theory has been applied to the SAS process in an attempt to relate
particle size to antisolvent density (Dixon, et al., 1993). The Weber number (Nw e) is
defined as the ratio of the deforming external pressure forces and the reforming surface
tension forces experienced by a liquid droplet encountering flowing air (Lefebvre, 1989).
It is expressed by:

where PA is the density of the antisolvent, VR is the relative velocity, D is the droplet
diameter and a is the surface tension. In the SAS process, the spray of solution through
the nozzle into the supercritical CO2 phase produced fine droplets due to the jet break-up
effect. The initial droplet size determined the particle size of final product. According to
theory, the higher the antisolvent density, the smaller the droplets that are formed. Dixon,
et al., 1993 and Thies and Műner, 1998 found that particle size decreases with increase in
antisolvent density. Their findings were in good agreement with the hydrodynamic
theory.
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However, Randolph et al., 1993, in their research found that nucleation and
growth of the solute induced by mass transfer played a critical role in the determining the
particle size. Similarly, Bristow, et al., 2001 proposed that the supersaturation rate rather
than the initial droplet size was directly related to the particle size.
Enhancing the rate of mass transfer in the SAS process favors a higher degree of
supersaturation, leading to the formation of smaller particles. The rate of mass transfer
can be enhanced by efficiently mixing the sprayed solution with the bulk supercritical
CO2. To improve the rate of mass transfer, different nozzle designs have been reported.
Hanna and York, 1994 designed a coaxial nozzle and applied this nozzle in the SAS
process, which is termed as SEDS. This specially designed nozzle improved the mass
transfer rate due to the intense mixing of the supercritical CO2 with the solution. A
schematic of the coaxial nozzle used in SEDS s shown in Figure 2.5. Chattopadhyay and
Gupta, 2002 combined the use of an ultrasonic vibration surface with the spray nozzle to
enhance mass transfer.

Figure 2.5 Schematic of the coaxial nozzle used in SEDS.
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The SAS process offers the advantage of flexibility in choosing the solvent and
the antisolvent. In addition, high throughput and mild operating conditions are enticing
for pharmaceutical compounds. The SAS process has received a lot of attention and a
large number of studies were published. Most of the research effort focuses on the
formation of particles of pharmaceutical agents. Yeo, et al., 1993 studied the formation of
protein powders (insulin) using the SAS process. The protein was dissolved in
dimethylsulfoxide (DMSO) and N, N-dimethylformamide (DMFA) and the solutions
were sprayed into SC CO2 through a nozzle having an ID of 30 gm. Amorphous protein
powders were produced in the continuous SAS process with 90 % of the particles less
than 4 pm and 10 % of the particles less than 1 pm. The results of in vivo tests on rats
showed that the micronized insulin maintained the same biological activity as that of
unprocessed insulin. Thus the SAS process is suitable for the micronization of bio-active
agents of proteins and peptides.
Reverchon and Porta, 1999 reported the production of antibiotic micro and nanoparticles by the SAS process. In this work, griseofulvin, ampicillin, amoxicillin, and
tretracycline in organic solvents of N-methylpyrrolidone (NMP), DMSO, ethyl alcohol,
and methylene chloride were used in the SAS process. The micronization of tetracycline
using NMP as the solvent was successfully achieved and sub-micron particles were
produced. The other combination of solutes and solvents failed due to the formation of
either long needle-shaped crystals or serious aggregation of the precipitated particles. The
effect of SAS parameters on morphology, particle size and size distribution was also
investigated using the system of tetracycline and NMP. It was found that higher operating
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pressure reduced the coalescence of tetracycline particles, and that higher solution
concentration favored size enlargement of the tetracycline aggregates.
In another study Revechon, et al., 2001 performed research on SAS precipitation
of salbutamol microparticles. In their SAS work, salbutamol was tested in different
solvents of DMSO, methyl alcohol, and ethanol-water mixture. Rod-like particles with a
dimension of 1-3 gm in length and 0.2-0.35 gm in diameter were produced when DMSO
was used as the solvent. Sintering of precipitated particles occurred with the other two
solvents. It was interesting to notice that the length of particles decreased as the solution
concentration increased. In addition, the residual organic solvent in the final product was
low enough so that it was below the detection limit of the FT-IR.
Steckel, et al., 1997 investigated the ASES process for the micronization of
several steroids (triamcinolone acetonide, flunisolide, prednisolone, budesonide, and
fluticasone-17-propionate, beclomethasone-17, 21-dipropionate, b eclomethasone-17valerate) for pulmonary delivery. The drugs were dissolved in dichloromethane,
methanol, and a mixture of both. The median particle size of the micronized steroid
(triamcinolone acetonide, flunisolide, prednisolone, budesonide, and fluticasone-17propionate) particles was mostly less than 5 gm. No particles were obtained with the
drugs of beclomethasone-17, 21-dipropionate and beclomethasone-17-valerate in the
ASES process due to extraction by SC CO2. HPLC tests revealed that no chemical
decomposition occurred during SAS processing. However, some of the micronized drugs,
such as triamcinolone acetonide, flunisolide, prednisolone, and fluticasone-17propionate, changed their crystallinity and polymorphism. The addition of a surface-
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active ingredient, phosphatidylcholine, in the solution resulted in a slight increase in
particle size, but considerably reduced the contact angle, improving wettability.
Moshashaée, et al., 2000 studied lysozyme precipitation from organic solution
using the SEDS process. The hen egg lysozyme in a solution of DMSO was sprayed
through a specially designed coaxial nozzle, shown schematically in Figure 2.5. The
primary particle size was in the range of 1-5 lam. The residual DMSO in the final product
was less than 20 ppm. It was noticed that a lower operating pressure favored the
maintenance of bio-activity of the processed lysozyme. Also the lower pressure resulted
in the formation of well-defined 1-5 gm particles while a higher pressure gave rise
aggregates of particles.
Chattopadhyay and Gupta, 2002 recently reported SAS with an enhanced mass
transfer technique. In this study lysozyme was dissolved in DMSO and the resulting
solution was sprayed onto a vibrating surface, which was in a high pressure chamber
filled with SC CO2. The solution jet was deflected by the surface vibrating at an
ultrasonic frequency, atomizing the jet into much smaller droplets so that lysozyme
nanoparticles and microparticles were produced. It was found that the ultrasound field
generated by the vibrating surface not only enhanced the mass transfer, but also
prevented the agglomeration of precipitated particles through improved mixing. The
vibration intensity of the surface, which was a function of the power supplied to the
ultrasound transducer, affected particle size. The biological activity of the protein was
retained during the SAS processing. In a similar study (Chattopadhyay and Gupta, 2001),
tetracycline was micronized to 125 nm using this SAS with enhanced mass transfer
technique.
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The SAS process is also capable of micronizing biopolymers, e.g., poly (L-lactic
acid) (PLA), which is very popular for pharmaceutical drug delivery applications, has
been micronized by the SAS process (Thies and Miller, 1998; Randolph, et al., 1993;
Reverchon, et al. 2000; Breitenbach, et al. 2000, Mawson, et al., 1997). In these SAS
studies PLA microparticles were produced with various sizes and morphologies, which
were influenced by the operating conditions, e.g., organic solvents used, solution
concentration, temperature, pressure, and nozzle geometry. Some other biopolymers,
dextran, poly (hydroxypropylmethacrylamide) (HPMA) (Reverchon, et al., 2000), poly
(β-hydroxy-butyric acid) (PHB) (Breitenbach, et al., 2000), and polysaccharide (HYAFF11) (Benedetti, et al., 1997), were successfully micronized by the SAS process.
In addition to the micronizaiton of organic substances for pharmaceutical
applications, the SAS process was also extended to produce nanoparticles for material
science applications. Reverchon, et al., 1998 studied the production of nanoparticles of
superconductor precursors using the SAS process. In this study, yttrium acetate (AcY),
samarium acetate (AcSm), and neodymium acetate (AcNd) were dissolved in DMSO and
were sprayed into SC CO2. Nanoparticles, down to 100 nm of AcY, AcSm, and AcNd
were successfully produced with a narrow particle size distribution. The nanoparticles of
these precursors could then be applied to produce high temperature superconductors.
Similar research was performed by Reverchon, et al., 1999 to produce nanoparticles of
zinc oxide precursor.
To better understand the SAS process, Bristow, et al., 2001 performed a
fundamental study of the SAS process using acetaminophen as a model drug. In this
carefully designed study, an on-line dynamic solubility measurement was used to monitor
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the solution supersaturation in the nozzle, S m , and in the residual organic effluent, Se . It
was found the magnitude of S m had a direct effect on the mean particle size, and the
analysis of supersaturation provided a simple and effective way for optimization of the
SAS process. Also, they investigated the SAS process under two different operating
conditions of partial and complete miscibility, and proposed that above the mixture
critical pressure, crystallization was determined by mixing and primary nucleation.
Below the mixture critical pressure, droplets with very low surface tension were
produced due to hydrodynamic effect and jet break-up. The solute underwent nucleation
and immediate post-nucleation growth was confined within the droplets.
In another fundamental research study carried out by Lengsford, et al., 2000, it
was shown that complete miscibility of the solvent and the SC CO2, above the critical
point of the mixture occurred; no distinct droplets formed and the polymer solute would
nucleate and grow within the expanding gas plume. This finding supported the
conclusion reached by Bristow, et al., 2001. These fundamental research studies were
very helpful to elucidate the SAS process.
In the SAS process, the particle size, size distribution and morphology were
thought to be strongly dependent on the mass transfer as described above. However, it
was not quite understood quantitatively and qualitatively. Werling and Debenedetti,
1999; 2000 attempted to simulate the mass transfer behavior in the SAS process. In their
simulation, mathematic models were set up to calculate the mass transfer between toluene
and SC CO2 at conditions below and above the mixture critical point. Calculated results
showed that the interfacial flux was always into the droplet, resulting in the swelling of
the droplet. This was attributed to the fact that the solubility of CO2 was very high in
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toluene. It was suggested that supercritical conditions resulted in faster mass transfer so
that supercritical operation would cause a higher degree of droplet supersaturation in the
presence of a solute, resulting in higher nucleation rates and smaller particles. This
simulation work allowed for a better understanding of the SAS process and could provide
a theoretic basis for choosing operating conditions.
Lora, et al., 2000 proposed an even more comprehensive model.
Thermodynamics, hydrodynamics, and mass-transfer were all considered in this model so
that it could be utilized to calculate the composition and flow-rate profiles of the vapor
and liquid phases and the amount of solid product along the precipitator. The antisolvent
was found to dissolve in the liquid phase faster than the evaporation of the solvent. This
was consistent with the calculated result by Werling and Debenedetti, 1999. In addition,
it was found that two solutes might behave completely in different ways at the same
conditions and it was possible to selectively precipitate a solute from a ternary system of
solute-solute-solvent using the SAS process. The proposed model was very useful for
simulation of the SAS process if a suitable thermodynamic model representing the phase
equilibrium of the system was available.

2.1.2.3 Precipitation from Gas Saturated Solutions/Suspensions (PGSS). In addition
to the supercritical processes discussed above, there is another process, precipitation from
gas saturated solutions/suspensions (PGSS), used for particle generation. This process
takes advantage of the fact that the solubility of the compressed gas in liquid solutions or
melt solids is much higher than the solubility of solids in the compressed gas. In this
process, supercritical CO 2 is dissolved in solid melts or liquid solutions/suspensions. The
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gas-saturated solutions or suspensions are then expanded through a nozzle, leading to the
formation of solid particles. A few publications (Xu, et al., 1997, Sievers, et al., 1999,
Xu, et al. 1998) described this process for particle formation; however, PGSS is much
less popular than either GAS or SAS.

2.2 Previous Particle Coating or Encapsulation Work Using Supercritical Processes
Particle coating, encapsulation or dispersion in microspheres using SC CO2 is of great
interest for controlled drug delivery, and for food, agriculture, material science, and
cosmetics applications. Coating/encapsulation of pharmaceutical substrates for drug
controlled or sustained release using compressed or SC CO2 has been a fast growing
field. Various processes using SC CO2 have been developed, such as RESS,
SAS/GAS/ASES, and thermal decomposition processes.

2.2.1 Particle Coating or Encapsulation Using RESS
In a RESS coating or encapsulation process, the coating material is dissolved in SC CO2
with or without cosolvent involved. A sudden decompression causes a significant loss of
solvent strength of SC CO2, resulting in nucleation and precipitation of the solute
(coating material). The coating material either deposits onto the surface of any host
particles that are present in the precipitation vessel or coprecipitates along with the host
particles. Tom, et al., 1994 initiated a study of coprecipitation of PLA and pyrene in a
RESS process for controlled drug delivery applications. In their work two streams of
solutions of pyrene in SC CO2 and PLA in SC CO 2 with CHClF2

as the cosolvent were

not mixed until they reach the precipitation unit. When the supercritical solutions flowed
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through expansion device, it underwent a rapid decompression, resulting in
coprecipitation of PLA and pyrene. It was shown that the morphology and particle size
were strongly dependent on the expansion device (orifices or capillaries). Using
fluorescence and transmission microscopy, pyrene was found to be uniformly
incorporated in polymer microspheres after the RESS coprecipitation .
In another RESS work, Kim, et al., 1996 investigated the microencapsulation of
naproxen with PLA. In their study, a model system of naproxen and PLA was packed in
the same extraction unit instead of using two different units (Tom, et al., 1994) and
extracted with supercritical CO2. The supercritical solution was then expanded through a
capillary tube. Composite particles with a naproxen core encapsulated by a PLA coating
were reported. Microparticles and agglomerates were observed as the dominant
morphology. Mishima, et al., 2000 studied the microencapsulation of proteins with poly
(ethylene glycol) (PEG) by RESS. In this research, ethanol (about 38.5 wt. %) was
employed as a co-solvent to enhance the solubility of PEG in SC CO2 even though PEG
was not soluble in ethanol. In their experiments protein particles were suspended in SC
CO 2 , in which polymers were dissolved with the assistance of ethanol. The resulting
suspension was sprayed through a nozzle and microspheres were produced without
agglomeration. The results indicated that lipase and lysozyme particles were completely
encapsulated by PEG.
Tsutsumi, et al, 2001 combined the RESS process with fluidized bed technology
to achieve particle coating. In this research, catalyst particles in a fluidized bed were
fluidized by air, and a solution of paraffin in supercritical CO 2 was sprayed into the bed
through a nozzle. Coating material was directly deposited onto the surface of the catalyst

50
particles with no binder or solvent involved, resulting in no significant agglomeration. A
more recent study of particle coating granulation using the RESS process in a fluidized
bed was carried out by Wang, et al., 2001.
However, the main drawback of the RESS technique is that SC CO2 has a limited
solvent strength for many polymers of interest, which greatly restricts its application.
There is another disadvantage in that it is very difficult to control the coating or
encapsulation because nucleation and precipitation of the coating material take place very
rapidly (less than 10 -5 seconds) during RESS (Matson, et al., 1987).

2.2.2 Particle Coating or Encapsulation Using SAS/GAS/ASES/SEDS
The use of SC CO2 as an antisolvent for coating or encapsulation of particles received
considerable attention recently because of its flexibility in choosing a suitable solvent.
For example, coprecipitation of a drug substance and a polymer using antisolvent
processes is of great interest for drug delivery system design. In this approach, a
homogeneous solution containing the drug and polymer is sprayed into SC CO2 through a
nozzle and nucleation and coprecipitation of the drug and polymer occurs due to the
extraction of the solvent by SC CO2. The drug-loaded microspheres are produced as a
matrix structure of drug particles dispersed in the polymer.
Bleich and Muller, 1996 reported an ASES process for drug loaded particle
preparation. The drugs and carrier polymer PLA were dissolved in methylene chloride
and the solution was atomized into SC CO2. The extraction of the organic solvent results
in the formation of drug loaded microparticles. Polar drugs were successfully
encapsulated in their ASES process. However, less polar drugs failed to be encapsulated
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because they were extracted by the SC CO2 with the organic solvent acting as the
co solvent.
Falk, et al., 1997 investigated composite microparticle production using the SAS
process. In their research a homogeneous solution of solutes (gentamycin, naloxone, and
naltrexone) and PLA, which was prepared by the hydrophobic ion-pairing (HIP) method,
was sprayed into SC CO2 as an antisolvent. Co-precipitation of the solutes and polymer
took place and composite microspheres or drug-loaded microcapsules were formed.
Spherical composite particles were successfully produced with sizes in the range of 0.2 to
1.0 11M. The gentamycin loaded microspheres showed a 25 % (w/w) loading rate and
exhibited diffusion controlled release behavior. Naloxne and naltrexone were found to be
less efficiently encapsulated because these two drugs were more lipophilic and could be
dissolved in SC CO2, causing the drug to be bound on the surface of microspheres.
Ghaderi, et al., 2000 described the preparation of microparticles containing
hydrocortisone in DL-PLA polymer by the SEDS process using a combination of SC

N2

and CO2. Results showed that microparticles with a mean size less than 10 μm were
produced. Hydrocortisone was successfully entrapped in DL-PLA microparticles with an
entrapment efficiency of 22 %. It was found that the combination of SC

N2 and CO2

favored a more efficient dispersion of the polymer solutions than SC CO2 alone.
In a recent study of the coprecipitation of solute and polymer using the SAS
process, Elvassore, et al., 2001 studied the production of protein loaded polymeric
microcapsules. Insulin and PLA, as a model system, were dissolved in a mixed solvent of
DMSO and dichloromethane. This homogeneous solution was then sprayed into SC CO2
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through a 50 pm fused silica nozzle. It was shown that 0.5 to 2 μm insulin loaded
microspheres were produced with an incorporation efficiency of up to 80 %.
Recently Moneghini, et al., 2001 produced a Carbamazepine-PEG solid
dispersion using SC CO2. In this GAS coprecipitation study, the carbamazepine and PEG
were dissolved in acetone in a high-pressure chamber. The SC CO2 was injected from the
bottom of the chamber. The dissolution of SC CO2 in the solution induced nucleation and
precipitation of the carbamazepine and PEG. Therefore, microparticles of the solid
dispersion of carbamazepine-PEG were produced and the dissolution rate was
considerably improved compared with the slow dissolution rate of pure carbamazepine.
However, coprecipitation of drug and polymer requires that both be dissolved in a
suitable solvent which is a challenge for proteins since many proteins are insoluble in
organic solvents. Moreover, some organic solvents might cause the protein to lose its
bioactivity. In addition, the coprecipitation of two different solutes is difficult to achieve
unless the two solutes have similar thermodynamic properties and undergo a similar
precipitation pathway.
An alternative particle coating or encapsulation antisolvent process to those
described above involves suspending the host particles in a coating polymer solution. The
suspension is either sprayed into SC CO2 or SC CO2 is injected into the suspension. Due
to the mutual diffusion between SC CO2 and the organic solvent, the polymer precipitates
out and is deposited onto the surface of host particles, forming a film coating.
Bertucco and Vaccaro, 1997 did a preliminary study of particle encapsulation by
polymers using compressed CO2 as an antisolvent (GAS). In their study, particles of KCl
were suspended in a solution of various polymers (hydroxypropyl methylcellulose
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phthalate, Eudragit E 100, ethylcellulose) in various organic solvents (toluene, acetone,
1,4-dioxane, ethylacetate). Compressed CO2 was introduced into the high-pressure vessel
as an anti-solvent to precipitate the polymer on the surface of suspended KCl particles
and partial polymer encapsulation was achieved. It was found that processing conditions,
such as, pressure, temperature, solute concentration, and polymer-to-drug ratio, strongly
influenced the polymer coating on the surface of the particles.
Young, et al., 1999 studied the encapsulation of lysozyme in a biodegradable
polymer by precipitation with a vapor-over-liquid antisolvent, which is simply a modified
precipitation with a compressed anti-solvent (PCA) process. In this work, a suspension of
1-10 micron lysozyme particles in a polymer solution was sprayed into CO2 vapor over a
CO2 liquid phase (below supercritical conditions) through a nozzle. By delayed
precipitation, particles were allowed to grow large enough to encapsulate lysozyme. The
experiments were operated at a temperature of —20 ° C so that the precipitated particles
were sufficiently hard and agglomeration was remarkably reduced compared with higher
temperatures. The process offered an effective encapsulation approach with high
encapsulation efficiency and less agglomeration.

2.2.3 Other SC CO2 Processes for Particle Coating or Encapsulation
Some other SC CO2 processes were developed for particle coating or encapsulation.
Ribeiro Dos Santos, et al., 2002 studied the microencapsulation of protein (bovine serum
albumin, BSA) particles with lipids (Dynasan® 114 and Gelucire® 50-02). The BSA
particles and lipids were charged into a high-pressure chamber, which was equipped with
an agitator. The Dynasan® 114 and Gelucire® 50-02 were dissolved in SC CO2 at 45 °C
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and 200 bars and 35 ° C and 200 bars, respectively. The subsequent cooling of the
pressure chamber induced a phase change from the supercritical to the liquid state,
leading to the precipitation of the coating materials onto the surface of the BSA particles.
Thus, microencapsulation of protein particles was successfully achieved.
Pessey, et al., 2000; 2001 described a thermal decomposition process for particle
coating in a supercritical fluid. In their research, an organic metallic precursor and host
particles were loaded in a high-pressure chamber. The chamber was then filled with SC
CO2 with ethanol as a co-solvent. When the operating temperature was raised to 200 ° C,
higher than the deposition temperature of the precursor, 195 ° C, the precursor underwent
decomposition and copper was released and deposited onto the surface of core particles at
a pressure up to 190 bars. However, their methods are less attractive from the point of
view of safety and cost and probably cannot be applied to the pharmaceutical industry
since the high temperature could adversely effect or even destroy most drug powders.
Schreiber, et al., 2002 developed a supercritical fluidized bed for particle coating.
In this research silica particles or glass beads were fluidized with SC CO2 at a pressure up
to 300 bars and temperature from 40 to 80 ° C. The coating material of paraffin was first
dissolved in SC CO2 in an autoclave and then the solution was sprayed into the fluidized
bed. The difference in operating conditions between the fluidized bed and the autoclave
made the paraffin precipitate and adhere to the surface of particles in the fluidized bed,
forming a film coating.
Liu and Yates, 2002 took the advantage of the exceptional transport properties of
compressed CO2, such as high diffusivity and very low viscosity and developed a
microencapsulation technique for polymer latexes using compressed CO2. In this work,
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CO2 was emulsified in water and ethanol latexes with the assistance of a surfactant, poly
(propylene oxide)-(ethylene oxide)-(propylene oxide) (PPO-PEO-PPO), Pluronic F 108.
The compressed CO2 was used to plasticize the synthesized monodisperse polystyrene
particles and dyes were impregnated into the polymer particles. The surfactant
accelerated the transport of dye into the polymer phase.
Although the various supercritical fluid processes for particle formation, coating
and/or encapsulation have been comprehensively reviewed in this chapter, some of this
material will be repeated in Chapters 3, 4, 5, and 6 so that the research described in each
of these chapters can stand on its own as a publishable research paper.

CHAPTER 3
EXTRACTION AND PRECIPITATION PARTICLE
COATING USING SUPERCRITICAL CO2
In order for the research described in this chapter to stand on its own (as a publishable
research paper), some of the pertinent literature review that has already been described in
Chapter 2 is repeated in the following introduction.

3.1 Introduction
Particle coating involves the application of another material onto the surface of individual
particles to modify their surface properties, such as flowability, wettability, time release,
flavor, taste, etc. Conventional particle coating processes usually employ wet chemistry
or solutions of the coating material, requiring the use of large quantities of organic
solvents, surfactants, and other chemicals. In general, these processes are
environmentally unfriendly and can lead to the emissions of volatile organic compounds
(VOCs) and other waste streams. Dry particle coating (Pfeffer, et al., 2001) is a good
alternative because no organic solvents are employed, not even water. Moreover no
drying is needed; thus these processes save energy. Coating is achieved through
mechanical forces between host and much smaller guest particles, which are attached to
the surface of the host particles. But it is often difficult to control the film structure on the
surface of the host particles, such as the film thickness, uniformity, texture and robustness
of the coating. Furthermore, some bio-active particles, for example, proteins and
peptides, may lose much of their bio-activity due to the high shear and compressive
forces employed and the local increase in temperature produced in dry coating processes.
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A supercritical fluid (SCF) is a fluid above its critical temperature (TO and critical
pressure (P a ) and has many advantages over conventional fluids. Its gas-like viscosity and
high diffusivity is advantageous for mass transfer applications. Its density and related
solvent strength can be tuned by controlling the temperature and pressure. Carbon
dioxide is the most widely used SCF because of its low critical temperature (31.1 ° C) and
mild critical pressure (73.8 bars), non-toxicity, non-flamability, and low price. During the
past two decades, SCF technologies have developed very rapidly. Originally, SCF
processes were developed and widely used in extraction and separation because of the
good solvent properties of SCFs. Since the mid 1980s, however, particle synthesis and
engineering using supercritical CO2 has emerged as a fast-growing field. The rapid
expansion of supercritical solution (RESS) process to form fine particles was first
suggested by Krukonis, 1984. In RESS (Chang and Randolph, 1989; Matson, et al., 1987;
Tom and Debenedetti, 1991 and 1994) a SCF solution is expanded through a nozzle or
capillary tube, resulting in a very high pressure drop and a high degree of supersaturation.
The solute will nucleate and grow, forming very small particles.
Another technique, using a SCF as an anti-solvent, for particle engineering has
been developed in a variety of forms. These include the supercritical anti-solvent (SAS)
technique (Cai, et al., 1997; Yeo, et al., 1993; Dillow, et al. 1997; Reverchon, et al., 1998
and 2000) gas anti-solvent (GAS) (Gallagher, et al., 1992; Lim, et al., 1998; Dixon, et al.,
1993; Winter, et al., 1999), aerosol solvent extraction system (ASES) (Reverchon, et al.,
1999; Chou and Tamasko, 1997; Thies and Willer, 1998), and solution enhanced
dispersion by SCFs (SEDS) (Hanna, et al., 1994). However, all of these techniques and
the investigators who used them, focused on single component powder formation.
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Multi-component particle formation, such as particle composites or encapsulation
of particles with polymer using SCFs is of great interest for controlled drug delivery,
food, agriculture, and cosmetics applications. Recently, Kim, et al., 1996 reported the
microencapsulation of naproxen with poly L-lactic acid (PLA) using RESS. Naproxen
and PLA were packed in an extraction unit and extracted with supercritical CO2. The
supercritical solution was then expanded through a capillary tube. Composite particles
with a naproxen core encapsulated by a polymer coating were produced. Microparticles
and agglomerates were observed as the dominant morphology. Mishima, et al., 2000
investigated the microencapsulation of proteins with poly ethylene glycol (PEG) by
RESS. In this research, ethanol (about 38.5 wt. %) was employed as co-solvent to
enhance the solubility of PEG in supercritical CO2 even though ethanol, by itself, is a
nonsolvent for PEG. The results indicated that lipase and lysozyme particles were
completely encapsulated by PEG without agglomeration.
Tsutsumi, et al., 1995 used a combination of RESS with fluidized bed technology.
Catalyst particles in a fluidized bed were fluidized by air, and a solution of paraffin in
supercritical CO2 was sprayed into the bed through a nozzle. Coating material was
directly deposited onto the surface of the catalyst particles with no binder or solvent
involved, resulting in no significant agglomeration. A more recent study of particle
coating granulation using the RESS process in a fluidized bed was carried out by Wang et
al., 2001. However, the main drawback for the RESS technique is that SCFs have a
limited solvent strength for many polymers of interest, which restricts its application.
There is another disadvantage in that it is very difficult to control the coating or
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encapsulation because the nucleation and precipitation of coating materials take place
very fast (less than 10 -5 seconds) during RESS (Matson, et al., 1987).
Bertucco and Vaccaro, 1997 used the GAS technique for particle encapsulation.
In their research, particles of KC1 were suspended in a solution of polymer
(hydroxypropyl methylcellulose phthalate, Eudragit E 100, ethylcellulose) in various
organic solvents (toluene, acetone, 1,4-dioxane, ethylacetate). Compressed CO2 was
introduced into the vessel as an anti-solvent. Preliminary results showed that partial
polymer encapsulation was achieved.
A recent study of Young, et al., 1999 investigated the encapsulation of lysozyme
with biodegradable polymer by precipitation with a vapor-over-liquid antisolvent, which
is a modified precipitation with a compressed anti-solvent (PCA) process. A slurry of 110 micron lysozyme particles suspended in a polymer solution was sprayed into CO2
vapor over CO2 liquid (below supercritical conditions) through a nozzle. By delayed
precipitation, particles were allowed to grow large enough to encapsulate lysozyme. The
polymer particles entraining lysozyme vitrified after falling into the CO2 liquid phase and
agglomeration was avoided.
There are also some studies (Falk, et al., 1997; Elvassore, et al., 2001) dealing
with composite microsphere production by the SAS process. A homogeneous solution of
interesting solutes and polymer, which was prepared by the hydrophobic ion-pairing
(HIP) method (Falk, et al., 1997) or by mixed solvents (Elvassore, et al., 2001), was
sprayed into supercritical CO2 antisolvent. Co-precipitation of the solutes and polymer
was expected and composite microspheres or microcapsules were formed. However, coprecipitation of two different solutes is difficult to achieve even when the precipitation
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pressures of the solutes are close to each other (Bertucco and Vaccaro, 1997). In addition,
exposure of proteins to solvents required for SAS leads to denaturing of the proteins
probably due to a change in conformation (Yeo, et al., 1994), although some denaturation
is partially reversible (Yeo, et al., 1994; Winter, et al., 1996).
In this research a modified RESS technique was used to explore the coating of
host particles with polymer using supercritical CO2 and a small amount of co-solvent to
increase the solubility of the polymer in supercritical CO2. The modified RESS technique
involves extracting the polymer with supercritical CO 2 , with or without a co-solvent in an
extraction vessel, and then precipitating the polymer onto the surface of host particles in a
second precipitation vessel by adjusting the pressure and temperature inside the
precipitator to lower its solubility in supercritical CO2.
Spherical glass beads (315 and 500 μm) were chosen as host particles for the
reason that glass beads are spherical and nearly monodisperse and therefore the coatings
obtained could be more easily characterized. Two different polymers were tested in the
coating experiments. The coating of much finer powders with biodegradable polymers
using supercritical processing for drug delivery purposes will be reported in a future
paper.

3.2 Materials, Methods, and Characterization
3.2.1 Materials
CO2 was obtained from Air Liquide Company (France); purity is 99.995 %. Two
polymers, poly vinyl chloride-co-vinyl acetate (PVCVA) (Aldrich, USA) and
hydroxypropyl cellulose (HPC), which is soluble in water, were used. The properties of
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the two polymers are listed in Table 3.1. Unfortunately, no solubility data for these two
polymers in supercritical CO2 could be found in the literature, but it was assumed that
their solubility was extremely limited. Therefore, acetone (99.5%, Fisher, France) was
chosen as a co-solvent since it is widely used to increase polymer solubility by improving
dispersion, inducing dipolar interactions and by increasing the solvent density [35].
Monodisperse spherical glass beads with diameters of 315 and 500 pm (Potters-Ballotini
S.A., France) were chosen as host particles.

Table 3.1 Polymer Properties
Polymers

Molecular Weight

Glass

Transition Content (% wt.)

Temperature (Tg, ° C)
PVCVA

27,000 (Mn*)
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86% poly vinyl chloride

HPC

100,000

-

100%

* Mn, number average molecular weight.

3.2.2 Methods
The coating experiments using supercritical CO2 were performed on a pilot-scale
apparatus (Separex, France), which is shown schematically in Figure 3.1. Liquid CO2 was
delivered by a Lewa metering pump from a CO2 tank and was cooled down to around
0 ° C before entering the pump head. Co-solvent was introduced using a Gilson piston
pump. The polymer substrate was packed in a stainless steel vessel having a volume of
1.5 liter, which served as the extraction unit. Another vessel with the same capacity was
used as a precipitator and held the glass beads. The temperature of each of the two
vessels was maintained relatively constant by an electrical heating mantle. CO 2 , with or
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without co-solvent, was charged from the bottom of the extraction unit to extract the
packed polymer. The supercritical solution of polymer was then introduced into the
bottom of the precipitator. By adjusting the pressure and temperature inside the
precipitator, the solute would precipitate and deposit on the surface of the host particles.
After a certain amount of running time, the co-solvent supply was stopped and pure CO2
was continued to flush the precipitator for some time under the same conditions to
remove the co-solvent. Then the CO2 supply was shut off and the precipitator was slowly
depressurized. The coated glass beads were recovered from the precipitator for
characterization and further analysis. The operating parameters are given in Table 3.2.

Table 3.2 Experimental Conditions
Coating Experiments

PVCVA - 1

PVCVA - 2

HPC

Size of glass beads (pm)

315

500

500

Weight of glass beads (g)

3.1558

2.8224

4.0268

Weight of polymer (g)

1.1789

0.5036

0.9336

Extraction T and P ( ° C, bars)

80, 127

84, 130

80, 106

Precipitation T and P ( ° C, bars)

30, 118

48, 115

30, 80

Running time (minutes)

25

12

20

Flushing time (minutes)

10

0

10

Flow rate of CO2 (kg/hour)

15-20

15-20

15-20

Co-solvent used

Acetone

None

Acetone
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3.2.3 Characterization
In this study a Leo 982 Scanning Electron Microscope (SEM) was employed for the
morphological analysis. Samples were sputtered by palladium (SPI Sputter). Energy
dispersive X-ray spectrometry (EDS) was used to analyze the elements on the surface of
the uncoated and coated glass beads. The energy dispersive X-ray mapping technique
was used to image the spatial distribution of elements on the surface of the particles. A
TGA7 Thermo-gravimetric Analyzer (TGA) was used to estimate the thickness of the
coating.

3.3 Results and Discussion
3.3.1 Coating with PVCVA
In the experiment of coating glass beads (315 1.1m) with PVCVA the temperature of the
extraction unit was maintained around 80 ° C and the pressure up to 127 bars. Acetone as
co-solvent was delivered at a rate of 2 ml/min, to improve the solubility. The temperature
of the precipitator was kept at 30 ° C and the pressure of the precipitator was kept around
118 bars by the back pressure regulator. These conditions of temperature and pressure
were chosen because it was assumed that any inherent solubility of the polymer in
supercritical CO2 would decrease rapidly as the pressure and temperature approaches the
critical point (Debenedetti and Kumar, 1986), and because they allow for a single-phase
mixture after depressurization. Furthermore, O'Neill, et al., 1998 stated: "Polymers in
general have very limited solubility in supercritical fluid (SF) CO2 at temperatures below
80 ° C, although solubilities can increase significantly at higher temperature." Thus, in

Figure 3.1 Diagram of coating process using supercritical CO2.

Key: 1. CO 2 cylinder, 2. Cooling, 3. Pump, 4. Preheating, 5. Co-solvent, 6. HPLC pump, 7. 3-way valve
8. Extraction unit, 9. Precipitator, 10. On-off valve, 11. Filter, 12. Separator, 13. Back pressure regulator
14. Control panel 15. Heating mantle
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Thus, in spite of a marked increase in the density of supercritical CO2 (e.g., using the
Peng-Robinson equation of state (Peng and Robinson, 1976), the density of pure CO 2 is
0.321 at 127 bars and 80 ° C and 0.770 at 118 bars and 30 ° C), polymers appear to be
much less soluble at lower temperatures (Tom and Debenedetti, 1991). This was also
verified by the experiments since polymer-coated glass beads could be harvested by
decreasing both the pressure and the temperature in the precipitation vessel.

Figure 3.2 SEM photographs of unprocessed glass beads at different magnifications:
(a) 315 inn x 100; (b) 315 μm x 3,000; (c) 500 μm x 110; (d) 500 JAM x 3,000.
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After 25 minutes of operation and 10 minutes of flushing (See Table 3.2, PVCVA
- 1), the sample was collected from the precipitator for characterization. Figure 3.2 shows
SEM photographs at two different magnifications of both the unprocessed 315 lam and
500 pin glass beads, which were used as host particles. As can be seen in the Figure 3.2
the unprocessed glass beads are monodisperse and are quite smooth and clean on the
surface with some small defects. SEM photographs of the 315 tun glass beads coated
with PVCVA are shown in Figure 3.3. Compared with Figure 3.2, Figures 3.3 (a) and (b)
clearly show that the glass beads are coated with polymer, although the coating is not
uniform, nor is it continuously distributed over the surface.

Figure 3.3 SEM photographs of coated glass beads (315 μA) at different magnifications:
(a) x 100; (b) x 360; (c) x 10,000; (d) x 3,000.
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In this coating process, due to changes in pressure and temperature (pressure from
127 to 118 bars and temperature from 80 to 30 ° C), the solvent strength of the
supercritical CO2 is strongly affected, leading to a decreasing solubility of the polymer in
the supercritical fluid. As the pressure and temperature decrease, the polymer nucleates.
The nuclei grow into crystalline aggregates and deposit on the surface of the glass beads.

Figure 3.4 EDS of unprocessed (a) and coated (b) glass beads (315 μm).
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This mechanism of polymer precipitation and coating is supported by Figure 3.3 (c),
which shows a crystalline aggregate on the glass bead surface. Many discrete polymer
aggregates are seen attached on the surface in Figure 3.3 (d).
Surface elemental analysis, using the EDS technique, can indicate what elements
are on the surface of a particle. Figure 3.4 (a) shows the EDS pattern of unprocessed glass
(315 pm) beads. Obviously, the dominant element is silicon on the surface because it is a
primary component of glass. Oxygen and sodium are secondary elements contained in the
glass beads. The carbon peak, however, is very small compared with that of silicon and is
probably due to some impurities or contaminants attached on the surface. The EDS
pattern of the processed glass beads is shown in Figure 3.4 (b). Here the carbon signal is
very strong, and it is the primary element on the surface, with oxygen seen as the second
dominant element on the surface of the processed glass beads. This is consistent with the
polymer's composition. Moreover, the silicon signal is very weak because it is blocked
by the polymer coating layer. From Figure 3.4, it is evident that the processed glass beads
are coated with polymer, confirming the observation in Figure 3.3.
The processed glass beads were also examined by using the EDS mapping
technique, which reflects the spatial distribution of different elements. Figure 3.5 (a)
shows the SEM image of the surface of a coated glass bead. Figure 3.5 (b) is the EDS
mapping pattern for the element carbon on the same glass bead. The white dots represent
the signals of carbon on the surface of the glass bead; it is clear that the glass bead is not
uniformly covered with PVCVA polymer. Similarly, an EDS mapping of silicon can be
found in Figure 3.5 (c). A comparison of 3.5 (b) and 5 (c) shows that the carbon signal is
much weaker than that of the silicon signal over most of the surface because the polymer
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coating is very discrete. Also, it can be seen that where the carbon signal is strong, the
silicon signal is weak. The polymer on the surface blocks the X-ray so that there is a very

Figure 3.5 EDS mapping of coated glass beads (315 μm). (a) SEM image; (b) carbon
mapping; (c) silicon mapping.
weak silicon signal in the area where the polymer deposits. The result of EDS mapping
strongly supports the conclusion that the white material seen in Figure 3.5 (a) is polymer
precipitated on the surface of the glass beads.
Another set of coating experiments was carried out by using 500 μm glass beads
as the host particles. It should be noted that no co-solvent was added in these
experiments. They were operated under the conditions that the extraction temperature and
pressure were maintained at 84 ° C and 130 bars and the precipitation temperature and
pressure were maintained at 48 ° C and 117 bars. The experiment was run for 12 minutes
(See Table 3.2, PVCVA - 2) with no CO2 flushing necessary since no co-solvent was
used.

Figure 3.6 SEM photographs of coated glass beads (500 11.m) at different magnifications:
(a) x 130; (b) x 3,000; (c) x 3,000; (d) x 5,000.
SEM photographs of the coated glass beads at different magnifications are shown
in Figure 3.6. When compared to the unprocessed 500 μm glass beads shown in Figure 2,
it is evident that the morphology and surface texture of the coated glass beads are
different from those of the uncoated glass beads. Figures 3.6 (a) clearly show that the
glass beads are coated with polymer. However, it can be observed that parts of the
surface are heavily covered by polymer, while a loose and discrete coating is developed
on other parts of surface (Figures 3.6 (b), and (c)). The highest magnification, Figure 3.6
(d), shows that fine polymer particles (around 2 μm aggregate on the surface. The 2 μm
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polymer particles were produced due to the change in the temperature and pressure of
CO2, which lowers the solubility of polymer in the supercritical CO2 (Chang and
Randolph, 1989; O'Neill, et al., 1998).
In the present coating experiments, the glass beads simply sat on the bottom of the
precipitator vessel and no stirrer was used. Thus, there were many dead areas and the
precipitating polymer could not deposit on all of the surfaces of the glass beads even
though there was sufficient precipitant available. Consequently, uneven coating is
observed. However, fluidizing or stirring the host particles to avoid dead areas so that
entire glass bead surface can be exposed to the polymer precipitant may overcome this
problem.

Figure 3.7 SEM photograph of glass bead agglomerate (a) and polymer bridge (b).

Figure 3.7 (a) shows two glass beads "glued" together by polymer. Due to the
CO2 pressure and temperature variation, the polymer nucleates and grows, falling into the
area between neighboring glass beads, forming a bridge as well as covering the surface. If
enough polymer precipitant is present, it would spread between all of the neighboring
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glass beads during polymer vitrification. Figure 3.7 (b) shows a high magnification of the
polymer bridge between two glued glass beads.
Figure 3.8 (a) shows the EDS pattern of the unprocessed 500 glass beads.
Again, silicon appears as one of the main component elements on the surface, and the
carbon intensity is negligible compared with that of silicon, indicating that carbon shows
up on the surface only as a contaminant. For the coated glass beads (Figure 3.8 (b)),
carbon appears as one of the two dominant elements and silicon has a much smaller peak.
These results are consistent with what was observed in Figure 3.4 when the 315 μm glass
beads were coated.
It is interesting to observe that the coating of the 315 pm glass beads appears very
different from that of 500 pm glass beads even though the same polymer PVCVA was
employed in the experiments. The polymer coating on the surface of the315 μm glass
beads (Figure 3.3) appears much more crystalline than the polymer coating on the surface
of the 500 pm glass beads (Figure 3.6). These results are probably due to the use of
acetone as a co-solvent in the coating of 315 μm glass beads. Acetone is a good solvent
for PVCVA and thus the solubility of PVCVA in the mixture of supercritical CO2 and
acetone will increase. The mobility of the polymer chains will also increase. Therefore,
the polymer chains can rearrange into a crystalline state during the precipitation (Falk and
Randolph, 1998). When coating the 500 pm glass beads without acetone as co-solvent,
by adjusting the temperature and pressure in the precipitation vessel, the polymer nuclei
that are formed will be less inclined to rearrange into a crystalline state. Therefore, the
polymer coating on the surface of the 500 pm glass beads is observed to be amorphous
rather than crystalline.

Figure 3.8 EDS of unprocessed (a) and coated (b) glass beads (500 lam).

In order to measure the average thickness of the coating, a thermo-gravimetric
analyzer (TGA) was used to remove the polymer from the surface of the glass beads. The
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mass of polymer can be determined by the weight loss during the heating process. The
temperature of the sample was raised to 580 ° C at a heating rate of 30 ° C/min in air
atmosphere. Figure 3.9 shows the TGA patterns of both the uncoated glass beads and the
glass beads coated with PVCVA polymer. As can be seen in Figure 3.9, the weight of the
uncoated glass bead sample stays constant during the experiment. For the coated glass
beads, the weight loss is about 0.7 % when run under the same conditions as the uncoated
glass beads. Therefore the TGA analysis results also support the conclusion that the glass
beads are coated with the polymer. Assuming that the coating is continuous and

Figure 3.9 TGA pattern of uncoated and coated glass beads (500 pm) with PVCVA.
the coating thickness is negligible compared with the diameter of the host particle, the
average thickness of the coating material is estimated using the formula below,
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where h is coating thickness, pH and pc are the densities of the host particles and polymer
coating, respectively and m a and me are the weight of the host and polymer, respectively.
D is the diameter of the host particle.

3.3.2 Coating with HPC
Hydroxypropyl cellulose (HPC) is a natural cellulose and is often used in pharmaceutical
applications. However, it is hard to handle due to the lack of an appropriate solvent.
Usually ethanol is used, but it will form a gel or highly viscous liquid when small
amounts of ethanol are added. Moreover, other organic halide solvents are strictly
prohibited in food and pharmaceutical handling because residual solvents could have ill
effects on health.
As part of this research of particle coating with polymer, HPC was used for the
coating of glass beads using supercritical CO2. Although acetone is not considered to be a
good solvent for HPC, it can improve the solvating power of supercritical CO2 and was
used as a co-solvent (Kiran and Pöhler, 1998).
For the coating of 500 1,1m glass beads with HPC, the extraction pressure and
temperature were set at 106 bars and 80 ° C, respectively. The precipitator was kept at 80
bars and 30 ° C, very close to the critical point of CO2 where the solubility of polymer is
much lower (Debenedetti and Kumar, 1988). Acetone was delivered at 2 ml/min. The
experiment was run for 20 minutes, followed by 10 minutes of flushing with CO2 (See
Table 3.2, HPC).

Figure 3.10 SEM photographs of coated glass beads (500 μm) with HPC at different
magnifications: (a) x 90; (b) x 500; (c) x 3,000; (d) x 10,000.
Figure 3.10 shows SEM pictures of 500 μm glass beads processed with HPC.
Compared with Figure 3.2, it appears that while the glass beads are coated with HPC, the
coating is less than that with PVCVA. Moreover, the coating is very discrete with large
areas of the surface left uncoated. When examining the SEM pictures in Figure 3.6 and
Figure 3.10, it is observed that a higher degree of covering occurred with PVCVA on the
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glass bead surface than with HPC. This might be due to a lower solubility of HPC as
compared to PVCVA in SC CO2. In the coating experiments with HPC, the first run was
performed under the same conditions mentioned above except no co-solvent was added.
Without the co-solvent, it was observed that no coating occurred on the surface of the

Figure 3.11 SEM photographs of glass bead agglomerate.

glass beads. Since HPC is polar and a hydrophilic polymer, the solubility of HPC in
supercritical CO2 is extremely low. Acetone acts as a co-solvent and improves the solvent
strength of the supercritical CO2 considerably. The addition of organic solvents as a cosolvent to improve solvating power of supercritical fluid had been widely reported
(Chang and Randolph, 1989; Tom and Debenedetti, 1991 and 1994; Mishima, et al.,
2000).
Figures 3.11 (a) and (b), at different magnifications, show two glass beads stuck
together with HPC. The polymer precipitant acts as binder between the glass beads and
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glues them together. This is again attributed to the fact that the glass beads were not
stirred or fluidized in the precipitator.

Figure 3.12 EDS pattern of coated glass beads (500 μm) with HPC.

The EDS pattern of the uncoated glass beads shows that silicon and oxygen are
the two dominant elements on the surface, while carbon is negligible (Figure 3.8).
However, in Figure 3.12, which shows the EDS pattern of the coated glass beads, the
carbon intensity increases greatly and becomes one of three dominant elements on the
surface, indicating that the surface of the glass beads was coated by HPC.
A TGA analysis of glass beads coated with HPC is shown in Figure 3.13.
Compared with uncoated glass beads (Figure 3.9), the weight loss of about 0.17%
confirms the conclusion that the glass beads are coated with polymer. Based on the

Figure 3.13 TGA pattern of coated glass beads (500 μm) with HPC.

Equation (1), the average coating thickness is about 0.24 11111, as compared to an average
thickness of about 0.8 lam for PVCVA. This supports the previous observation that more
coating is obtained with PVCVA as compared to HPC due to a difference in solubility.

3.4 Conclusions

A modified RESS process was developed in this study for coating particles by using a
solution of polymer in supercritical CO 2 . The results show that the coating of glass beads
with PVCVA and HPC was successfully achieved using this technique. Solubility plays
a very important part in the coating process. The use of a co-solvent can improve the
solubility of polymers and will also affect the degree of crystallinity of the polymer
coating on the surface of glass beads. The extraction and precipitation technique takes
advantage of the properties of a supercritical solution in that the polymer would nucleate,
grow and deposit on the host particle surface due to changes in its solubility caused by
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adjusting the temperature and pressure. Fluidizing or stirring the host particles would
probably result in a much more continuous and uniform coating than was obtained here.
The process of particle coating using a supercritical solution is a promising alternative
method for the coating of fine particles, with little or no organic solvents involved. It
should be attractive for the pharmaceutical, food, cosmetic and other industries.

CHAPTER 4
NANOPARTICLES COATING/ENCAPSULATION WITH POLYMER
USING A SUPERCRITICAL ANTISOLVENT (SAS) PROCESS

In order for the research described in this chapter to stand on its own (as a publishable
research paper), some of the pertinent prior work that has already been described in
Chapter 2 may be repeated here.

4.1 Introduction

The rapid development of nanotechnology and nanomaterials has led to a need for
nanoparticle surface modification for a variety of applications (Ruys and Mai, 1999;
Zhang and Gao, 2001; Chang, et al., 1994; Leroux, et al., 1996; Cohen, et al., 2000). The
surface can be tailored to specific physical, optical, electronic, chemical, and biomedical
properties by coating a thin film of material on the surface of the nanoparticles.
Conventional nanoparticle coating methods include dry and wet approaches. Dry
methods include: (a) physical vapor deposition (PVD) (Zhang, et al., 2000), (b) plasma
treatment (Shi, et al., 2001; Vollath and Szabó, 1999), (c) chemical vapor deposition
(CVD) (Takeo, et al., 1998), and (d) pyrolysis of polymeric or non-polymeric organic
materials for in-situ precipitation of nanoparticles within a matrix (Sglavo, et al., 1993).
Wet methods for coating nanoparticles include: (a) sol-gel processes (Ruys and Mai,
1999; Zhang and Gao, 2001) and (b) emulsification and solvent evaporation techniques
(Cohen, et al., 2000; Hrkach, et al., 1997; Wang, et al., 1999).
The coating or encapsulation of nanoparticles has been found to be of particular
interest for the controlled release of drugs, genes, and other bioactive agents. Controlled
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release systems provide the benefits of protection from rapid degradation, targeting
delivery, control of the release rate, and prolonged duration of bioactive agents. Leroux,
et al., 1996 studied the surface modification of nanoparticles of poly D,L-lactic acid
(D,L-PLA) loaded with drugs to improve site-specific drug delivery. The drug delivery
system was prepared using the emulsion method. Results indicated that drug loaded
nanoparticles of D, L-PLA, which were coated with poly ethylene glycol (PEG),
provided protection from uptake by human monocytes. The findings revealed that surface
modified nanoparticles with PEG could temporarily avoid the mononuclear phagocyte
system and substantially prolong the circulation time of the nanoparticles.
Cohen, et al., 2000 prepared a sustained gene delivery system of DNA
encapsulated in polymeric nanoparticles using a double emulsion approach. In their
research the gene delivery system was found to offer increased resistance to nuclease
degradation since the polymeric coating provides protection from serum nuclease. The
activity of plasmid DNA administration was found to be in the sustained duration mode.
The gene delivery system is a potential formulation for the application of gene therapy.
The emulsion techniques used above are associated with the following four steps:
(a) preparing the solution of polymer and bioactive agent in an organic solvent, (b)
dispersing the solution in another phase under vigorous stirring, (c) stabilizing under
certain temperature and pH conditions, and (d) evaporating the organic solvent. However,
during the emulsion preparation, the organic solvent and the strong shearing force,
temperature, pH, and the interface between the oil and water phases may affect and/or
alter the structure of the bioactive agents (Leong, et al., 1998; Jong, et al., 1998; Yang, et
al., 1999; Fu, et al., 1999). Moreover, some severe drawbacks such as residual organic
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solvent in the final product, VOC (Volatile Organic Compounds) emission, and heavy
downstream processing are involved in emulsion processes.
The objective of this research is to develop a new technique for coating or
encapsulation of ultrafine particles (sub-micron and nanoparticles) to modify their surface
properties by using supercritical CO2 (SC CO2) in a SAS process. CO2 is an ideal
processing medium because of its relatively mild critical conditions (T c =32 ° C, P c =73.8
bars). Furthermore, carbon dioxide is non-toxic, non-flammable, relatively inexpensive
and recyclable.
There are a number of studies dealing with particle coating or encapsulation using
SC CO2. Kim, et al., 1996 reported the microencapsulation of naproxen using rapid
expansion of supercritical solutions (RESS). The RESS process was also used to
coat/encapsulate particles by Mishima, et al., 2000. In the RESS coating process the
material to be coated and the coating material (polymer) are both dissolved in SC CO2
with or without a cosolvent. The solution is then released from a nozzle (de-pressurized),
generating microparticles with a polymer coating on the surface. In RESS the rapid depressurization of the supercritical solution causes a substantial lowering of the solvent
power of CO2 leading to very high super-saturation of solute, precipitation, nucleation
and particle growth. However, the application of the RESS process is severely limited by
the fact that polymers, in general, have very limited solubility in SC CO2 at temperatures
below 80 ° C (O'Neill, et al., 1998). Also, the operating pressure in RESS is usually above
200 bars so that it is less attractive economically.
Tsutsumi, et al., 1995; 2001 used a combination of the RESS process and a
fluidized bed for coating particles. In their research, a solution of coating material in SC
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CO2 rather than in an organic solvent is sprayed into the fluidized bed of particles to be
coated. However, particles less than 30-50 JAM fall into Geldart's group C particle
classification and are very difficult to fluidize. Hence this method cannot be used to coat
ultrafine particles
Pessey, et al., 2000; 2001 also demonstrated particle coating using a supercritical
fluid process. Their research involved the thermal decomposition of an organic precursor
and the deposition of copper onto the surface of core particles in SC CO2 under
conditions of temperature up to 200 ° C and pressure up to 190 bars. However, their
methods are less attractive from the point of view of safety and cost and probably cannot
be applied to the pharmaceutical industry since high temperature could adversely effect
or even destroy most drug powders.
The use of SC CO2 as an anti-solvent (SAS process), however, can usually be
performed at a pressure lower than 100 bars and at a temperature just above the critical
temperature (32 ° C). Also the SAS process is quite flexible in terms of solvent choice.
Thus the synthesis of ultrafine particles using SAS has been reported in a number of
studies (Reverchon, et al., 2000; Dixon, et al., 1993; Falk, et al., 1997; Young, et al.,
1999).
Falk, et al., 1997 investigated the production of composite microspheres by the
SAS process. In their research a homogeneous solution of various solutes and polymer
was sprayed into SC CO2 antisolvent. Co-precipitation of the solutes and polymer
occurred and composite microspheres or microcapsules were formed. Recently, Young,
et al., 1999 investigated the encapsulation of lysozyme with a biodegradable polymer by
precipitation with a vapor-over-liquid antisolvent, which is a modified precipitation with
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a compressed anti-solvent (PCA) process. In their research, the vapor-over-liquid
antisolvent coating process was used to encapsulate 1-10 µm lysozyme particles.
The SAS process is based on the principle of SC CO2 induced phase separation in
which the solute precipitates due to a high super-saturation produced by the mutual
diffusion of organic solvent into SC CO2 and vice versa when an organic liquid solution
comes into contact with SC CO2. An important feature of the SAS process is that the
organic solvent can be almost completely removed by simply flushing with pure CO2.
Thus, dry particles are produced after a CO2 extraction step (flushing) following feeding
of the organic solution (Randolph, et al., 1993).

4.2 Experimental
4.2.1 Materials
To evaluate the efficiency of the SAS coating process, both hydrophobic and hydrophilic
silica nanoparticles of different sizes (Table 4.1) from Degussa, USA and Catalysts &
Chemicals Ind. Co., Japan were chosen as host particles. Eudragit ® RL 100 (Rohm
America LLC, USA), a copolymer of acrylate and methacrylate, with an average
molecular weight of 150,000, was chosen as the coating material. The chemical structure
of Eudragit ® RL 100 is shown in Figure 4.1. Bone-dry grade liquid CO2 was supplied by
Matheson Gas, USA. HPLC grade acetone was purchased from Fisher, USA. All of the
materials were used as received without further treatment.
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Table 4.1 Silica Nanoparticles Used in the Experiments
Suppliers

Degussa (USA)

Catalysts & Chemicals
Ind. Co. (Japan)

Trade Name

COSMO 55

Aerosil® 90

Aerosil® R 972

Particle Size (nm)

600

20

16

Surface Property

Hydrophilic

Hydrophilic

Hydrophobic

4.2.2 Methods
The experimental set-up, schematically shown in Figure 4.2, consists of a CO2 supply
system, solution delivery system, and a high-pressure vessel (Parr Instruments, USA)
having a capacity of one liter. The high-pressure vessel is immersed in a water-bath to
keep the temperature constant during an experiment. A metering pump (Model EL-1A,
AMERICAN LEWA ® , USA) was used to deliver liquefied CO2 from a CO2 cylinder to
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the high-pressure vessel. However, before entering the pump head the liquefied CO2 was
cooled down to around zero degrees Centigrade by using a refrigerator (NESLAB, RTE111) to minimize cavitation. After leaving the pump head, liquefied CO2 was pre-heated
using a heating tape (Berstead Thermolyne, BIH 171-100).
A polymer solution was prepared by dissolving Eudragit in acetone. Silica
nanoparticles were suspended in the polymer solution to produce the desired ratio of
surface area than 16-20 nm silica, less polymer is required to coat the 16-20 nm silica

Figure 4.2 Schematic diagram of nanoparticle coating process using SAS.

Key:

1. CO2 Cylinder, 2. Cooling, 3. CO 2 pump, 4. Pre-heating, 5. On-off valve, 6. Highpressure vessel, 7. Filter, 8. Capillary tube, 9. Water bath, 10. Needle valve, 11 Highpressure pump, 12. Slurry, 13. Mass flow meter.

polymer to silica particles by weight. Since the 600 nm silica particles possess less
nanoparticles. Therefore, 14 %-20 % by weight of polymer was used for coating the 600
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nm silica as compared with 33 %-50 % for coating the 16-20 nm silica. An ultrasonicator
was used to break up the nanoparticle agglomerates in the silica-acetone suspension.
During the experiments the temperature and pressure were kept at 32.5 ° C and 82.7 bars,
respectively. When steady state conditions were reached in the high pressure vessel, i.e.,
the pressure and temperature of the CO2 became stable, the suspension was delivered by a
high pressure pump (Beckman, 110B) at a rate of 0.7 ml/min and was sprayed through a
stainless steel capilliary nozzle (125 μm ID) into the high pressure vessel. The spraying
lasted about 20 minutes followed by another 30 minutes for settling. Thereafter, CO2 was
supplied at a rate of less than 3.0 standard 1/min to remove any residual organic solvent.
The cleaning step continued for about 3 hours (e.g., at a CO2 flow rate of 1.8 standard
l/min) depending on the CO2 flow rate and the temperature. The higher the flushing
velocity and higher the temperature, the less flushing time is required. When the cleaning
step was completed, the high pressure vessel was slowly depressurized and samples were
collected for characterization. The experimental parameters are given in Table 4.2.

4.2.3 Characterization
In this study it is necessary to use a high-resolution field emission scanning electron
microscope (FE-SEM) (Jeol, JSM-6700F) for morphological observations since the
primary particles are less than 100 nm. Specimens were sputter coated with palladium
(SPI Sputter) for 20 seconds to make the surface conductive without compromising fine
surface microstructure. A nonconductive surface would produce a severe surface charge
problem under the high intensity electron beam and accumulated surface charge would
cause abnormal contrast, image deformation and distortion. A Leo 922 Omega
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Transmission Electron Microscope (TEM) was also used to examine the structure of the
encapsulated nanoparticles.

Table 4.2 Experimental Parameters in SAS Coating Process
Parameters

Polymer Concentration

Ratio of polymer to

(g/ml)

nanoparticles (g/g)

0.8

1:2

0.8

1:1

0.4

1:4

Experiments
Coating of 16 nm
hydrophobic silica
Coating of 20 nm
hydrophilic silica
Coating of 600 nm
Hydrophilic silica

1:5
1:6

FT-IR spectroscopy measurements were carried out using a Spectrum One FT-IR
Spectrometer (PerkinElmer Instruments) with PerkinElmer V3.02 Software Spectrum for
control of the instrument, data acquisition and analysis. The spectra were taken in the
range of 400-4000 cm -1 using a resolution of 8 cm -1 and 25 scans. The spectra of the
polymer, uncoated and coated silica nanoparticles were measured as pellets. The pellets
of uncoated and coated silica nanoparticles were made by mixing them with ground KBr
at a ratio of 0.85% (w/w) and were pressed by a press kit (International Crystal
Laboratories) and a 12-ton hydraulic Carver Laboratory Press (Fred S. Carver Inc.). KBr
has no absorbance in the IR range, and served as a diluent for the solid samples. In
preparing the polymer specimen, Eudragit pellets were ground into powder using a
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mortar and pestle. The ground Eudragit was then mixed with ground KBr at a ratio of
0.5% (w/w). Afterward, the mixture was made into a pellet for characterization.

4.3 Results and Discussion
4.3.1 Fundamentals of the SAS Process
In the SAS process, SC CO 2 acts as an anti-solvent, which is dissolved in the organic
solvent, reducing the solvent strength significantly (Chang and Randolph, 1990) leading
to a high degree of super-saturation and nucleation of the solute. While the actual SAS
process is complicated due to the interplay of thermodynamics, mass transfer, and

Figure 4.3 Example of ternary phase diagram for Solvent-Polymer-CO2 at constant P
and T.
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hydrodynamic effects (Dixon, et al., 1993), a schematic phase diagram of SC CO2,
solvent and solute at constant temperature and pressure is useful to understand the SAS
process and is shown in Figure 4.3. In this example, SC CO2 is completely miscible with
the solvent, while the polymer and SC CO2 are partially miscible. The solubility of
polymer in SC CO2 is very limited. Generally, almost all polymers have very low
solubility even at 50 ° C and 300 bars (Dixon, et al., 1993). In this diagram, the one-phase
region 01 represents the polymer dissolved in solvent, forming a polymer solution with
some CO2 dissolved in the solution. Region 02 is glassy region, a polymer-rich phase,
with a small amount of CO2 and solvent absorbed in the polymer. In the two-phase
region, solvent-rich phase all and polymer-rich phase 02 coexist and are in equilibrium.
The bold line (from C to B, Figure 4.3) represents the polymer solubility in the
mixture of solvent and SC CO2. The dotted straight line is an operating line that
represents the addition of polymer solution into SC CO2 (from A to B). During the
addition of polymer solution into SC CO2, an initial very small amount of solute will be
dissolved in SC CO2 with the solvent acting as co-solvent (01 region) until the saturation
of polymer in the mixture of SC CO2 and the solvent is reached (Si, saturation point).
Continued feeding of the solution into SC CO 2 results in crossing over the equilibrium
boundary and super-saturation of the polymer in the mixture of SC CO2 and solvent.
Subsequently, a phase transition will take place, depending on the starting conditions.
The phase transition will occur initially either by nucleation, an activated process in
which a free energy barrier must be surmounted, or by spinodal decomposition, a
spontaneous process in which no free energy barrier must be overcome (Kiran, et al.,
2000). In either case nucleation and precipitation of polymer induced by the phase
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transition will take place on the surface of the nanoparticles, forming a thin layer of
polymer coating.
In the present work of nanoparticle coating or encapsulation with polymer using
the SAS coating process, the polymer solution with suspended nanoparticles is sprayed
through a nozzle. If the solvent and the SC CO2 are completely miscible and the
operating conditions are above the critical point of the mixture, distinct droplets will
never form as reported by Lengsford, et al., 2000 and Bristow, et al., 2001 and the
polymer will nucleate and grow within the expanding gas plume. However, the present
experiments were operated at a temperature of 32.5 ° C and a pressure of 82.7 bars, which
is in the partially miscible region since the mixture's critical point is 35.0 ° C and 73.2
bars. Furthermore, Luo, et al., 2002 has recently submitted for publication a new
experimental paper which shows that a transient jet and jet-induced droplets exist even
when the pressure is slightly above the mixture critical pressure. It was observed that
only when the pressure is somewhat above the mixture critical pressure does the flow
behave like a single-phase gaseous jet without any definable interfacial boundaries or the
formation of droplets. Therefore, it can be assumed that in this study, droplets of polymer
solution with entrapped nanoparticles were generated due to jet break-up.
When a droplet contacts the SC CO 2 , since acetone is highly miscible with SC
CO2, a very fast mutual diffusion into and out of the droplet occurs. The polymer solution
in the droplet approachs saturation very rapidly due to the extraction of solvent from the
droplet. The subsequent crossing over the equilibrium boundary initiates the gelation of
the polymer. Meanwhile, the SC CO2 continuously diffuses into the droplet and is
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dissolved in the acetone solution. This process leads to swelling of the droplet (Randolph,
et al., 1993).
When the solvent expansion is high, Reverchon, 1999 proposed that an empty
shell or balloon structure is formed due to the interplay of mass transfer and the phase
transition. This empty shell structure was clearly observed in experiments using the SC
CO 2 SAS process for particle formation (see figure 6, Reverchon, 1999). The stability of
the balloon structure depends mainly on the expansion of the solvent by SC CO 2 , which
depends on the miscibility of the solvent and SC CO 2 . In this study acetone, which is
highly miscible with SC CO2, was used as the solvent for the polymer. Thus it is highly
probable that a balloon structure was formed which then burst into very fine viscous
droplets containing nanoparticles and polymer as shown in the cartoon in Figure 4.4.

Figure 4.4 Mechanism of fine particle encapsulation using SAS process.
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Further extraction of the solvent by SC CO2 from the gelled droplets containing
nanoparticles induced the glass transition of the polymer. Therefore, the nanoparticles
were encapsulated within a polymer film attributed to the nucleation and precipitation of
polymer on the surface of the nanoparticles. However, the encapsulated nanoparticles
within the polymer film were aggregated and agglomeration took place. Thus, a
nanocomposite with a matrix structure was formed with the nanoparticles as the host
particles and the polymer as a coating.

4.3.2 Coating of Hydrophobic Silica Nanoparticles
Hydrophobic silica nanoparticles R972 (See Table 4.1) were chosen to evaluate the
coating of nanoparticles with a hydrophobic surface. Figure 4.5 shows the morphology
and size of the hydrophobic silica nanoparticles at two different magnifications. As can
be observed, the hydrophobic silica nanoparticles exhibit the typical chained structure.
From the scale bar of the higher magnification micrograph the primary particle size is
estimated to be about 16-30 nm.
Figure 4.6 shows the SEM micrographs of the hydrophobic silica nanoparticles
coated with Eudragit at two different magnifications. When compared with Figure 4.5,
the morphology of the coated nanoparticles is quite different from that of uncoated
nanoparticles. Furthermore, the primary particle size of coated hydrophobic silica
nanoparticles is found to be increased to 50-100 nm. The morphological change and size
enlargement is attributed to polymer nucleation and subsequent growth on the surface of
the nanoparticles during the SAS coating process, forming a thin film encapsulation. The
thickness of the polymer film is estimated to be around 10-40 nm.

Figure 4.5 SEM micrographs of uncoated hydrophobic silica nanoparticles. (a) x
100,000; (b) x 300,000.

Figure 4.6 SEM micrographs of hydrophobic silica nanoparticles coated with Eudragit.
(a) x 50,000; (b) x 300,000.
TEM-EELS, which is a powerful tool in multi-component material
characterization, was used to characterize the encapsulation of the nanoparticles. In
TEM-EELS specimen preparation, a wet method was employed to achieve a good
dispersion. The encapsulated samples were dispersed in very dilute alcohol, and then
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were spread over an extremely thin carbon film (3 nm) supported by a copper grid. Zeroloss micrographs of uncoated and coated silica nanoparticles are shown in Figures 4.7 (a)
and 4.8 (a), respectively. Compared with Figure 4.7 (a), the coated primary particle size
(Figure 4.8 (a)) is estimated to be about 50 nm from the scale bar. The silicon mapping
(Figure 4.8 (b)) exhibits the same shape and morphology of the silica nanoparticle
agglomerate as the TEM Zero-Loss micrograph (Figure 4.8 (a)). As one of the major
component of the polymer, carbon shows up in a carbon mapping micrograph (Figure 4.8
(c)). The carbon signal is generally weaker than the silicon signal because the amount of
carbon is much less than that of silicon. Furthermore, carbon is number six in the
periodical table, while silicon is number fourteen, and the higher the atomic number, the
stronger the signal response to electrons.

Figure 4.7 TEM-EELS micrographs of uncoated hydrophobic silica nanoparticles. (a)
Zero loss; (b) Silicon mapping.
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Figure 4.8 TEM-EELS micrographs of coated hydrophobic silica nanoparticles. (a) Zero
loss; (b) Silicon mapping; (c) Carbon mapping.
From the carbon mapping, it is clear that the silica nanoparticles are coated with a
thin layer of polymer. Interestingly, the coating layer looks like a shell encapsulating the
nanoparticle agglomerate. However, from the carbon mapping, it also appears that the
polymer is not uniformly distributed on the surface of the silica nanoparticles. In general,
the stronger the carbon signal, the more the polymer has precipitated on the surface of the
silica nanoparticles. In region B, it appears that more polymer coating occurs. Another
feature in the carbon mapping micrograph is seen at the upper-left corner where an
amorphous region appears (A in Figure 4.8 (a)). The corresponding carbon signal is
strong (Figure 4.8 (c)), whereas there is practically no silicon signal in that region (Figure
4.8 (b)). Therefore, it can be concluded that the amorphous region is heavily coated with
polymer.
FT-IR spectrometry is a valuable characterization tool to determine the chemical
composition before and after the coating process. Three sets of FT-IR spectra of silica
nanoparticles coated with polymer, uncoated silica nanoparticles, and of the Eudragit
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powder are shown in Figure 4.9. The spectrum of Eudragit, which is a copolymer of
acrylate and methacrylate, is shown in Figure 4.9 (c). The peaks at 2992.61 cm -1 and
2954.18 cm -1 are the absorbances of the alkyl groups (-CH 3 and -CH2) stretching
vibrations. The corresponding absorbances of bending vibrations occur at 1480.47,
1448.6, and 1388.0 cm -1 . A major peak at 1732.27 cm -1 is attributed to the stretching
vibration from the carbonyl group. The band between 1300 cm -1 and 1000 cm -1 is
assigned to the polymer's C-O double bond stretching mode. The peaks before 1000 cm -1
is the fingerprint region of the polymer. The spectrum of silica nanoparticles in Figure 4.9
(b) shows a major peak at 1104.38 cm -1 , this is assigned to the Si-O stretching vibration.

Figure 4.9 FT-IR spectra for hydrophobic silica nanoparticles. (a) Coated nanoparticles;
(b) Uncoated nanoparticles (R972); (c) Eudragit.
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When compared with Figure 4.9 (c), it can be observed in the spectrum of coated
silica nanoparticles in Figure 4.9 (a) that the peaks at 2992.61 cm -1 and 2954.18 cm -I
associated with alkyl groups' stretching modes and peaks at 1480.47, 1448.6, and 1388.0
-1
cm associated with their bending vibrations show up. At exactly the same position as in
the spectrum of polymer, the absorbance at 1732.27 cm -1 assigned to carbonyl group
stretching vibration can be found in Figure 4.9 (a). However, the Si-O stretching
vibration and the C-O double bond stretching vibration have almost the same absorbance
region from 1300 cm -1 to 1000 cm -1 . The absorbance of the Si-O stretching mode is much
stronger than that of the C-O, hiding the peaks attributed to C-O. Therefore, C-O double
bond peaks do not show up in the spectrum of coated silica nanoparticles. From the FTIR chemical analysis above, a conclusion can be reached that the surface of silica
nanoparticles is coated with polymer. This strongly supports the TEM-EELS
observations.
However, it is observed that no new peak shows up in the spectrum of silica
nanoparticles coated with Eudragit, indicating that there is no chemical bond between the
polymer and the surface of the silica nanoparticles during the process of nanoparticle
coating with polymer using the SAS coating process. The SAS coating process is a
process of polymer nucleation and subsequent growth on the surface of a particle,
typically a physical process. Thus, it is desirable for pharmaceutical applications since
any chemical interaction between the coating and the substrate may result in a change in
the properties of the pharmaceutical component, which could change the effectiveness of
the drug.
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4.3.3 Coating of Hydrophilic Silica Nanoparticles
Hydrophilic silica nanoparticles (See Table 4.1) were also studied to determine the effect
of the hydrophilic surface (if any) on coating with polymer. The uncoated and coated
samples were examined using the FE-SEM. Figure 4.10 shows micrographs of
hydrophilic silica nanoparticles before and after coating. It is clear that a morphological
change occurred indicating that the hydrophilic silica nanoparticles were coated with
polymer.
The coated hydrophilic silica nanoparticles were also characterized using TEM.
The TEM micrographs of hydrophilic silica nanoparticles before and after SAS coating
can be seen in Figure 4.11 (a) and (b), respectively. The most important feature of Figure
4.11 (b) is that an amorphous region shows up in the right-upper corner of Figure 4.11
(b), indicating the polymer phase formed with a matrix structure of embedded silica
nanoparticles.

Figure 4.10 SEM micrographs of hydrophilic silica nanoparticles. (a) Uncoated x
250,000; (b) Coated x 200,000.
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Figure 4.11 TEM micrographs of hydrophilic silica nanoparticles. (a) Uncoated x
100,000; (b) Coated x 100,000.

The TEM-EELS technique was used to distinguish between the thin layer of
polymer coating and the hydrophilic silica nanoparticles. Although the wet method used
for the coated hydrophobic nanoparticles produced a good dispersion of agglomerated
nanoparticles as shown in Figure 4.8, a dry method was used for the analysis of the
encapsulated hydrophilic silica nanoparticles. In the dry method, a copper grid held by
tweezers was ploughed through the coated silica nanoparticles. The very fine
agglomerates of nanoparticles become attached to the copper grid due to Van der Waals
and electrostatic forces. This sampling method was used to better preserve the integrity of
the coated silica nanoparticles.
The Zero-loss micrograph of the agglomerate of coated hydrophilic silica
nanoparticles is shown in Figure 4.12 (a) and the micrographs of silicon and carbon
mapping can be found in Figure 4.12 (b) and Figure 4.12 (c), respectively. When
comparing the regions A and B in Figure 4.12 (b) and Figure 4.12 (c), it can be seen that

102

Figure 4.12 TEM-EELS micrographs of coated hydrophilic nanoparticles. (a) Zero-Loss;
(b) Silicon mapping; (c) Carbon mapping.
the carbon signal in the carbon mapping micrograph exactly outlines the configuration of
the silica nanoparticles shown in the silicon mapping micrograph. From the carbon
mapping micrograph, it appears that the hydrophilic silica nanoparticles were also
completely encapsulated in a polymer matrix structure.
The hydrophilic silica nanoparticles were also tested using FT-IR, to identify any
chemical changes after being coated with the polymer. Figure 4.13 shows the spectra of
uncoated silica nanoparticles, coated silica particles, and pure polymer powder,
repectively. The results are practically the same as those found for the hydrophobic silica
particles, again supporting the observations in the SEM and TEM micrographs (Figures
4.11 and 4.12) that the surface of the hydrophilic silica nanoparticles is coated with
polymer in a matrix structure.
The Degussa hydrophobic silica (Aerosil ® R972) was manufactured by modifying
the surface with dimethyldichlorsilane so that it exhibits a hydrophobic (water-repelling)
property. It was a surprise to find that the FT-IR spectra of the uncoated hydrophobic
silica (Figure 4.9 (b)) appeared to be exactly the same as that of the uncoated hydrophilic
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Figure 4.13 FT-IR spectra for hydrophilic silica nanoparticles. (a) Coated nanoparticles;
(b) Uncoated nanoparticles; (c) Eudragit.

silica (Figure 4.13 (b)). The peaks from the methyl groups and from the C-Si bond were
not observed in the Figure 4.9 (b). This is attributed to the very low concentration of
methyl groups on the hydrophobic silica, which is below the detection limit of the
Spectrum One FT-IR (0.1 % weight percent). As observed in Figure 4.9 (a) and Figure
4.13 (a), the spectra of the coated hydrophobic and hydrophilic silica also appear to be
the same. This result indicates that the SAS coating process is a purely physical
deposition of precipitated polymer on the surface of particles and is therefore independent
of the hydrophilicity or hydrophobicity of the surface of the silica nanoparticles
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However, the surface coverage of polymer on the hydrophobic silica particles
appears to be somewhat less than that of the hydrophilic silica particles when comparing
Figure 4.8 (c) to Figure 4.12 (c). This is due to the fact that a somewhat larger polymer to
silica ratio was used in the hydrophilic coating experiments (see Table 4.2)

4.3.4 Coating of 600 nm Silica Nanoparticles

To further evaluate the SAS coating process, experiments to encapsulate 600 nm silica
hydrophilic nanoparticles were conducted. The SEM microphotograph in Figure 4.14 (a)
shows the uncoated monodisperse spherical silica particles with a size of about 600 nm
from the scale bar. After the SAS coating process, it is observed that silica particles were
coated with a polymer film on their surface (Figure 4.14 (b), (c), (d)) for all three weight
ratios of polymer to silica investigated. When a ratio of polymer to nanoparticles (1:4
weight) is used, a composite particle (agglomerate), containing many primary particles,
of about 4 1.1M was formed (Figure 4.14 (b)). The formation of these large agglomerates
could be due to the plasticization of the polymer by CO2 (O'Neill, et al., 1998) under
high-pressure conditions since the glass transition temperature of the polymer is
depressed by SC CO2 (Condo, et al., 1994). The agglomerates are also formed when
using a lower ratio of polymer to nanoparticles by weight (Figure 4.14 (c) and figure 4.14
(d)). However, it appears that less agglomeration occurs when less polymer is used.
To estimate the thickness of the coating layer on the surface of the 600 nm
particles the Eugragit coated nanoparticles (1:4 weight) were heated in a Perkin Elmer
thermo gravimetric analyzer (TGA) to 800 ° C to burn off the polymer coating. If it is
assumed that the coating forms a spherical layer of constant thickness, h, then

where R is the radius of the uncoated nanoparticle, p H and p c are the densities of the host
nanoparticles and polymer coating, respectively and m H and me are the weight of the host
and polymer, respectively. From Figure 4.15 and Equation (1), h is estimated to be 75
nanometers.

Figure 4.14 SEM microphotographs. (a) Uncoated 600 nm particles; (b) Coated (polymer
to silica, 1:4, w/w) particles; (c) Coated (1:5) particles; (d) Coated (1:6) particles.
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Figure 4.15 TGA experiment to estimate the thickness of the coating layer on the surface
of 600 nm silica particles coated with Eugragit (1:4 weight ratio).
4.4 Concluding Remarks
Nanoparticle coating or encapsulation with polymer using the SC CO2 SAS coating
process was investigated in this research. The results revealed that 16-20 nm
nanoparticles were successfully coated or encapsulated in polymer by the SAS coating
process. The coating or encapsulation of nanoparticles using SC CO 2 SAS coating
process appears to be independent of surface hydrophilicity. The mechanism of the SC
CO 2 SAS coating process appears to be a heterogeneous polymer nucleation with
nanoparticles serving as nuclei with a subsequent growth of polymer on the surface of the
nanoparticles induced by mass transfer and phase transition. A polymer matrix structure
of encapsulated nanoparticles was formed by agglomeration of the coated nanoparticles.
For larger 600nm particles the thickness of the polymer coating can be controlled by
adjusting the ratio of polymer to host particles.

107
TEM-EELS was found to be the best approach for the characterization of the
coated nanoparticles since different elements can be detected at the nanoscale. FT-IR
analysis is another valuable qualitative analysis method for material characterization.
The SAS coating process is a promising environmentally friendly technique for
nanoparticle coating/encapsulation with polymer with applications to pharmaceuticals
and other products where chemical interactions must be avoided.

CHAPTER 5
ENCAPSULATION OF FINE PARTICLES WITHIN POLYMER
BY A SUPERCRITICAL ANTISOLVENT (SAS) PROCESS

In order for the research described in this chapter to stand on its own (as a publishable
research paper), some of the pertinent literature review that has already been described in
Chapter 2 is repeated in the following introduction.

5.1 Introduction

Coating or encapsulation of fine particles to produce tailored surface properties is of
great interest in the pharmaceutical, cosmetic, food and agrochemical industries. The
particle surface can be engineered to specific physical, chemical, and biochemical
properties by spreading a thin film of material on the surface of the particles.
Consequently, the flowability, dissolution rate, dispersability, chemical reactivity, bioefficacy, and hydrophilicity of particles can be modified for a variety of applications
(Davis, et al., 1998; Wang, et al., 1999; Soppimath, et al., 2001).
As discussed in Chapter 1, the conventional techniques for the encapsulation of
fine particles, such as emulsion evaporation, phase separation, spray-drying, freezedrying, etc., require large amount of organic solvents, surfactants, and other additives,
leading to volatile organic compound (VOC) emissions and other waste streams. Other
drawbacks include low encapsulation efficiency and further processing of the products
such as down-stream drying, milling and sieving, which are usually necessary. In
addition, residual toxic solvent in the end products, temperature and pH requirements,
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and strong shear forces are big challenges for maintaining the fragile protein structure in
the encapsulation of pharmaceutical ingredients.
During the past decade, supercritical fluid processes such as RESS, SAS and GAS
have attracted increasing attention for particle engineering, including fine particle
formation, coating and encapsulation. Supercritical carbon dioxide (SC CO2), in
particular, is an ideal processing medium for particle encapsulation for its relatively mild
critical conditions (T c =31.1 ° C, P c =73.8 bars). Furthermore, SC CO2 is non-toxic, nonflammable, relatively inexpensive, readily available, and chemically stable.
A number of supercritical processes for the encapsulation of particles with
polymer or composite particle formation for the controlled release of drugs have been
reported. Tom, et al., 1994 studied the co-precipitation of poly (L-lactide) (PLA)-pyrene
composite particles by a RESS. In their research, PLA and pyrene were extracted by SC
CO2 in two separate extraction columns. The two supercritical solutions were
subsequently co-introduced through a nozzle into a precipitation vessel. A sudden
depressurization results in the loss of solvent strength of the SC CO 2 , leading to a high
degree of supersaturation of the solute and the formation of composite particles of pyrene
distributed in a polymer matrix of PLA. Similar research involving the
microencapsulation of naproxen with polymer using RESS was done by Kim, et al., 1996.
Mishima, et al., 2000 reported the microencapsulation of proteins with poly ethylene
glycol (PEG) by RESS. Ethanol (about 38.5 wt. %) was used as a co-solvent to enhance
the solubility of PEG in SC CO2. The results indicated that core particles of lipase and
lysozyme were completely encapsulated by PEG without agglomeration.
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Recently, Wang et al., 2002 used a modified RESS process of extraction and
precipitation to coat particles with polymer. The coating polymer and particles to be
coated (host particles) were placed in two different high-pressure vessels, respectively.
The coating polymer was first extracted by SC CO2. The resulting supercritical polymer
solution was then introduced into the host particle vessel. By adjusting the temperature
and pressure, the polymer solubility in SC CO2 was lowered and nucleation and
precipitation of polymer took place on the surface of the host particles and a fairly
uniform polymer coating was formed. However, the potential application of RESS for
particle coating or encapsulation is limited because the solubility of polymers in SC CO2
is generally very poor (O'Neill, et al., 1998).
Pessey, et al., 2000; 2001 demonstrated the deposition of copper on nickel
particles and of copper on permanent magnetic SmCo5 particles by the thermal
decomposition of an organic precursor of bis(hexafluoroacetylacetonate) copper(II) in a
supercritical fluid. They produced a core-shell structure of copper on the surface of core
(host) particles in SC CO2 under conditions of temperature up to 200 ° C and pressure up
to 190 bars. Clearly this encapsulation method is not attractive to the pharmaceutical
industry interested in coating drug powders because the high temperature required will
be harmful for most drug powders.
In comparison to RESS, the supercritical antisolvent (SAS) process offers much
more flexibility in terms of choosing suitable solvents. Furthermore, SAS has advantages
over RESS since SAS is usually operated under mild conditions compared with RESS,
which is associated with relatively high temperature and high pressure (Chang and
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Randolph, 1989; Matson, et al., 1987; Tom and Debenedetti, 1991). Therefore RESS is
also less attractive from the point of view of safety and cost.
In SAS, SC CO2 is used as an antisolvent (instead of a solvent as in RESS) to
extract an organic solvent from a solution containing the solute, which is desired as the
coating or encapsulation material. The solution is in the form of tiny droplets, produced
by a nozzle through which the solution is sprayed into a high-pressure vessel. When the
droplets contact the SC CO2, very rapid diffusion between the droplets and the SC CO2
take place, inducing phase separation and precipitation of the solute. SAS offers the
capability of producing free flowing particles in a single step at moderate pressure and
temperature.
Young, et al., 1999 studied the encapsulation of lysozyme with a biodegradable
polymer by precipitation with a vapor-over-liquid antisolvent (below supercritical
conditions), which is a modified SAS process. Encapsulation of 1-10 micron lysozyme
particles was achieved in PLGA microspheres without agglomeration. More recently, our
research group applied the SAS process for the encapsulation of nanoparticles with
Eudragit (Wang, et al., 2003). A suspension of silica nanoparticles in a polymer solution
was sprayed into SC CO 2 through a capillary tube. The subsequent mutual diffusion
between SC CO2 and polymer solution droplets resulted in high degree of
supersaturation, causing a heterogeneous polymer nucleation induced by the phase
transition, with the silica nanoparticles acting as nuclei. Thus the nanoparticles were
individually encapsulated in polymer with very little agglomeration.
In the previous work, the amount of polymer used was found to affect both the
coating thickness and the degree of agglomeration. The objective of this study is to
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thoroughly investigate the effects of various process parameters, such as the polymer
weight fraction, polymer concentration, temperature, pressure, and flow rate, on the
coating of particles and the agglomeration of the coated particles in the SAS coating
process. Some CO2-soluble surfactants will also be applied to determine whether they
help minimize agglomeration. A mechanism for the SAS coating process based on the
experimental results was proposed.

5.2 Experimental
5.2.1 Materials
The host particles that were used in our SAS coating study were spherical silica particles
(approximately 0.5 1.1m) which were synthesized in our laboratory using the classic Stöber
process (Stöber, et al., 1968). Tetraethyl orthosilicate (TEOS) (MW 208, 98 %) was
purchased from Sigma-Aldrich Co., USA. Ammonia hydroxide (28.87 %) was purchased
from Fisher Scientific, USA and anhydrous ethyl alcohol from Aaper Alcohol, USA. The
chemicals were used without further treatment.
The coating material was poly lactide-co-glycolide (PLGA) (Resomer® 502,
MW 12,000, 50/50, T g 40-55 ° C). It was supplied from Boehringer Ingelheim Chemicals,
Inc., USA. Acetone was purchased from Aldrich (Milwaukee, WI) and used as received.
Liquid CO2 was obtained from the Matheson Company, USA. Surfactants of random poly
(fluoroalkylacrylate-co-styrene) (PFS) (29 mol% styrene) and poly(fluoroalkylacrylate)
homopolymer (PFA) were synthesized in Professor Robert Enick's laboratory at the
University of Pittsburgh. The surfactant Krytox 157 FSL, a perfluoropolyether terminated
with a carboxylic acid at one end, was supplied by DuPont Chemicals (Deepwater, NJ).

113
These surfactants were used as received without further treatment. The chemical
structures of the coating polymer and the surfactants are given in Figure 5.1. The polymer
and polymeric surfactant were listed in Table 5.1.

Figure 5.1 Repeat unit structure of poly lactide-co-glycolide (PLGA), poly
Fluoroacrylate-styrene (PFS), poly fluoroacrylate (PFA), and perfluoropolyether (PFPE)
used in this study.
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Table 5.1 Polymer and Polymeric Surfactant Properties

Polymers

State

Molecular

Content

Weight

(% mole)

Commercial Name

Solid
PLGA

50% poly
Resomer® 502 (RG 502)

12,000
glycolide

PFS

Solid

N/A

539,600

29% poly styrene

PFA

Solid

N/A

86,200

100%

PFPE

Liquid

Krytox® 157 FSL

2,500

100%

5.2.2 Methods
In the preparation of spherical silica particles, pure alcohol, ammonia hydroxide, and deionized water were mixed in an Erlenmeyer flask at desired concentrations. TEOS as then
added into the mixture that was stirred by a magnetic bar. TEOS underwent hydrolysis in
water and grew into spherical silica particles, with ammonia acting as a morphological
catalyst. After 24 hours of reaction, the solution turned into a milky suspension. The
resulting suspension was centrifuged at 3000 rpm for 5 minutes. The supernatant liquid
was then drained and the particulate sediment was re-dispersed in pure alcohol. This
washing step was needed for the removal of unreacted TEOS and water, and was
repeated twice. Finally, the sediment of silica particles was re-dispersed in acetone to
produce a suspension for further use in the SAS coating experiment.
Figure 5.2 shows a schematic diagram of the experimental apparatus which
consists of three major components: a suspension delivery system, a CO2 supply system,
and a stainless steel precipitation chamber equipped with a pressure gauge (Parr
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Instruments, USA). The precipitation chamber has a volume of 1000 ml. Its temperature
was kept at the desired value using a water bath. The stainless steel capillary nozzle used
to atomize the suspension, the CO2 inlet, and the CO2 outlet were all located on the lid of
the precipitation chamber. The system pressure was controlled by a downstream metering
valve (Swagelok, SS-31RS4, R.S. Crum & Company, USA) and was monitored by a
pressure gauge. Liquid CO2 was supplied from a CO2 cylinder by a metering pump
(Model EL-1A, American Lewa ® , USA). A refrigerator (Neslab, RTE-111) was used to

Figure 5.2 Schematic diagram of SAS coating process.

Key:

CO2 Cylinder 2. Refrigerator 3. Metering pump 4. Heating tape 5. On-off valve 6.
Precipitation chamber 7. Filter 8. Nozzle 9. Water bath 10. Metering valve 11
HPLC pump 12. Suspension 13. Pressure gauge 14. Mass flow meter 15. Wet gas
meter.
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chill the liquefied CO2 down to around zero degrees Centigrade to avoid cavitation. The
temperature of the liquefied CO2 was then raised up by using a heating tape (Berstead
Thermolyne, BIH 171-100).
In an experiment, the precipitation chamber was first charged with SC CO2.
When the desired operating conditions (temperature and pressure) were reached, a steady
flow of CO2 was established by adjusting the metering valve and the metering pump. The
flow rate of CO2 ranged from 1.0 to 5.0 standard liters per minute (SLPM). The coating
material, PLGA, was then weighed and dissolved into the acetone-silica suspension to
produce the desired polymer concentration and polymer to silica ratio. The prepared
suspension was delivered into the precipitation chamber through a capillary nozzle (ID
254 Jim) by using an HPLC pump (Beckman, 110B) for about 15 minutes. The flow rate
varied from 0.4 to 1.3 ml/min.
After spraying, fresh CO2 continued to flush the chamber in order to get rid of the
organic solvent. In this washing step, the temperature and pressure were maintained the
same conditions as before. This washing step is necessary since any condensed organic
solvent due to phase separation between the organic solvent and SC CO2 would
redissolve the polymer on the surface of particles during depressurization. The washing
step lasted about 3 hours depending on the process conditions. After the washing process,
the precipitation chamber was slowly depressurized and the coated particles were
harvested for characterization. The experimental operating conditions are listed in Table
5.2.
In the SAS coating experiments using a surfactant, a predetermined amount of
surfactant was charged into the precipitation chamber before the experiment began. Once
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Table 5.2 Experimental Operating Conditions without Surfactant

Run
T ( ° C)
No.

P
(bars)

1

33.0

89.6

PLGA
Conc.in
acetone
(mg/ml)
10.0

2

33.0

89.6

3

33.0

4

PLGA Weight
Fraction (%) of
coated particles

Flow
rate
(ml/min)

Observations

25.0

0.8

Fairly Loose agglomerates

10.0

16.7

0.8

Very loose agglomerates

89.6

10.0

12.5

0.8

Very loose agglomerates

33.0

110.3

10.0

25.0

0.8

5

38.0

89.6

10.0

16.7

0.8

6

42.5

89.6

10.0

16.7

0.8

7

33.0

89.6

4.0

16.7

0.8

8

33.0

89.6

13.0

16.7

0.8

Loose agglomerates

9

33.0

89.6

10.0

16.7

1.8

Loose agglomerates

10

33.0

89.6

10.0

16.7

2.8

Loose agglomerates

Heavily agglomerated
(Sintering)
Very loose agglomerates
Fairly loose agglomerates
(Some sintering)
No agglomerates
observed

Table 5.3 Experimental Operating Conditions with Surfactants
T (° C)

32.0

96.5

PFS

Surfactant
Conc. (wt.%)
in SC CO2
0.018

32.0

96.5

PFA

0.018

32.0

96.5

PFPE

0.018

P (bars)

Surfactant

Observations
Dense film coating on the
surface of vessel and stirrer.
Dense film coating on the
surface of vessel and stirrer.
Dense film coating on the
surface of vessel and stirrer.
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the pre-determined processing conditions were achieved, the magnetic stirrer was turned
on (600 rpm) to assist in the dissolution of the surfactant in SC CO2. The experiment then
followed the procedure described above. Table 5.3 lists the operating conditions for the
SAS coating experiments using the surfactants.

5.2.3 Characterization
The silica particles were observed under a field emission scanning electron
microscope (FE-SEM) (Leo, JSM-6700F) to observe any morphological changes before
and after the coating treatment. The samples were either spread on a carbon tape or on an
aluminum stub support device after dispersing in alcohol and evaporating. Particle size
(PS) and particle size distribution (PSD) were analyzed using a LS Particle Size
Analyzer (Beckman Coulter). Before particle size analysis, the coated and uncoated
particles were dispersed in ethyl alcohol, in which the PLGA was not dissolved, and the
resulting suspension was sonicated for 3 minutes. The sonicated suspension was then
added into the Beckman Coulter sample cell for the particle size measurement. In order
to examine the true polymer amount in the coating of silica particles at different polymer
weight fractions, thermogravimatric analyses were performed on a TGA machine (TA
Instruments, TA Q50). In this TGA analysis, 3-5 mg coated silica particles were used.
The atmosphere was air, and the flow rate was 20 ml/min. The temperature was
increased from room temperature to 500 ° C at a heating rate of 20 ° C/min, and then held
at 500 ° C for 15 minutes so that the polymer on the surface of the particles would be
completely burned off. The measured weight loss was assumed to consist entirely of
polymer since the silica particles are inert at this temperature.
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5.3 Results and Discussion
5.3.1 Theory
The solubility of the solute and solvent in SC CO2 are important considerations in the
SAS process. A successful SAS process requires good miscibility of the solvent and the
SC CO2, with the solute having negligible solubility in the SC CO2. There is also a
volumetric expansion when CO2 is dissolved in the solvent, which is important for the
precipitation of solute. The volumetric expansion AV% is defined as

where V(P, T) is the volume of solvent expanded by CO2 and V0 is the volume of pure
solvent.
In this system, acetone was used as the solvent and PLGA as the solute,
respectively. Unfortunately, there is no experimental data available for the expansion rate
and the solubility of PLGA in expanded acetone. However, the Peng-Robinson equation
of state (PREoS) (Peng and Robinson, 1976) can be used to predict the expansion
behavior of the binary system of CO2-acetone. The PREoS can be written as

where a and b are parameters of the mixture in the binary system. Originally, the PREoS
had only one interaction coefficient,

4. However, as suggested by Kordikowski, et al.,

1995, it is necessary to have a second interaction parameter l ij to account for a polar
compound in the binary system. In our system, klt is —0.007 and is —0.002, which are
regressed from the experimental data reported by Katayama et al., 1975. The mixing
rules are given as
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and P ci , T c i, and ωi are the critical pressure, critical temperature, and accentric factor of
component i, respectively.
The calculated volume expansion rate as a function of the CO2 mole fraction is
shown in Figure 5.3. The volume of acetone increases slowly with CO2 mole fraction
from 0 to 0.8. However, the volume expands significantly at higher CO2 mole fraction.
When the mole fraction is greater than 0.85, the acetone is fully expanded. The expansion
behavior of acetone results in a decrease in the partial molar volume of the solvent so that
the solvent strength is reduced. In order to predict the solubility of PLGA in expanded
acetone by CO2, the partial molar volumes of each component in the liquid phase
needs to be calculated. These are obtained by differentiating the PREoS (Walas, 1985)
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where Z is the compressibility factor. The solubility of a solute in the liquid phase of the
expanded solvent, S3 (T, P), is expressed as (Chang and Randolph, 1990)

where S3 (T,1) is the solubility at 1 atm, 172 (T, P, x) is the partial molar volume of solvent
at T, P, and x, and v2 (T,1,0) is the partial molar volume of solvent at 1 atm and at the
same temperature with no CO2 dissolved.

Figure 5.3 Volume expansion rate of acetone as a function of CO2 mole fraction at
33.0 ° C.
The predicted solubility of PLGA in acetone expanded by CO2 is shown in Figure
5.4. As seen in the figure, the solubility of PLGA in the liquid phase drops as the CO2
mole fraction is increased. When the CO2 mole fraction is above 0.7, the solubility
decreases considerably. Above 0.85, the solubility of PLGA in acetone is negligible. The
CO2 molecules tend to surround the solvent molecules and reduce the partial molar
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volume of the solvent (Chang and Randolph, 1990), causing the decreased solvent
strength.

Figure 5.4 Solubility of PLGA in expanded acetone as a function of CO2 mole fraction at
33.0 ° C.
A phase diagram is helpful to explain the SAS polymer coating process although
the overall process is very complicated due to the effects of hydrodynamics, kinetics,
thermodynamics, and mass transfer which all need to be considered. Figure 5.5 shows a
schematic ternary phase diagram for the solvent-antisolvent-polymer. The three regions
(S1), (S2) and (S3) in the diagram, represent a single phase region of polymer dissolved in
acetone with some CO2 absorbed, a single phase region of mostly polymer with some
acetone and CO2 absorbed, and a two-phase region made up of the polymer-rich phase
and the polymer-lean phase, respectively. The bold line is the solubility curve,

123
representing the solubility of PLGA in the mixture of acetone and CO 2 . The dotted line
depicts the addition of polymer solution into SC CO2.

Figure 5.5 Schematic ternary phase diagram for solvent-polymer-antisolvent at constant
P and T.
When the acetone-polymer solution (suspended with silica particles) is pumped
through a nozzle to form small droplets and contacts SC CO2, a mutual diffusion between
the SC CO2 and the polymer solution occurs instantaneously. The SC CO2 is dissolved in
acetone, leading to swelling of the droplets (Randolph, et al., 1993). With the continuing
diffusion of SC CO2 into polymer solution and acetone into SC CO2, the polymer
solution very quickly reaches saturation in the mixture of acetone and CO2 as shown in
Figure 5.5 (D, saturation point). Subsequently, the polymer solution forms two phases, a
viscous polymer-rich phase with particles entrapped and a dilute polymer-lean phase
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(From D to C). Since the solubility of most polymers is very limited, it is reasonable to
assume that the polymer-lean phase composition consists mostly of acetone and SC CO 2 .
As the mutual diffusion continues, the polymer-rich phase becomes more concentrated
and more viscous. Further removal of solvent from the polymer-rich phase induces a
phase transition to the glassy region (S2) (Lines from L to L', M to M', and N to N').
Eventually, the polymer vitrifies, forming a polymer film on the surface of particles. A
cartoon illustrating the SAS process for fine particle encapsulation (as described above) is
shown in Figure 5.6.

Figure 5.6 Cartoon of SAS process for fine particle encapsulation.

5.3.2 Coating of Fine Silica Particles
High resolution SEM pictures were taken to illustrate morphological changes before and
after polymer coating. As seen in Figure 5.7, the synthesized silica particles are spherical
and smooth on the surface. The PS and PSD of uncoated silica particles were determined
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using the LS Particle Size Analyzer. From Figure 5.8, the average PS of uncoated silica
particles is 0.556 micron with a standard deviation of 0.1 micron.

Figure 5.8 Particle size and particle size distribution of uncoated silica particles.
Figure 5.9 shows the silica particles coated with polymer at a polymer fraction of
25.0 % of the total coated particle mass. Compared with Figure 5.7, the coated silica
particles (Figure 5.9a) exhibit a different morphology and surface feature. The coated
particles are heavily agglomerated due to the polymer coating, which acts as a binder.
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During the precipitation of the polymer, the entanglement of polymer chains between
neighboring particles binds them together, forming agglomerates as shown in Figure 5.9
(a). However, after sonication in alcohol for 3 minutes, the solid polymer bridges
between the coated particles appeared to be broken as shown in the outlined area in
Figure 5.9 (b). In SEM, a high intensity electron beam is used to scan the surface of
particle. Since some of the kinetic energy of the electron beam is absorbed by the
particles, the local temperature of the area that is scanned increases. Therefore, after the
coated silica particles are exposed to the high intensity electron beam for 15 minutes, the
coating polymer becomes soft and spreads over the surface of particles (Figure 5.9 (c))
due to the low glass transition temperature of the polymer (40-55 ° C).

Figure 5.9 Coated silica particles at a polymer fraction of 25.0 % after sonication for 3
minutes. (a) Coated silica particles before sonication; (b) Coated silica particles after
sonication for 3 minutes; (c) Coated particles after being bombarded for 15 minutes with
the electron beam.
The quality of the coating and the degree of agglomeration were found to be
affected by several operating parameters including the polymer weight fraction, polymer
concentration in acetone, temperature, pressure, flow rate, and the addition of surfactants.
These will be described in detail below.
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5.3.3 Effect of Polymer Weight Fraction
The amount of polymer applied in the coating of particles is important in controlling the
coating thickness and agglomeration of the coated particles in the SAS process. The SAS
coating process was operated at 33 °C and 89.6 bars, respectively and the polymer weight
fraction was varied from 12.5 % to 25.0 % (runs 1, 2 and 3). SEM photographs of the
coated particles at different polymer weight fraction are shown in Figure 5.10. At a high
polymer weight fraction of 25.0 %, the coated particles were seriously agglomerated
(Figure 5.10 (a)). When the polymer weight fraction was lowered to 16.7 %, the
agglomeration became much less pronounced (Figure 5.10 (b)). When the polymer
weight fraction was lowered even further to 12.5 %, the agglomeration between the
coated particles also appeared to decrease (Figure 5.10 (c)).
The coated particles were analyzed in terms of particle size and particle size
distribution to determine the degree of agglomeration. In measuring the particle size and
particle size distribution, the coated particles were dispersed in ethyl alcohol. The
resulting suspension was sonicated for 3 minutes. Figure 5.11 shows the results of the

Figure 5.10 SEM photographs of coated particles at different polymer weight fractions.
(a) 25.0 % (Run 1); (b) 16.7 % (Run 2); (c) 12.5 % (Run 3).
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Figure 5.11 Average size and distribution of coated particles at different polymer weight
fractions. (a) 25.0 % (Run 1); (b) 16.7 % (Run 2); (c) 12.5 % (Run 3).
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particle size and particle size distribution at different polymer weight fractions. The
average size of agglomerates of coated particles at the fraction of 25.0 % is 10.31
microns with a standard deviation of 7.78 microns as shown in Figure 5.11 (a). It is
obvious that agglomeration among the coated particles occurred since the average size of
the uncoated particles is 0.556 microns with a narrow size distribution of 0.1 micron.
This is consistent with the observation in Figure 5.10 (a). The average size of
agglomerates of coated particles decreased considerably, to 4.29 microns with a
distribution of 2.5 microns when the particles were coated at the polymer weight fraction
of 16.7 % (Figure 5.11 (b)). When the weight fraction was reduced to 12.5 %, the
average size of agglomerates of coated particles decreased to 2.18 microns with a
distribution of 1.14 microns. There is a good agreement between the SEM photographs in
Figure 5.10 and the results of particle size and particle size distribution analysis using the
Beckman Coulter LS Particle Size Analyzer in Figure 5.11.
The true polymer amount coated on the silica particles at different weight
fractions was analyzed with TGA. The TGA curves of pure polymer and coated silica
particles at different weight fractions were shown in Figure 5.12. The pure PLGA
polymer started to decompose at about 200 ° C from the TGA analysis. When the
temperature was increased to 500 ° C and held for 15 minutes, the PLGA was totally
burned off and the TGA curve was leveled off. The TGA curve of coated particles at a
weight fraction of 25 % showed a 24.3 % weight loss. It is very close to the theoretical
polymer loading. Similarly, the TGA curves of coated samples at polymer weight
fractions of 16.7 % and 12.5 % have weight losses of 18.4 % and 13.4 %, respectively.
The true polymer weight fractions are consistent with the theoretical polymer loadings.
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Figure 5.12 Weight loss profiles of coated silica particles at different weight fraction.

5.3.4 Effect of Polymer Concentration
Polymer concentration was found to be very important in controlling the agglomeration
of coated particles in the SAS process. The polymer concentration was varied from 4.0 to
13.0 mg/ml while keeping all other operating parameters constant (runs 2, 7 and 8). SEM
photographs of coated particles at different concentrations are shown in Figure 5.13. At
high polymer concentration of 13 mg/ml, the coated particles were heavily agglomerated.
In addition, the polymer coating on the surface of particles was found to be unevenly
distributed (Figure 5.13 (a)). When the polymer concentration decreased to 10.0 mg/ml,
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the polymer coating on the surface of particles appeared smoother. Nevertheless,
agglomeration of coated particles can be seen in Figure 5.13 (b). A further decrease in the
polymer concentration to 4.0 mg/ml showed smooth particle coating with minimal
agglomeration as seen in Figure 5.13 (c).

Figure 5.13 SEM photographs of coated particles at different polymer concentrations.
(a) 13.0 mg/ml (Run 8); (b) 10.0 mg/ml (Run 2); (c) 4.0 mg/ml (Run 7).

The results of the particle size analysis of the coated particles at different polymer
concentrations are shown in Figure 5.14. Although the polymer weight fraction was kept
at 16.7 %, a higher polymer concentration results in larger agglomerates. When particles
were coated at polymer concentration of 13.0 mg/ml, the average size of agglomerates is
7.45 microns with a distribution of 4.03 microns (Figure 5.14 (a)). However, the average
size of agglomerates decreased to 4.29 microns when the polymer concentration was
reduced to 10.0 mg/ml (Figure 5.14 (b)). When polymer concentration was lowered
further to 4.0 mg/ml, the average size of agglomerates decreased significantly to 0.613
microns with a distribution of 0.135 microns (Figure 5.14 (c)). Hence it appears that no
agglomeration occurred, and the increase in average particle size is simply due to the
polymer coating on the surface of the particles. The coating thickness is estimated to be

Figure 5.14 Average size and size distribution of coated particles at different polymer
concentrations. (a) 13.0 mg/ml (Run 8); (b) 10.0 mg/ml (Run 2); (c) 4.0 mg/ml (Run 7).
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28.5 nanometers based on the measurements of uncoated particles and coated particles at
a polymer concentration of 4.0 mg/ml.
The thickness of the coating layer on the surface of the particles can also be
estimated from the polymer weight fraction. If it is assumed that no agglomeration
occurs, that the PLGA only coats the silica particles and the coating is uniform on the
surface of a particle with a thickness, t, then

where R is the radius of the uncoated particle, p H and p c are the density of the host
particles and PLGA, and m H and m e are the weight of the host particles and polymer.
Knowing the polymer weight fraction and using Equation (11), t is estimated to be 29
nanometers, which is very close to the value obtained from the size measurements of the
uncoated particles and coated particles. This calculation strongly supports the conclusion
drawn above that no agglomeration among coated particles occurs when using a polymer
concentration of 4.0 mg/ml.

5.3.5 Effect of Temperature
In previous studies using the SAS process for particle formation (Randolph, et al., 1993;
Reverchon, et al., 1998; Yeo, et al., 1993), the operating temperature was found to affect
both the particle size and morphology of the final product. Since the SAS process for
particle formation, and that for particle coating used here, are very similar, except that for
coating the host particles are suspended in the polymer solution before being delivered
into SC CO2, it is likely that temperature will have an effect on the coating and
agglomeration of the coated particles. To determine the temperature effect experiments
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were carried out at different temperature from 33 to 42.5 ° C while the other operating
parameters were kept constant (runs 2, 5, and 6). Figure 5.10 (b) and Figure 5.15

Figure 5.15 SEM photographs of coated particles at different temperatures. (a). 38 ° C
(Run 5); (b). 42.5 °C (Run 6).
show the SEM photographs of the coated particles at different temperatures. Below the
glass transition temperature of PLGA (T g , 40-55 ° C), the coated particles at 33 and 38 ° C
appear to be very similar. The average size of the agglomerates at 33 ° C is 4.29 microns
with a distribution of 2.5 microns (Figure 5.12 (b)), and at 38 ° C, 4.61 microns with a
distribution of 3.25 microns (Figure 5.16 (a)). There is only a very slight increase in
agglomerate size with temperature. However, when the operating temperature is
increased to 42.5 ° C, above the glass transition temperature of PLGA, the coated particles
were heavily agglomerated as seen in Figure 5.16 (b) due to sintering. In addition, the
polymer coating is very unevenly distributed on the surfaces of the host particles. A
particle size measurement of the coated particles at 42.5 ° C shows that the average size of
the agglomerates increases significantly from about 4.5 to 12.9 microns (Figure 5.16 (b)).
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(b)
Figure 5.16 Average size and size distribution of coated particles at different
temperatures. (a). 38 ° C (Run 5); (b). 42.5 ° C (Run 6).

5.3.6 Effect of Pressure
The pressure of the system is one of the most important variables in the SAS process
since it affects the density of SC CO2. Thus, the rate of mutual diffusion between SC CO2
and the polymer solution will be influenced. Furthermore, Mawson, et al., 1997 and
Condo, et al., 1994 found that the glass transition temperature of polymers could be
depressed by compressed CO2. In order to examine the effect of pressure, experiments
were carried out at two different operating pressures of 89.6 and 110.3 bars while the
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temperature was kept constant at 33 ° C (runs 1 and 4). Figure 5.17 shows a SEM
photograph of coated particles under a pressure of 110.3 bars. The coated particles were
heavily agglomerated compared with the coated particles shown in Figure 5.10 (a) at 89.6
bars. In addition, it was found that the polymer coating was unevenly distributed. The
average size of the agglomerates increased to 24.8 microns with a distribution of 18.4

Figure 5.17 SEM photographs agglomerates of coated particles at a pressure of 110.3
bars (Run 4).

microns as shown in Figure 5.18. This may be due to a depression in T g of the polymer in
pressurized CO2. The agglomeration of coated particles appears to be enhanced by
plasticization of coating polymer under high pressure. The degree of plasticization of
polymer is proportional to the amount of CO2 absorbed into the polymer matrix, that is,
proportional to the operating pressure. This explains why the agglomeration of coated
particles at 110.3 bars is much worse than that at 89.6 bars. Also, T g depression appears to
favor a redistribution of polymer coating on the surface of particles as seen in Figure 5.18.
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Figure 5.18 Agglomerate size and distribution of coated particles at a pressure of 110.3
bars (Run 4).

5.3.7 Effect of Flow Rate
In SAS particle formation, the flow rate of the solution has been reported to have an
effect on the particle size and morphology of final products (Randolph, et al., 1993;
Chattopadhyay and Gupta, 2000; Tu, et al., 2002). To study the flow rate effect in our
SAS coating process, experiments were performed at different flow rates varying from
0.8 to 2.8 ml/min (runs 2, 9, and 10). The SEM photographs of the coated particles are
shown in Figure 5.10 (b) and Figure 5.19. The surface of the coated particles at all three
different flow rates is fairly smooth and there does not appear to be any difference in the
degree of agglomeration due to changes in flow rate.
The particle size measurements are shown in Figure 5.11 (b) and Figure 20. No
clearly defined trend can be observed from these figures, except that the average size of
the agglomerates at a flow rate of 2.8 ml/min is slightly increased. Thus it appears that

Figure 5.19 SEM photographs of coated particles at different flow rates. (a). 1.8 ml/min
(Run 9); (b). 2.8 ml/min (Run 10).

flow rate plays a less critical role in the coating of particles in the SAS process compared
to other operating parameters, such as polymer concentration, polymer weight fraction,
temperature, and pressure, which were discussed above. However, the concentration of
the organic solvent in the suspension droplets extracted by SC CO 2 should be sufficiently
low so that the polymer coating on the surface of the silica particles solidifies before
contacting other coated particles or the surface of the vessel. Otherwise, agglomeration
would take place when the viscous liquid polymer coating on the surface of particles
contact each other. Therefore, the flow rate should be lower than a certain limiting value
to prevent agglomeration.

5.3.8 Effect of Surfactants
To evaluate the effect of surfactants in the SAS coating process, various surfactants that
are fully soluble in SC CO2 at the concentration, temperature and pressure of interest
were used. The fluoroalkyl side chains of the PFA (Blasig, et al., 2002) and PFS (Xu, et
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Figure 5.20 Average size and size distribution of coated particles at different flow rates.
(a). 1.8 ml/min (Run 9); (b). 2.8 ml/min (Run 10).
al., 2003) polymers and the polyfluoroether tail of the Krytox 157 FS (Hoefling, et al.,
1993) are known to be CO2-philic and were expected to interact favorably with the SC
CO2. It was conjectured that the CO2-phobic backbone of PFA, the backbone and
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pendant aromatic groups of the PFS, and the carboxylic acid of the Krytox 157 FS could
coat the PLGA surface.
Before starting an experiment, a known amount of surfactant was put into the
high-pressure chamber. In order to compare the effect of surfactants on the reduction of
agglomeration of coated particles, the operating conditions were chosen to be the same as
in the coating experiments without using any surfactants. When the desired experimental
conditions were reached, the magnetic stirrer was turned on (300-600 rpm) to facilitate
the dissolution of the surfactant. After about 30 minutes agitation, the suspension of
particles in polymer solution was then supplied by the HPLC pump through the nozzle
into SC CO2 with the surfactant presumed to be dissolved. The subsequent steps of
flushing with fresh CO2 and depressurization are same as the SAS coating experiments
without surfactants.
In examining the literature of dispersion polymerization in SC CO 2 , it is found
that the effective concentration of surfactants used was usually in the range of 0.1 to 2.0
weight percent in CO2 at 65 ° C and over 340 bars (Shaffer, et al., 1996; Canelas, et al.,
1998; Yates, et al., 1999; Shiho and DeSimone, 2000). In a recent study of dye
impregnation microencapsulation for latexes using CO 2 , a surfactant, Pluronic F108 was
utilized to effectively disperse the dyes by emulsifying CO2-water and CO2-ethanol
systems at concentrations from 0.1 to 1.5 % at the conditions of 25 ° C and 310 bars (Liu
and Yates, 2002). Since the pressure in this SAS coating process is 89.6 bars, much lower
than the pressures in polymerization and impregnation work, 0.1 % of PFA surfactant in
SC CO2 was initially attempted. However, the surfactant, which was known to dissolve
very slowly in SC CO2 even when agitated (Xu, et al., 2003), was found not to have been
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completely dissolved since surfactant chunks were observed inside the vessel after
disassembly of the high-pressure chamber.
In a PCA microparticle formation study done by Mawson, et al., 1997, the
effective surfactant concentrations to stabilize polymer microparticles were found to be
in the range of 0.01 % to 0.05 % depending on which surfactants were introduced into
CO2 at the operating conditions of 23 ° C and 149 bars. Therefore, the amount of
surfactant was reduced to 0.0185 % and the pressure raised from 89.6 bars to 96.5 bars.
However, once again the surfactants were found not to completely dissolve in SC CO2,
even at the lower concentration.
When the experiment was completed (using PFA), no free flowing particles or
agglomerates were found inside the chamber. Instead, a film coating occurred on the
surface of the chamber, and on the surface of the stirrer as well. The film coating was
scraped from the surface and was observed underneath the SEM. Figure 5.21 (a) shows
the coated particles scraped from the surface of the vessel in the SAS coating experiment
with the addition of PFA. It can be seen that the coated particles are very heavily
agglomerated. Furthermore, the coating is found to be very different when compared with
that in Figure 5.10 (a), even though the polymer weight fraction is the same. In a separate
experiment to measure the solubility of PFA in SC CO2, it was observed that some of the
PFA was dissolved and some was liquefied by SC CO2 at these operating conditions.
Therefore, it is hypothesized that the coated particles might have been glued together by
the liquefied PFA. After depressurization, the PFA solidified and formed solid bridges
among the coated particles, resulting in extensive agglomeration.
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To further evaluate the effect of the surfactant, the SAS coating experiment using
PFA at the same concentration (0.0185 %) was operated at a higher pressure of 121 bars
and temperature of 32 ° C, at which PFA was fully dissolved in SC CO2. However, the
result (not shown) turned out to be even worse than the coating experiment at 96.5 bars.
At the higher pressure a molecular interaction between PLGA and PFA might have
occurred since they both have -000- groups. A molecular attraction may cause the
backbone of PFA to stick to PLGA while the pendent CO2-philic fluoroalkyl groups
extend into the SC CO 2 phase. After depressurization, the CO 2 -philic fluoroalkyl chains
may intertwine and collapse, forming a network and binding the coated particles
together.
The coating experiment with PFA as a surfactant was also performed at a much
lower concentration of 0.00185%, one-tenth the previous value. However, the result was
the same.
Two other SC CO2 soluble surfactants, PFS and Krytox, were also used following
the same experimental procedure as with PFA at the concentration of 0.0185%. Again,
particle coating on the surface of the vessel and stirrer was found in both experiments.
SEM photographs of the coated products from these experiments are shown in Figure
5.21 (b) and 5.21 (c), respectively. Clearly, the coated particles are very heavily
agglomerated in both cases due to interactions between the surfactants and the PLGA.
Since none of the SC CO2 soluble surfactants were effective, two other SC CO2
soluble surfactants, poly (dimethyl-siloxane) (PDMS) (Canelas, et al., 1998) and block
co-polymer poly (propylene oxide)-poly (ethylene oxide)-poly (propylene oxide) (PPOPEO-PPO), Pluronic 25R2 (Shiho and DeSimone, 2000; Liu and Yates, 2002), which are
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soluble in acetone and in SC CO2, were tried. These two surfactants were dissolved in the
coating polymer solution since they are soluble in acetone and were sprayed into SC CO2

Figure 5.21 SEM photographs of coated particles using surfactants. (a). PFA; (b). PFS,
(c). Krytox. (Polymer weight fraction 25.0 %, polymer conc. 10 mg/ml, flow-rate, 0.8
ml/min).
along with the silica particles and the coating solution. The results showed that the
coatings, with or without either of these surfactants present, were similar; no effect on the
minimization of agglomeration of coated particles was observed (Data not shown).

5.4 Concluding Remarks
Particle coating with polymer using the SAS process with SC CO 2 was systematically
studied. Our results show that submicron silica particles were successfully coated or
encapsulated by PLGA in the form of loose agglomerates. It was found that the polymer
weight fraction and the polymer concentration play critical roles in the agglomeration of
the coated particles. A high polymer weight fraction favors the agglomeration of the
coated particles and the uneven distribution of the polymer coating. A low polymer
concentration of 4.0 mg/ml appears to prevent agglomeration among the coated particles.
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The operating pressure and temperature were also found to influence agglomeration. A
higher pressure facilitates the agglomeration of coated particles due to sintering because
the glass transition temperature of the polymer, T g , is depressed. The operating
temperature appeared to have little effect on the agglomeration of the coated particles
when the temperature is below the glass transition temperature; however, when the
operating temperature is above T g , the polymer coating on the surface of particle appears
to be sintered causing strong agglomeration. The flow rate of the polymer suspension was
found to have little effect on the agglomeration.
Five surfactants, PFA, PFS, Krytox, PDMS, and Pluronic 25R2, all soluble in SC
CO2, were used in the hope that they would suppress agglomeration of the coated
particles in the SAS process. However, the results showed that the PDMS and Pluronic
25R2 surfactants, which are also soluble in acetone, had no effect on minimizing
agglomeration of the coated particles. The PFA, PFS, and Krytox surfactants,
surprisingly, actually, facilitated agglomeration.

CHAPTER 6
APPLICATION OF SUPERCRITICAL ANTISOLVENT
PROCESS FOR CONTROLLED DRUG DELVIERY SYSTEM

In order for the research described in this chapter to stand on its own (as a publishable
research paper), some of the pertinent prior work that has already been described in
Chapter 2 may be repeated here.

6.1 Introduction
The incorporation of a pharmaceutical ingredient into a polymer carrier is of great
interest for controlled drug delivery systems. Polymer based drug delivery carriers are
required for many reasons. Each drug has a concentration range that provides optimal
therapeutic effects. When the drug concentration falls out of this range, either higher or
lower, it may cause toxic effects or become therapeutically ineffective. Therefore, it is
desirable to release the drug content from a polymer carrier in a sustained or a controlled
manner so as to eliminate the potential of either underdosing or overdosing. A polymer
carrier can also provide protection for fragile drugs, such as proteins and peptides, from
hydrolysis and degradation. For highly toxic drugs, a polymer carrier for target release is
required to shield them until they are released at the target tissue. In addition, a drug
controlled release system can improve patient compliance by reducing the drug
administration frequency.
Polymer-based microsphere controlled drug release has attracted significant
attention recently because of flexibility of administration. Microspheres less than 100 gm
are suitable for intravenous injection. When the particle size is less than 5 pm, the
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microspheres can be administered via inhalation drug delivery. Submicron microspheres
can even be injected directly into circulation system. In controlled drug release, polymerbased microspheres usually have either a matrix or a microcapsule structure. In a matrix
structure, the drug is uniformly dispersed in a polymer matrix whereas a microcapsule is
composed of drug particles as core particles surrendered by a polymer coating film.
For both the matrix or microcapsule structure, drug release occurs by one (or
both), of two primary mechanisms: diffusion release or degradation release. Diffusion
release takes place when an incorporated drug passes through the polymer pores or
through polymer chains. This drug controlled release system can be designed by using a
smart polymer, whose permeability is dependent on the environmental conditions, such
as pH, temperature, and ionic strength, etc. (Dorski, et al., 1997). For example, pH is the
stimulant for an acidic or basic hydrogel, and temperature is the stimulant for a thermoresponsive hydrogel (poly N-isopropylacrylamide). Degradation release occurs when a
polymer degrades within the body as a result of natural biological processes, such as
hydrolysis. In this type of controlled release system, the selection of the polymer is
critical since the degradation is dependent strongly on its chemical structure and
molecular weight. The most popular biodegradable polymers for drug controlled release
systems include poly (lactic acid), poly (glycolic acid) and their copolymers (BrannonPeppas, 1995).
Drug loaded microspheres can be made by emulsion evaporation, phase
separation, spray-drying, freeze-drying, and interfacial polymerization techniques. All of
these methods involve the dissolution of the polymer and the drug in an organic solvent,
dispersion of the solution under a strong force, and stabilization under certain
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temperature and pH conditions. However, problems of residual organic solvent in the
final product and low encapsulation of drugs due to partitioning of the pharmaceutical
components between two immiscible liquid phases are frequently encountered.
Moreover, harsh conditions, such as temperatures, pH conditions, and strong shear forces,
may denature some bio-active agents. Also, extensive downstream processing is usually
required when using these conventional methods.
Supercritical CO2 (SC CO2) is the most widely used supercritical fluid because of
its mild critical conditions (T c =31.1 ° C, P c =73.8 bars), non-toxicity, non-flamability, and
low price. The low critical temperature of CO2 makes it attractive for processing heatsensitive flavors, pharmaceuticals and labile lipids (McHugh and Krukonis, 1994). The
use of SC CO2 for microparticle preparation has been widely reported using rapid
expansion of supercritical solution (RESS) (Krukonis, 1984; Matson, et al., 1987;
Mohamed, et al. 1989; Charoenchaitrakool, et al. 2000; Tom and Debenedetti, 1991) and
a variety of antisolvent processes (GAS/SAS/ASES/SEDS) (Yeo, et al., 1993; Dillow, et
al., 1997; Reverchon, et al., 1998; Gallagher, et al., 1989; Lim, et al., 1998; Dixon, et al.,
1993; Winter, et al., 1999; Thies and Miller, 1998; Hanna, et al., 1998).
The application of SC CO2 processes to prepare drug loaded polymer
microspheres for controlled drug release has become a fast growing field. Tom and
Debenedetti, 1994 investigated a SC CO2 process for the formation of drug loaded
microspheres for controlled drug release. In this pioneering work, a model system of
biopolymer PLA and pyrene was chosen for the composite powder formation study. PLA
and pyrene were dissolved in SC CO2 with acetone as a cosolvent in two different units.
The two resulting supercritical solutions were mixed and were pumped to an expansion
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device (orifices or capillaries, 25-50 pm). When the solution flowed through the
expansion device, it underwent a rapid decompression, resulting in co-precipitation of the
solutes. It was found that the pyrene was uniformly incorporated into the produced
polymer microspheres. Kim, et al., 1996 did a similar study using the RESS coprecipitation process and produced microspheres with a naproxen core encapsulated in a
PLA coating.
Mishima, et al., 2000 studied the microencapsulation of protein particles using the
RESS process. In this study the protein (lysozyme and lipase) particles were suspended in
a polymer solution in SC CO2 (with ethanol as the cosolvent) instead of being dissolved
as was done in the co-precipitation process (Tom and Debenedetti, 1994 and Kim, et al.,
1996). The suspension was then sprayed through a capillary nozzle (280 pm). The results
showed that the protein particles were successfully encapsulated in a polymer coating
without agglomeration.
However, the application of RESS process is severely limited by the fact that
most of the polymers and drugs of interest are not soluble in SC CO2 at a reasonable
concentration. As an alternative, antisolvent processes (GAS/SAS/ASES/SEDS) for drug
delivery system design has attracted a lot of attention recently because of its flexibility in
choosing a suitable solvent which is miscible with SC CO2.
Bleich and Miller, 1996 studied drug-loaded particle formation using the ASES
process. PLA was used as the carrier and several different drugs, such as hyoscine
butylbromide, indomethacin, piroxicam and thymopentin, were selected as model drugs
for this study. The drugs and PLA were dissolved in methylene chloride and the solution
was atomized into SC CO2 through a 400 pm nozzle at a flow rate of 6 ml/min. The
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solvation of SC CO 2 in the organic solvent resulted in the formation of drug loaded
microparticles. It was found that, with decreasing polarity of the incorporated drug, drug
loading was lowered as a result of an increase in extraction by SC CO 2 , with the organic
solvent acting as a cosolvent. Polar drugs, such as proteins and peptides, were
successfully encapsulated by the ASES process whereas non-polar drugs failed to be
encapsulated and were completely extracted by the SC CO2 and the organic solvent.
Falk, et al., 1997 proposed making drug loaded microspheres using the SAS
process. In this study drugs of gentamycin, naloxone and naltrexone and PLA were
dissolved in methylene chloride using the hydrophobic ion-pairing (HIP) complexation
method, which improved the solubility of the drugs considerably, to make a
homogeneous solution. The prepared solutions were sprayed into SC CO2 through an
ultrasonic nozzle vibrating at 120 kHz. The drug loaded microspheres (0.2-1.0 μm)
formed due to the co-precipitation of the drugs and the PLA. Drug release tests showed
that gentamycin was successfully incorporated into a PLA matrix, exhibiting diffusion
controlled drug release. However, naltrexone and rifampin were found to be poorly
incorporated because these two drugs were more lipophilic and somewhat soluble in SC

CO2, resulting in drug surface bonding on the microspheres.
Elvassore, et al., 2001 studied the formation of protein loaded polymeric
microcapsules in the SAS process. A model system of insulin and PLA was dissolved in a
mixture of DMSO and dichloromethane. The prepared solution was then sprayed into SC
CO2 through a 50 ,Lin fused silica nozzle. The results showed that insulin loaded
microspheres with particle size from 0.5 to 2 μm were produced and the incorporation
efficiency was as high as 80%.
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Ghaderi, et al., 2000 studied the formation of microparticles with hydrocortisone
loaded in DL-PLA polymer using a combination of SC N2 and CO 2 as the antisolvent in
the SEDS process. It was shown that microparticles of size less than 10 p.m were
produced. Hydrocortisone was successfully entrapped in DL-PLA microparticles with a
loading efficiency up to 22%. The combination of SC N2 and CO 2 was found to facilitate
a more efficient dispersion of the polymer solutions than SC CO 2 alone.
Recently Tu, et al., 2002 attempted the microencapsulation of parahydroxybenzoic acid (β-HBA) and lysozyme with PLA using the ASES process. In this
research the drug solution, polymer solution and SC CO2 were delivered through a
specially designed coaxial multiple nozzle. A higher loading efficiency of 15.6 % was
achieved for lysozyme encapsulation, while the β-HBA was poorly encapsulated with an
efficiency of only 9.2 %.
Most of the reported research on the formation of drug loaded microspheres for
controlled drug release has focused on the co-precipitation of the solute of interest (drug)
and the carrier polymer using an antisolvent process. However, since a SAS coprecipitation process requires the dissolution of both the drug and the polymer in a
solvent, this creates a challenge for proteins since many proteins are insoluble in organic
solvents. Also, many organic solvents can denature the protein's bioactivity. Moreover,
the co-precipitation of two different solutes is difficult to achieve except when the two
solutes have similar thermodynamic properties and undergo similar precipitation
pathways.
Therefore an alternative antisolvent process for particle coating or encapsulation
was developed for drug delivery applications. In this process the host particles of interest
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are suspended in a coating polymer solution instead of being dissolved as in the coprecipitation process. The prepared suspension is either sprayed into SC CO2, or SC CO2
is injected into the suspension. As a result of the mutual diffusion between SC CO2 and
the organic solvent, the polymer becomes supersaturated, is driven out of solution and
deposits on the surface of the host particles producing a film coating.
Bertucco and Vaccaro, 1997 did a preliminary study of particle encapsulation by
polymer using a GAS process. In their study, particles of KCl were suspended in a
solution of polymers (hydroxypropyl methylcellulose phthalate, Eudragit E 100,
ethylcellulose) in various organic solvents (toluene, acetone, 1,4-dioxane, ethylacetate).
Compressed CO2 was introduced into a high-pressure vessel, in which the suspension
was charged. The compressed CO2 was dissolved in the organic solution, leading to the
loss of solvent strength of the organic solvent. As a result, the polymer precipitated out
and deposited on the surface of suspended KCl particles.
Young, et al., 1999 studied the encapsulation of lysozyme in a biodegradable
polymer by precipitation with a vapor-over-liquid antisolvent, which is simply a modified
precipitation with a compressed anti-solvent (PCA) process. In this work, a suspension of
1-10 micron lysozyme particles in a polymer solution was sprayed into CO2 vapor over a
CO2 liquid phase (below supercritical conditions) through a nozzle. By delayed
precipitation, particles were allowed to grow large enough to encapsulate lysozyme. The
process showed a high encapsulation efficiency because the polymer precipitated onto the
surface of protein particles in a small droplet.
The objective of this research is to apply the SAS process to coat or encapsulate
drug particles to achieve controlled drug release. Drug particles less than 30 p.m in size
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were chosen as hosts and a biopolymer of PLGA (50:50) was used as the coating
polymer. The SAS process requires good miscibility of the solvent and SC CO 2 . Once the
polymer solution containing host particles in suspension contacts SC CO2, very rapid
mass transfer from the organic solvent to the bulk SC CO2, and vice versa, takes place so
that a high degree of supersaturation is achieved. The polymer nucleates and precipitates
out of solution and deposits on the surface of the host particles; a film coating can be
expected if sufficient polymer is deposited on the surface of the host particles.

6.2 Experimental
6.2.1 Materials
The coating material was poly lactide-co-glycolide (PLGA) (Resomer® 502, MW
12,000, 50/50 T g 40-55 0 C) supplied by Boehringer Ingelheim Chemicals, Inc., USA.
,

The structure of PLGA can be seen in Figure 5.1. Acetone was purchased from Aldrich
and used as received. Bone-dry liquid CO2 was obtained from the Matheson Company,
USA. Hydrocortisone (HC) (mean size less than 30 m) was supplied by ICN Biomedical
Inc., USA. It was used as received without further treatment. The molecular structure of
hydrocortisone is shown in Figure 6.1.

6.2.2 Methods
The experimental set-up is schematically shown in Figure 6.2. It consists of three major
systems: a suspension delivery system, a CO2 supply system, and a stainless steel high
pressure chamber with a volume of 1000 ml (Parr Instruments, USA). A water bath
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Figure 6.1 Molecular structure of hydrocortisone.

is used to keep the temperature at a desired value. A metering valve (Swagelok, SS31RS4, R.S. Crum & Company, USA) was utilized to control the system pressure; the
CO2 inlet and outlet, and a pressure gauge are located on the lid of the high pressure
chamber. A capillary nozzle (254 p.m ID) is used to spray the suspension into the high
pressure chamber and a metering pump (Model EL-1A, American Lewa®, USA) is used
to deliver liquid CO2 into the chamber from a CO 2 cylinder. The liquid CO2 is chilled to
around zero degrees Centigrade by a refrigerator (Neslab, RTE-111) to avoid cavitation.
A heating tape (Berstead Thermolyne, BIH 171-100) is used to preheat the liquid CO2
before it enters into the high-pressure chamber.
The experimental protocol is as follows. The precipitation chamber is first
charged with SC CO2. After the predetermined operating conditions (temperature and
pressure) are reached, a steady flow of CO2 is established by adjusting the metering valve
and the metering pump. The flow rate of CO 2 was usually less than 3.0 standard liters per
minute (SLPM). PLGA and hydrocortisone are then weighed and mixed into
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Figure 6.2 SAS coating process set-up.
Key:

1. CO 2 Cylinder, 2. Cooling, 3. CO 2 pump, 4. Pre-heating, 5. On-off valve, 6. Highpressure vessel, 7. Filter, 8. Capillary tube, 9. Water bath, 10. Needle valve, 11 Highpressure pump, 12. Slurry, 13. Mass flow meter.

dichloromethane (DCM) to produce a suspension with the desired polymer concentration
and PLGA to HC ratio. The made suspension is then injected at a flow rate of 0.8 ml/min
into the high pressure chamber through the capillary nozzle by using an HPLC pump
(Beckman, 110B) for about 10 minutes. After spraying, fresh CO2 is supplied
continuously to purge the chamber with about 1 equivelent volume of CO2 in order to
remove any remaining dichloromethane. After purging, the precipitation chamber is
slowly depressurized and the coated drug particles collected for characterization.
In addition, a parallel study of co-precipitation of hydrocortisone and PLGA was
performed for comparison purposes. In the co-precipitation experiment, PLGA and
hydrocortisone are dissolved in either acetone or a mixture of methanol and (volume ratio
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of 1:1) to make a homogeneous solution. The solution is then sprayed into the highpressure chamber at the same operating conditions as was used in the SAS coating
process. The operating conditions of the SAS coating and the co-precipitation
experiments are listed in Table 6.1.

Table 6.1 Experimental Conditions in SAS Coating and Co-precipitation Process
Parameters
Experiments
Coating of drug

Solvent

Polymer
Conc. (g/ml)

Ratio of polymer
to particles (g/g)

DCM

1.0

1:4

particles

1:2
1:1

Co-precipitation of

Acetone

1.0

1:1

drug and PLGA

Methanol and DCM

1.0

1:1

6.2.3 SEM Microscopy
Field emission scanning electron microscopy (FE-SEM) (Leo, 1530VP) was used to
observe any morphological changes before and after the coating treatment. The samples
were simply spread on carbon tape for observation under SEM.

6.2.4 HPLC Analysis
HPLC assay analysis of hydrocortisone was performed using a Hewlett Packard 1100
equipped with a reverse phase C-18 column (Microsorb-MV 100, 150x4.6 mm,
Varian). The mobile phase was made at a composition of acetonitrile : purified water
(40:60, v/v) and the injection volume was 10 Ill. The flow rate was 1.0 ml/min and
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hydrocortisone was detected at 242 nm by a UV detector. The run time for the assay was
4.0 minutes and the retention time for hydrocortisone was 2.9 minutes.

6.2.5 Determination of Encapsulation Efficiency (EE)
A known amount of coated drug samples was washed with ethanol, which is a good
solvent for hydrocortisone but a poor solvent for PLGA, to dissolve the uncoated or
partially coated drug particles. The suspension was centrifuged at 1500 rpm for 5
minutes. The supernatant fluid was sampled to determine the un-encapsulated drug
content using HPLC. The sediment was then dissolved with a mixture of acetone and
ethanol (50:50) and the drug content was determined using HPLC assay analysis. Each
sample was analyzed in triplicate. The encapsulation efficiency (EE) was calculated using
the following equation:

6.2.6 In vitro Drug Release Tests
The coated or encapsulated drug was weighed and put into a test tube along with 30 ml of
pH buffer solution (PBS, pH 7.4) with 0.05% Brij 58. A small magnetic stirrer bar was
used to improve the mixing. All samples were incubated at 37 0 C while being agitated.
At given time intervals the test tubes were centrifuged at 1500 rpm for 5 minutes and 200
Ill of supernatant fluid was transferred into small vials for HPLC assay analysis, and was
replaced with the same volume of fresh PBS. Dissolution tests of each sample were
performed in three replicates.
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6.3 Results and Discussion
SEM pictures of the original hydrocortisone particles are shown in Figure 6.3.
Hydrocortisone is seen to be in crystal form with defined facets and sharp edges. The
average particle size is less than 30 μm as seen from the scale bar. The coated
hydrocortisone particles, at a polymer to hydrocortisone weight ratio of 1:4, are shown in
Figure 6.4. The coated particles have a different shape (morphology) and no clear sharp

Figure 6.3 Original hydrocortisone particles at different magnifications.

Figure 6.4 Coated hydrocortisone particles at polymer to particle ratio of 1:4 at different
magnifications.

158
edges when compared with the uncoated drug particles. This indicates that some of the
drug particles were partially coated with polymer during the SAS process but no film
coating or encapsulation seemed to have occurred.
The difference in shape between the coated and uncoated drug particles may be
attributed to the fact that some hydrocortisone (about 17% of the total) dissolved in
DCM, although DCM is not a good solvent for hydrocortisone. The dissolved drug may
undergo nucleation and re-crystallization during the SAS process. Therefore, the recrystallized drug particles formed during the SAS process may have a different shape
than the original particles.
When the polymer to drug ratio was increased to 1:2, more polymer precipitated
out and deposited on the surface of the drug particles as seen in Figure 6.5. The smaller
drug particles seemed to be embedded or entrapped in the coating polymer. However, the
larger drug particles appeared to have been left uncoated, indicating that large, irregular
shaped particles may require even more polymer to encapsulate them.

Figure 6.5 Coated hydrocortisone particles at polymer to particle ratio of 1:2 at different
magnifications.
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In order to encapsulate the larger particles, the polymer loading was increased to a
polymer to drug ratio of 1:1. SEM pictures of the coated drug particles are shown in
Figure 6.6. As observed in Figure 6.6, more polymer coating took place on the surface of
the drug particles as compared with drug particles coated at a 1:4 (Figure 6.4) and a 1:2
ratio (Figure 6.5). Some of the smaller drug particles were even encapsulated in polymer
microspheres. However, it was found that the polymer coating on the surface of the drug
particles was still unevenly distributed due to the irregularity of the drug particles. Thus it
appears that uniformly coating or encapsulating irregular particles by SAS presents a
major challenge.

Figure 6.6 Coated hydrocortisone particles at polymer to particle ratio of 1:1 at different
magnifications.

A parallel study was performed to compare drug particle coating and coprecipitation using the SAS process. In the co precipitation experiments, hydrocortisone
-

and PLGA were dissolved in acetone or a mixture of methanol and DCM. A clear
solution instead of a suspension was sprayed into SC CO2 in the SAS process.
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SEM photographs of the co-precipitated particles of drug and polymer in Figure
6.7 clearly show that the co-precipitated particles have a very different morphology and
shape from the original particles. The re-crystallized drug particles have defined facets
and the polymer appeared to be simply attached to (rather than coating) the surface of the
re-crystallized drug particles. It was apparent that there was a phase separation during the
precipitation of polymer and drug from the acetone or mixture of DCM and methanol
solutions. Therefore, it appears that no coating or encapsulation occurred in the SAS coprecipitation process.

Figure 6.7 Co-precipitated particles of polymer to drug ratio at 1:1. (a) Methanol and
DCM; (b) Acetone.

The coated drug particles and co-precipitated drugs were analyzed to determine
the encapsulation efficiency. The results are listed in Table 6.2. The coated drug particles
at a polymer to drug ratio of 1:4 showed that drug particles were not encapsulated within
the polymer. This supported the conclusion that the drug particles were only partially
coated by polymer as shown in Figure 6.4. In the encapsulation efficiency test, if an
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uncoated part of the surface of a drug particle is exposed to ethanol, the whole drug
particle would be dissolved gradually. Therefore, partially coated drug particles did not
show any encapsulation efficiency. When the polymer loading was increased to a ratio of
1:2, more polymer coating occurred on the surface of drug particles and the average
encapsulation efficiency increased to 6.7%. When more polymer was used, the smaller
drug particles were probably completely encapsulated by the polymer. Consequently,

Table 6.2 Encapsulation Efficiency (EE) of Coated and Co-precipitated Drug Particles
Ratio of
PLGA to HC
1:4
1:2

Average
(%)
0

SD

*Coating

Encapsulation
Efficiency (EE) (%)
0

Coating

8.4

6.7

± 1.4

22.6

± 2.3

0

0

0

0

0

0

SAS Process

0

6.3
5.4
1:1

Coating

21.5
25.2
21.2

1:1
1:1

*Co-precipitation from
methanol and DCM
*Co-precipitation from
acetone

* Analysis was performed in three replicates on each sample.

these encapsulated drug particles were not washed away by ethanol in the encapsulation
efficiency test and they contributed to the encapsulation efficiency. However, the
encapsulation rate was not improved considerably even though the polymer loading was
doubled. This was probably due to the fact that the larger, irregular-shaped drug particles
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left some sharp edges or corners uncoated and therefore were completely dissolved by the
ethanol treatment.
When the polymer to particle ratio was further raised to 1:1, more drug particles
were encapsulated and the encapsulation efficiency increased to 22.6%. This supported
the observation in Figure 6.6 that more of the drug particles were completely
encapsulated or trapped in polymer microspheres. This suggests that the encapsulation
efficiency could be further improved by either increasing the amount of polymer or
reducing the size of host particles.
The co-precipitated drug and polymer particles from either acetone or a mixture
of methanol and DCM showed no encapsulation of drug particles even at a polymer to
drug ratio of 1:1. This is in good agreement with what was observed in Figure 6.7 that the
re-crystallized drug was not encapsulated with polymer and that the polymer was simply
attached on the surface of the drug particles.
In vitro drug release tests were carried out to determine the release behavior of

coated drug particles at different polymer to drug ratios. The release profiles are plotted
in Figure 6.8. The drug particles coated at a 1:4 ratio showed a fast release behavior;
almost all of the drug content was released in about 1.5 hours. This rapid release rate was
attributed to the fast dissolution of the drug particles. The release behavior confirmed the
result of the encapsulation test of the coated particles at a 1:4 polymer to drug ratio that
no drug particles were entirely encapsulated.
The coated particles at a 1:2 ratio showed an initial release of about 90% of the
drug content in about 1.5 hours. After the initial burst, a second phase of much slower
drug release (Figure 6.8) occurred. At day 9 the PLGA started to degrade and the rest of
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the encapsulated drug was released in about 1 day. This suggested that about 10% of the
drug particles were completely encapsulated, which was close to the encapsulation
efficiency test result. The uncoated or partially coated drug particles were quickly
dissolved in the release medium and this accounted for the burst release.
The drug particles coated at a 1:1 ratio showed a lower amount of fast release of
drug than those coated at the 1:2 ratio. About 80% of drug was released during this phase.
After this initial burst stage, a period of much slower drug release occurred before the
onset of the polymer degradation stage. In about 9 days, PLGA started to degrade and the
encapsulated drug was continuously released for about 3 days. This release behavior

Time(days)

Figure 6.8 Overall hydrocortisone release profiles of coated drug particles at different
polymer to drug ratios.

164
again supported the results of the encapsulation efficiency test on the coated drug
particles at a 1:1 ratio. The sigmoidal release profile exhibited by the drug articles coated
with at a 1:1 polymer to drug ratio was typical of polymer degradation controlled drug
release (Fitzgerald and Corrigan, 1996; Gallagher and Corrigan, 2000). By increasing the
amount of polymer used for coating or reducing the size of the drug particles, a larger
fraction of drug particles would be incorporated into polymer microspheres. Thus, the
initial burst release would be reduced and the release of drug would last longer.
To compare the SAS coating and co-precipitation processes, a drug release test of
the co-precipitated sample from acetone was performed following the same procedure.
The release profile is shown in Figure 6.9. It is clear from the figure that the recrystallized drug and PLGA from the co-precipitation process exhibited a very fast

Figure 6.9 Overall hydrocortisone release profiles of coated drug particles and coprecipitated drug and PLGA from acetone.
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release of the drug throughout the entire duration of the test. This suggests that no
encapsulation occur ed during the co-precipitation of drug and PLGA even at a polymer
to drug ratio of 1:1. This release test result confirmed the encapsulation test result.

6.4 Concluding Remarks
Hydrocortisone particles were shown to be successfully coated with PLGA in the
SAS coating process. At a low 1:4 polymer to drug weight ratio the drug surface was
only partially coated and no encapsulation (encapsulation efficiency of zero) occurred
The encapsulation efficiency improved with an increase in polymer to drug ratio and
increased to 22.6% when the polymer to drug ratio was 1:1. At polymer to drug ratios of
1:2 and 1:1, the coated drug particles exhibited a sustained release behavior. However,
coprecipitations of drug and polymer (both in solution) failed to achieve encapsulation;
the polymer appeared to be simply attached in chunks on to the surface of the drug
particles.
Although the encapsulation efficiency achieved was low and an initial burst stage
was observed, an impovement in the drug sustained release properties could probably be
obtained by increasing the polymer loading or reducing the size of the drug particles
because smaller particles have a greater chance to be encapsulated or entrapped. Thus the
SAS coating process is a promising technique for the design of drug delivery systems and
might be especially useful for inhalation drugs where the particle size cannot be larger
than a few microns.

CHAPTER 7
RECOMMENDATIONS FOR FUTURE WORK
The research presented in this dissertation has focused on applying supercritical fluid
processes for particle coating or encapsulation. Two main processes have been
investigated: a modified RESS and a SAS coating process. An important commercial
application of the SAS coating process is in the coating or encapsulation of drug particles
for controlled drug release system design. The results of this research showed that
supercritical CO2 could be been successfully applied as an antisolvent for particle coating
or encapsulation when using a polymer as the processing (coating) medium. The SAS
coating process, in particular, because of its flexibility in choosing a solvent for
dissolving the polymer and the mild operating conditions associated with supercritical
CO2, has been utilized to coat or encapsulate particles in a very broad size range from 20
nm to 30 p.m. Moreover, it was found that each individual particle could be coated or
encapsulated with polymer with minimum agglomeration.
The nature of the physical deposition process due to a phase separation, which is
prompted by mutual mass transfer between SC CO2 and an organic solvent, made the
SAS coating process attractive for controlled drug release. A case study of
hydrocortisone particle coating or encapsulation with PLGA polymer utilizing the SAS
coating process revealed that the coated or encapsulated drug particles showed sustained
release behavior. Thus the SAS process is very promising for coating or encapsulating
those drugs, which are heat sensitive and less likely to be dissolved (e.g. peptide or
proteins) in organic solvents.
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Although supercritical coating processes (Modified RESS and SAS) are
technically feasible alternatives for particle coating or encapsulation, they are still in their
nascent stage. The results of this dissertation suggest many opportunities for future
research work. Since the solubility of many substances of interest in supercritical CO2 is
very low, the application of a modified RESS particle coating process is limited.
Therefore specific recommendations for future work are directed to the SAS coating
process; these include a better understanding of its fundamentals, applicability,
productivity enhancement, and applications for controlled drug release.

7.1 Recommendation for Future Work in the SAS Coating Process
7.1.1 Fundamental understanding of the SAS coating process
The SAS process has been extensively investigated both in the academic and industrial
arena. Numerous research results have been published covering its applications for
particle formation and particle coating, modeling and computer simulations, and
mechanisms. The SAS process is very complicated since thermodynamics, kinetics, mass
transfer, and hydrodynamics are all involved. Although many mechanisms were proposed
from different point of views in many publications (Dixon, et al., 1993; Thies and Műller,
1998; Randolph et al., 1993; Bristow, et al., 2001), the fundamental understanding of
SAS process remains unclear and contradictory observations were revealed (Reverchon
and Porta, 1999; Moshashaée, et al., 2000). Due to the interplay of thermodynamics,
kinetics, mass transfer, and hydrodynamics, an isolated consideration of one or two
effects is not sufficient to address this complex issue. This is the reason why
contradictory findings were reported on different systems.
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To fully understand the SAS process, the thermodynamics of solvent sColOut2e
-

phase behavior should be considered first. It determines the mass transfer, the degree of
supersaturation of solute, and the interfacial energy of the solute and solvent, which will
affect the particle size, particle size distribution, morphology and crystalline structure.
Therefore, it is necessary to investigate the thermodynamic behavior before one considers
a system for particle formation. In consideration of mass transfer, the diffusion
coefficient between the SC CO2 and organic solvent is important because the time scale
for the solution to reach a high degree of supersaturation is strongly dependent on the
mass transfer between the two miscible phases. Faster mass transfer favors primary
nucleation, which results in smaller particles according to classical nucleation theory.
Kinetics is directly related to the formation of particles and should be carefully
considered (see for example, Bristow, et al., 2001). Hydrodynamic considerations are
also very important and influence the design of the nozzle. The effects of nozzle
geometry on the final particle properties, which were reported by Thies and Miller, 1998,
Reverchon, et al., 2000, Breitenbach, et al., 2000, and Mawson, et al., 1997, can be
correlated to the hydrodynamic effects.
When a polymer is used as the solute, the SAS process becomes more
complicated because the viscosity of the polymer solution increases considerably as the
mass transfer between SC CO2 and organic solvent proceeds (Dixon and Johnston, 1993).
In addition, CO2 is a small molecule substance and can easily diffuse into polymer
chains. The dissolved or absorbed CO 2 causes a depression of the glass transition
temperature (T g) (Chiou, et al., 1985; Wissinger and Paulaitis, 1991 a, b; Condo, et al.,
1994) and the subsequent plasticization of the polymer will facilitate the agglomeration
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of polymer particles. Therefore an understanding of the correlation between the viscosity
of the polymer solution, the mass transfer rate and a knowledge of the plasticization of
the polymer by compressed CO 2 would be very helpful to better control either polymer
particle formation or particle coating/encapsulation with polymer in the SAS process.

7.1.2 Enhancement of productivity and controllability of the SAS coating process
In this research the SAS coating process was operated in batch mode and in each
experiment only a small amount of sample was collected for performing different
characterizations. However, the SAS process has the potential to be operated in
continuous mode as described by Randolph, et al., 1993. Theoretically, as long as an
equilibrium is established between the inlet and outlet CO2 flow rate, and if the extraction
of organic solvent is fast enough so that the coated particles become solidified before
contacting other coated particles, the spraying of a suspension of host particles in the
coating polymer solution can be continued until the amount of coated particles reaches a
predetermined value in the high pressure chamber. At this point in time the spraying of
the suspension can be switched to another high pressure chamber and the SAS coating
process can be continued. Meanwhile, the first chamber containing the coated particles
can be depressurized for product collection. A multi-nozzle spraying system can also be
considered to increase the throughput of product.
Process control can also be implemented as long as the critical parameters, which
are based on an understanding of the mechanisms of the SAS process, are identified and
found to have a direct influence on the quality of the final product. From the observations
and results reported in this dissertation, parameters such as temperature, pressure, flow
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rate of CO2, flow rate of solution, solution concentration, solvent molar fraction in the
chamber, should all be carefully monitored.

7.2 Recommendation for Future Work for Controlled Drug Release Using SAS
Although the SAS coating process for controlled drug release showed very promising
results, the encapsulation efficiency was low, 22.6 %, at a polymer to drug ratio of 1:1.
This is attributed to the large particle size and irregular shape of drug particles that were
used in the experiments. Smaller particles would have a greater chance to be encapsulated
or entrapped in the polymer microspheres. It is recommended that future research for the
design of a controlled drug release system using SAS should focus on smaller drug
particles (less than 10 gm). Moreover, smaller particles incorporated into polymer
microspheres could make a matrix structure.
In this dissertation, it was found that the PLGA biopolymer used to coat the drug
was a degradation controlled release biopolymer (Gallagher and Corrigan, 2000), in
which the PLGA absorbed water from the medium and underwent hydrolysis. This was a
very slow process. Furthermore, once the coating polymer degrades on a surface with a
very thin film coating, the whole drug particle is eroded right away. This drug release
behavior is undesirable. Therefore, smaller particles entrapped in polymer microspheres
with a matrix structure are desirable to give a better controlled release behavior.
Usually PLGA is used to produce a long-term sustained release, sometimes as
long as 30 days or more. For some drugs it is not necessary to have such a long time
release, normally 1 or 2 days is sufficient. Diffusion controlled polymer release would be
useful for this purpose. These polymers include Eudragit (copolymer of methacrylates
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and acrylates), chitosan (cationic polysaccharide), hydrogels, etc. In terms of selecting
the model drug for research purposes, the drug should have a relative easy assay analysis
method available.
Another research direction should that might be useful in the design of a drug
delivery system using the SAS process is the method of solid dispersion composite
particle fabrication (Moneghini, et al., 2001). When drugs with low solubility are
dispersed in polymer at the molecular level so that the drug is in an amorphous state
instead of having a crystalline structure, the dissolution and bioavailability of the drugs
can be improved. The carrier polymer, such as povidone, cyclodextrin (Chulia, et al.,
1998) and PEG (Moneghini, et al., 2001), is used to stabilize the drug and to improve the
bioavailability. The SAS process appears to be very attractive for a drug delivery system
design for this category of drugs.
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